Radius Residential Care Limited logo

Radius Care Announces First FY Results as a Listed Company

Full Year Results27 May 2021RADHealthcare

Radius Residential Care Limited
Full Year

Results

31 March 2021

Radius Care
2

Importance

Notice and

Disclaimer

ThispresentationhasbeenpreparedbyRadiusResidentialCareLimited(“RadiusCare”),forinformationalpurposes.Thisdisclaimer

appliestothisdocumentandtheverbalorwrittencommentsofanypersonpresentingit.

ThispresentationsetsoutinformationrelatingtoRadiusCare’sfullyearresultfortheperiodto31March2021.Assuch,itshould

bereadinconjunctionwiththeauditedconsolidatedfinancialstatementsforRadiusCareanditssubsidiariesfortheperiodended

31March2021(“FinancialStatements”)andothermaterialthatRadiusCarehasreleasedtoNZXalongwiththispresentation.That

materialisalsoavailableatwww.radiuscare.co.nz.

Incertainsectionsofthispresentation,RadiusCare haschosentopresentcertain financialinformationexclusiveofthe impactof

significantitems.Anumberofnon-GAAPfinancialmeasuresareusedinthispresentationwhichareusedbymanagementtoassess

the performance of the business and have been derived from the Financial Statements. You should not consider any of these

financialmeasuresinisolationfrom,orasasubstitutefortheinformationprovidedintheFinancialStatements.

Thispresentationmaycontainforward-lookingstatementsandprojections.Suchforward-lookingstatementsarebasedoncurrent

expectations,estimatesandassumptionsandaresubjecttoanumberofrisksanduncertainties,includingmaterialadverseevents,

significant one-off expenses and other unforeseeable circumstances. There is no assurance that results contemplated in any of

theseprojectionsandforward-lookingstatementswillberealised.Actualresultsmaydiffermateriallyfromthoseprojected.Except

as required by law, or the NZX Listing Rules, no person is under any obligation to update this presentation at any time after its

releaseortoprovidefurtherinformationaboutRadiusCare.

TheinformationinthispresentationhasbeenpreparedingoodfaithbyRadiusCare.NeitherRadiusCarenoranyofitsdirectors,

employees, shareholders nor any other person given any representations or warranties (either express or implied) as to the

accuracy or completeness of the information in this presentation and to the maximum extent permitted by law, no such person

shall have any liability whatsoever to any person for any loss (including, without limitation, arising from any fault or negligence)

arisingfromthispresentationoranyinformationsuppliedinconnectionwithit.

Thispresentationisnotaproductdisclosurestatementorotherdisclosuredocument,oranofferofsharesforsubscription,orsale,

inanyjurisdiction.Theinformationinthispresentationdoesnotconstitutefinancialproduct,legal,financial,investment,taxorany

otheradviceorarecommendation.

Radius Care
3

Radius Care
4

Presenting Today

Brien Cree

Executive Chairman / Managing Director

•Founded Radius Care in 2003, then part of

Radius Health Group

•Moved into Executive Chairman role in

June 2020 focusing on growth

opportunities through development and

acquisition

•Majority shareholder since undertaking

management buy out in 2010 and currently

holds 54.0% through Wave Rider Trust

•Board member of the New Zealand Aged

Care Association for more than 10 years

•Over 30 years’ experience in the Aged Care

sector

Stuart Bilbrough

Chief Executive Officer

•Appointed Chief Executive Officer in

June 2020

•Formerly Radius Care Chief Financial

Officer from 2010 to 2017

•Over 30 years’ experience in finance

roles in industries including

healthcare, FMCG, logistics, telecoms

and financial services

•New Zealand Chartered Accountant

and holds an MBA with distinction

from Massey University.

•Joined Radius Care in 2016

•Has nearly 25 years’ experience in

finance roles in various

•Industries worked in include

healthcare and financial services

•Michelle trained with

PricewaterhouseCoopers in South

Africa

•She is a New Zealand Chartered

Accountant.

Michelle Slabber

General Manager, Finance

Radius Care
5

Radius Care

at a Glance

HIGH ACUITY AND

SPECIALIST AGED

CARE PROVIDER

Radius Care operates 22 aged

care facilities nationally,

comprising more than 1,700

aged care beds.

We own three of these facilities

and lease 19 from 3rd party

property investors.

We also own two retirement

villages comprising of 76 units.

Radius Care OwnedLeased from 3

rd

Parties*

Total

Existing Portfolio

Sites51924

Aged Care Beds1781,5371,715

Retirement Village Units

1

76-76

Total Places2541,5371,791

Existing Facility - Landbank

Aged Care Beds4460104

Retirement Village Units202040

Belfast, Christchurch194-194

Total Existing + Landbank5121,6172,129

* All leases are triple net lease and long term in nature -with an average term to next renewal of 9.1 years but 27.7 years after

accounting for all renewals.

Portfolio summary as at 31 March 2021Portfolio summary as at 31 March 2021

Radius Care

announced on 7 April

2021 the exercise of

its option to acquire

4.3 hectares of

development land in

Christchurch

Note: As part of its December 2020 listing Radius Care prepared:

•A Listing Profile (which contains similar information to a Product Disclosure Statement) providing an overview of the business, the industry, risks and financial performance.

•Supplementary Financial Information providing more granular financial and operational information.

This information is contained on the Radius Care website https://www.radiuscare.co.nz/investors-centre/listing-documents

Radius Care
6

4.2% 95.8%

UnitsCare Beds

Radius Care

at a Glance

National aged care focused portfolio with strong regional presenceNational aged care focused portfolio with strong regional presence

Residents and EmployeesResidents and Employees

1,500+

employees

1,700+

beds

Denotes leasehold sitesDenotes freehold sites

A U C K L A N D

Sites Beds ILUs Total

Leased 3 248 -248

W A I K A T O

Sites Beds ILUs Total

Leased 4 334-334

Owned 1-2222

N E W P L Y M O U T H

Sites Beds ILUs Total

Leased 155-55

Owned 163-63

N O R T H L A N D

Sites Beds ILUs Total

Leased 3 155 -155

B A Y O F P L E N T Y

Sites Beds ILUs Total

Leased 2 266 -266

Owned 163-63

N A P I E R

Sites Beds ILUs Total

Leased 145-45

PALMERSTON NORTH

Sites Beds ILUs Total

Leased 162-62

CANTERBURY

Sites Beds ILUs Total

Leased 3 279 -279

Owned 252 54106

Units vs Care BedsUnits vs Care Beds

OTAGO

Sites Beds ILUs Total

Leased

193-93

Radius Care
7

Agenda

Appendix

— Key operational and

financial metrics

— Summary P&L, Balance

Sheet, Cash Flow

44

Overview

of FY21 financial

performance

First year as a listed

company

22

Analysis of result

Continuation of strong track

record

33

Positioning Radius Care

for Growth phase,

strategy update and

FY22 guidance

11

Radius Care
8

Overview of

FY21 Financial

Performance

FIRST YEAR AS A LISTED

COMPANY

Radius Care
9

FY21 Highlights

and Key Events

FY21 Guidance provided at

the time of listing met or

exceeded across all metrics.

Progress on Strategy

- Option exercised to purchase 4.3 hectares of Greenfield

Development land in Belfast, Christchurch post balance date

1

- Increases Greenfield Development pipeline by 70 Care Beds,

30 Care Suites and 94 Retirement Village Units

- Work progressing on final design, building consents and

construction discussions

- Multi-stage development approach provides funding

flexibility

Progress on Strategy

- Option exercised to purchase 4.3 hectares of Greenfield

Development land in Belfast, Christchurch post balance date

1

- Increases Greenfield Development pipeline by 70 Care Beds,

30 Care Suites and 94 Retirement Village Units

- Work progressing on final design, building consents and

construction discussions

- Multi-stage development approach provides funding

flexibility

Financial Performance

- Record result -all guidance metrics met or exceeded

- Underlying EBITDA up 28% to $23.4m (vs. guidance of $23.0m

to $23.8m)

- Underlying EBITDA per bed up 13% to $19.5k

- Continued strong occupancy, private accommodation

supplements and cost control

Financial Performance

- Record result -all guidance metrics met or exceeded

- Underlying EBITDA up 28% to $23.4m (vs. guidance of $23.0m

to $23.8m)

- Underlying EBITDA per bed up 13% to $19.5k

- Continued strong occupancy, private accommodation

supplements and cost control

1

See NZX release dated 7 April 2021

Radius Care
10

Enhanced management

and governance for listing

- Brien Cree transitioned in

Executive Chairman role focused

on growth opportunities through

development and acquisition

- Stuart Bilbrough returned as CEO

- Hamish Stevens and Mary

Gardiner appointed as

independent directors

- Direct listing undertaken on 10

December 2020

Enhanced management

and governance for listing

- Brien Cree transitioned in

Executive Chairman role focused

on growth opportunities through

development and acquisition

- Stuart Bilbrough returned as CEO

- Hamish Stevens and Mary

Gardiner appointed as

independent directors

- Direct listing undertaken on 10

December 2020

COVID-19 resilience

- Processes and procedures

introduced in mid-2000s for

Bird Flu performed well

through COVID-19 period

- Locked down facilities early

with industry following

- No COVID-19 cases amongst

residents or staff

1

COVID-19 resilience

- Processes and procedures

introduced in mid-2000s for

Bird Flu performed well

through COVID-19 period

- Locked down facilities early

with industry following

- No COVID-19 cases amongst

residents or staff

1

Balance Sheet Position

- Net debt of $24.5m down $4.7m

from pcp (31 March 20)

- Lease liabilities of $184.3m down

from $185.3m for pcp

Balance Sheet Position

- Net debt of $24.5m down $4.7m

from pcp (31 March 20)

- Lease liabilities of $184.3m down

from $185.3m for pcp

Balance Sheet Position

- Net debt of $24.5m down $4.7m

from pcp (31 March 20)

- Lease liabilities of $184.3m down

from $185.3m for pcp

FY21 highlights

and key events

FY21 Guidance provided at

the time of listing met or

exceeded across all metrics.

1

As at the date of this presentation

Radius Care
11

7.7

8.0

5.8

10.5

0.0

2.0

4.0

6.0

8.0

10.0

12.0

$m

FY18 FY19 FY20 FY21

Financial performance overview

FY21 Underlying EBITDA and Pre-NZ IFRS 16 Underlying EBITDA within Guidance range provided at time of listing

Pre-NZ IFRS 16 Underlying EBITDA

- FY21 Pre-NZ IFRS 16 Underlying EBITDA

of $10.5m up 82%

FY21 guidance range $10.2m –11.0m

Underlying EBITDA

- FY21 Underlying EBITDA of $23.4m up

28%

FY21 guidance range $23.0 -$23.8m

FY21 Guidance achievedFY21 Guidance achieved

19.7

20.4

18.2

23.4

0.0

5.0

10.0

15.0

20.0

25.0

$m

FY19FY18FY20

FY21

Total Revenue

- FY21 Revenue of $126m up 11%

$m

100.2

110.1

113.7

126.0

0.0

20.0

40.0

60.0

80.0

100.0

120.0

140.0

FY19

FY20 FY21FY18

Radius Care
12

Cash Flow and Dividends

AFFO

- FY21 AFFO of $3.7m

- Outperformance partly due to lower maintenance capex

Achieved AFFO in excess of FY21 Guidance

Dividends

FY21 Final Dividend

- Gross fully imputed FY21 final dividend declared of

0.89 cents per share (which includes 0.25 cents per

share of attaching imputation credits)

- Ex Dividend date Friday 11 June 2021

- Record date Monday 14 June 2021

- Payment date Monday 21 June 2021

FY21 Total Dividends

- Including February dividend of 0.58 cents per share

gives a total gross dividend in relation to the FY21

financial year of 1.46 cents per share (which includes

attaching imputation credits of 0.41cents per share)

- The total FY21 cash dividend of 1.05 cents per share is

above the FY21 cash dividend guidance of 0.83 to 1.00

cents per share

FY21 Guidance exceeded

FY21 guidance range $2.9m to $3.5m

1.3

2.0

(0.5)

3.7

(1.0)

0.0

1.0

2.0

3.0

4.0

$m

FY18 FY19 FY20 FY21

Radius Care’s dividend policy is target to pay 50% to 70% of AFFO

Radius Care
13

Summary of Key Drivers of FY21 Financial Performance

Strong growth in Underlying EBITDA driven primary by (1) improving care occupancy (2) increasing

accommodation supplements (3) cost control containment and (4) contributions from new developments

Aged Care: $4.3m

-Bureau: $1.6 million improvement

through strong cost control focus

-Brownfield and Greenfield

Developments contribution: $0.8

million from Windsor Court

Brownfield development ($0.6m)

and Glaisdale (Hamilton)

Greenfield development ($0.2m)

-Other aged care: $1.9 million.

Primarily driven by the increase in

occupancy $0.7m,

accommodation supplements

$0.7m and other $0.4m

Retirement Village: $0.7m

- Compounding impact of DMF and

additional unit sales

Group Support: $0.2m

- Reduced travel as a result of

COVID-19 disruptions

$1.6

$0.8

$0.7

$0.7

$0.4

$0.4

$0.4

$0.2

$(0.1)

$18.2

$23.4

17.0

19.0

21.0

23.0

25.0

FY20 Underlying

EBITDA

Bureau costs Brownfield &

Greenfield

Developments

Occupancy Accommodation

supplements

Other aged care

operations

DMF and weekly

service fees

Realised Gains on

Resales and

Development

Margin

Other village

operations

Support office

expenses

FY21 Underlying

EBITDA

NZ$m

Aged care

Retirementvillage

Group

support

Radius Care
14

Analysis of result

CONTINUATION OF STRONG

TRACK RECORD

Radius Care
15

Strong revenue growth continues with an increasing proportion from direct private (non-Government) revenue streams

Revenue Growth and Diversification

65.4

70.3

70.0

76.1

87.0

100.2

110.1

113.7

126.0

0.0

20.0

40.0

60.0

80.0

100.0

120.0

140.0

FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Total revenueAged careRetirement villageGroup support

End of Financial

period

FY13FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

No. of Beds

1,3071,382 1,371 1,379 1,525 1,682 1,701 1,704 1,715

No. of Units

222222 36 48 55 63 73 76

Total revenue Total revenue Direct private (non-Government) revenue

1

Direct private (non-Government) revenue

1

1

Includes accommodation supplements, retirement village units, Radius Online Shop and other privately paid revenues

2.2

3.0

3.0

4.5

6.2

7.1

10.1

9.2

13.8

3.4%

11.0%

0.0%

2.5%

5.0%

7.5%

10.0%

12.5%

0.0

2.5

5.0

7.5

10.0

12.5

15.0

FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Proportion of total revenue (%)

Direct Private Revenue (NZ$m)

Direct private revenue (LHS)

Direct private proportion of total revenue (RHS)

Radius Care
16

Bed Mix Oriented to High Acuity and Specialist Care

Over FY21, beds certified for high acuity and specialist care have increased from 82% to 86% of the portfolio. Radius Care

continues to provide more care offerings and in particular more specialist care offerings per facility than peers.

Care Beds by use and typeCare Beds by use and type

1 Source: CBRE analysis, September 2020

2 Source: Ministry of Health audit reports as disclosed on Ministry of Health website –https://www.health.govt.nz/your-health/certified-providers/aged-care/based on data as at 4 May 2021

3 Dementia and Specialist offerings include Dementia, Psychogeriatric, Physical and Intellectual but does not include Rest Home or Hospital –Geriatric or Hospital –Medical care. Average based on simple average of all certified facilities

3.9

3.2

3.2

3.0

3.6

Radius Oceania Arvida Summerset Ryman

0.9

0.5

0.5

0.2

0.8

Radius Oceania Arvida Summerset Ryman

Total and specialist offerings

2

Total and specialist offerings

2

Total offerings aged care

(per Aged Care facility)

Dementia and Specialist offerings

3

(per Aged Care facility)

Care bed

type

Care bed

use

47.1%38.1%11.1%3.6%

Industry

average

1

17.9%

14.4%

34.1%

41.4%

30.3%

26.5%

10.3%

11.1%

6.6%

5.7%

0.8%

0.9%

FY20

FY21

85.6% high acuity and specialist

52.9% high acuity and specialist

34.4%

32.8%

47.9%

49.6%

10.2%

10.8%

6.3%

5.8%

1.2%

1.0%

FY20

FY21

Rest homeSwingHospitalDementiaPsychogeriatricPhysical and intellectual

65.6% high acuity and specialist

67.2% high acuity and specialist

82.1% high acuity and specialist

Radius Care
17

Strong Occupancy Growth

1.

Aging New Zealand population

1

1.

Aging New Zealand population

1

Growing Occupancy v.s. industry

3

Growing Occupancy v.s. industry

3

3. Increasing years in dependency3. Increasing years in dependency

•Life expectancy is increasing but more years are being spent in dependency

90.1%

89.2%

89.1%

90.4%

90.9%

91.3%

91.0%

92.1%

93.0%

93.7%

93.4% as

at 31

March

2021

87.2%

87.2%

86.9%

86.5%

86.9%

87.0%

86.8%

87.6%

87.9%

87.8%

85.0%

86.0%

87.0%

88.0%

89.0%

90.0%

91.0%

92.0%

93.0%

94.0%

95.0%

Jun-19 Sep-19 Dec-19 Mar-20 Jun-20 Sep-20 Dec-20 Mar-21

Occupancy rate %

Radius Care (monthly)Industry average (quarterly)

0.0%

2.0%

4.0%

6.0%

8.0%

Jan-03 Jan-08 Jan-13 Jan-18 Jan-23 Jan-28 Jan-33 Jan-38 Jan-43 Jan-48 Jan-53 Jan-58

Rolling 5-year pop. CAGR

(%)

65 - 85 5-yr CAGR85+ 5-yr CAGR

Aged care demand peak growth

from 2023 -2043

Occupancy growth underpinned by supportive industry backdrop of (1) aging population (2) increasing bed demand

particularly for high acuity and specialist care and (3) rising years in spent in dependency

Increasing number of high occupancy facilitiesIncreasing number of high occupancy facilities

88

7

11

9

3

7

7

5

4

2

5

6

4

2

0

5

10

15

20

25

FY18FY19FY20FY21

Number of Facilities

95.0% to 100%90.0% to 94.9%85.0% to 89.9%<85%

1 Source: Statistics New Zealand

2 Source: EY Aged Residential Care Funding Model Review analysis using ARC model, August 2019. Historical information based on actual demand data per the ARC demand model which EY have extended using the past 5 year trend over the projection period

3 Source: Industry Information based on NZACA Occupancy –TAS Aged Residential Care Quarterly Reporting Survey as at 31 December2020. Includes ORA ARRC-certified beds and residents

2. Increasing high acuity bed demand

2

2. Increasing high acuity bed demand

2

-

2,000

4,000

6,000

8,000

20062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028202920302031

ActualProjection

Bed days (000s of days)

DementiaHospitalPsychogeriatricResthome

Radius Care
18

Growing Underlying EBITDA per Care Bed

Underlying EBITDA per Care Bed ($000)

Strong Occupancy

(see previous page)

Increasing Underlying EBITDA per care bed

1

Increasing Underlying EBITDA per care bed

1

Growing accommodation supplementsGrowing accommodation supplements

Strong wage controlStrong wage control

18.3

17.9

17.2

19.5

0.0

5.0

10.0

15.0

20.0

FY18FY19FY20FY21

51.9

57.6

62.8

64.4

52.9%

54.1%

56.1%

53.9%

0.0%

10.0%

20.0%

30.0%

40.0%

50.0%

60.0%

0.0

10.0

20.0

30.0

40.0

50.0

60.0

70.0

FY18FY19FY20FY21

$m

Direct Employee Costs% of Direct Revenue

$3.03

$4.07

$4.92

$5.61

$1,819

$2,400

$2,902

$3,300

0

500

1,000

1,500

2,000

2,500

3,000

3,500

0.0

1.0

2.0

3.0

4.0

5.0

6.0

FY18FY19FY20FY21Accommodation supplement per

Care Bed NZ$

Accommodation supplements

NZ$m

Accommodation supplements (LHS)Accommodation supplements per available Care Bed (RHS)

1 Underlying EBITDA for aged care segment divided by the average number of care beds occupied during the period

Radius Care
19

Positioning Radius

Care for Growth

Phase, Strategy

Update and FY22

Guidance

Radius Care
20

Senior management and board strengthened

and sized for next phase of growth.

Positioning

Radius Care for

Growth Phase

- Brien Cree transitioned to Executive Chairman role

focused on growth opportunities through

development and acquisition

- Stuart Bilbrough returned as CEO (previously CFO

from 2010 to 2017)

- Hamish Stevens and Mary Gardiner appointed as

independent directors

- Employee turnover reduced vs. FY20

- A focus on employees continuing professional

development and ongoing property investments

that enhances accommodation supplement

revenue is a focus for the coming year

Radius Care
21

GO FORWARD STATERGYHISTORICAL TRACK RECORDCURRENT STATUS

1. Brownfield development

•Windsor Court (FY18) –15 Care Beds

•Waipuna (FY17) –28 Care Beds

•Elloughton Gardens (FY17) –27 Care Beds

Brownfield potential identified at owned sites at:

- Lexham Park (Katikati)

- Thornleigh (New Plymouth)

Detailed feasibility studies underway

2. Purchase of strategically

important facilities already

operated by Radius

•Lexham Park (FY20) –63 Care Beds

•Thornleigh Park (FY14) –63 Care Beds

•St Helenas (FY14) –52 Care Beds

Continuing work to identify strategically important facilities

3. Greenfield development

Greenfield Development on owned facilities undertaken and funded by

Radius Care:

•Elloughton Grange Village (FY21) –54 Units

Greenfield Development on leased facilities undertaken with and funded

by landlords:

•Glaisdale (FY18) –80 Care Beds

•Millstream (FY18) –80 Care Beds

Purchase of Belfast, Christchurch Greenfield development land

•As announced in April 2021, Radius Care has exercised its right

to acquire c. 4.3 hectares of land

•Settlement of the land ($5.5m) is expected to take place

between December 2021 and March 2022

•Work progressing on final design, building consents and

construction discussions

•Multi-stage programprovides funding flexibility

4. Opportunistic value accretive

acquisition

•Acquired the operations of 26 aged care facilities and retirement

villages comprising 1,998 Residences since 2003

•Continuing to seek and evaluate potential acquisition

opportunities

Strategy Update

Focus continues on the execution of Radius Care’s growth strategy, with the exercise of Radius Care’s option to acquire the

4.3 hectare Belfast, Christchurch site being a key milestone since Listing


-

Execution of strategy

-


Growth Strategy as outlined in the Listing Profile

Radius Care
22

Radius Care
23

Aged Care

•Average occupancy expected to increase further in FY22 given current run

rate

•Continued accommodation supplements growth in FY22 expected

•Additional funding from the Government as part of the Equal Pay claim

for Health Care Assistants

•Operating costs will increase with staffing wage growth but wages to

revenue expected to remain stable

•Conversion of Dementia rooms at Arran Court

Retirement village

•Sale of final 4 units at Elloughton Grange Village expected

•Resale of 5 units expected

Guidance for the

12 months to 31 March 2022

demonstrates expected

continued earnings uplift.

FY22 Outlook

and Guidance

Guidance

FY21Listing Profile FY21FY22

Actual ($m) Guidance($m) Guidance ($m)

Underlying EBITDA 23.423.0 -23.823.5 –25.5

Pre-NZ IFRS 16Underlying

EBITDA

10.510.2 -11.010.5 –12.5

AFFO3.72.9 -3.53.7 –4.7

Radius Care
24

Radius Care provides unique exposure to a high acuity, specialised care provider that remains committed to and

focused on delivering compassionate and outstanding clinical care outcomes

1. Demand

2. Portfolio

3.

Systematic

Approach

4. Growing

Non-

Government

Revenues

5. Growth

Pathway

6. Strong

Founder

Backed

Team

KeyInvestmentHighlights

0.0%

2.0%

4.0%

6.0%

8.0%

2003 2008 2013 2018 2023 2028 2033 2038 2043 2048 2053 2058

Rolling 5-year pop. CAGR (%)

65 - 85 5-yr CAGR85+ 5-yr CAGR

1

Demand underpinned by population demographics

1

3.9

3.2 3.2

3.0

3.6

Radius Oceania Arvida Summerset Ryman

2

Portfolio oriented to high acuity and specialist care

2

Systematic approach to provision of care

1) Centralised head-office systems and support

2) Leading IT systems

3) Immigration accreditation

4) Early engagement through Radius Online Shop

3

3.4%

11.0%

0.0%

2.0%

4.0%

6.0%

8.0%

10.0%

12.0%

FY13FY14FY15FY16FY17FY18FY19FY20FY21

Direct private portion

of total revenue (%)

Growing direct non-Government revenues

4

5

Clear growth pathway via

1) Purchase of strategically important

facilities’ land and buildings

2) Brownfield and greenfield development

with ownership of land and buildings

3) Opportunistic acquisitions

Strong founder backed team

Brien Cree

Founder and Executive Chairman

Stuart Bilbrough

Chief Executive Officer

6

1 Source: Statistics New Zealand

2 Source: Ministry of Health audit reports as disclosed on Ministry of Health website –https://www.health.govt.nz/your-health/certified-providers/aged-care/based on data as at 4 May 2021

3 Includes accommodation supplements, retirement village units, Radius Online Shop and other privately paid revenues

Radius Care
25

Appendix

Radius Care
26

Financial periodFY18 FY19 FY20 FY21

$m

Aged Care

27.2 27.2 26.3 30.6

Retirement Village

0.3 0.80.81.4

Group support

(7.8) (7.6) (8.9) (8.7)

Underlying EBITDA

19.7 20.4 18.2 23.4

Key operational and financial metrics

Financial periodFY18FY19FY20FY21

Number of Care Beds (period end)

1

1,682 1,701 1,704 1,715

Average Care Bed Occupancy

2

89.1% 89.5%90.092.4%

Underlying EBITDA per Care Bed

3

(000s)$18.3 $17.9 $17.2 $19.5

Number of Units (period end)

4

55637376

Number of new Unit sales 91186

Number of existing Unit resales23-7

Realised gains on resales (m)$0.2$0.1-$0.5

Realiseddevelopment margins (m)$0.2$0.5$0.4$0.3

Cash DMF realised uponresale (000s)$67$66-$525

Average resale price (000s)$323$355-$407

Average new unit saleprice (000s)$395$377$403$408

Operating metricsOperating metrics

1 Comprises Care Beds occupied, available to be occupied or unavailable due to refurbishment

2 Total occupied Care Bed days divided by total Care Bed days available during the period

3 Underlying EBITDA for aged care (as set out in the lower right table) divided by the average number of Care Beds occupied during the period

4 Comprises Units occupied, available to be occupied or unavailable due to refurbishment

Financial periodFY18 FY19 FY20 FY21

Accommodation Supplements Revenue

$3.0m $4.1m $4.9m $5.6m

Number of Care Beds

1,682 1,701 1,704 1,715

Number of Available Care Beds with Accommodation Supplements

1,005 1,134 1,138 1,146

Percentage of Care Beds with Accommodation Supplements

59.8% 66.7% 66.8% 66.8%

Accommodation supplementsAccommodation supplements

Financial periodFY18 FY19 FY20 FY21

$m

Aged Care

98.8 107.3 112.6 120.3

Retirement Village

1.3 2.30.54.4

Group support

0.1 0.50.61.3

Total revenue

100.2 110.1 113.7 126.0

Revenue by segmentRevenue by segment

DMF terms for Retirement Village unitsDMF terms for Retirement Village units

•30% over three years

•FY20 –21 average resident tenure: 4 years

Underlying EBITDA by segmentUnderlying EBITDA by segment

Corporate function growth from FY19 to FY20 and FY21 reflects strengthening of senior management and board for

next phase of growth.

Radius Care
27

Underlying EBITDA to AFFO Reconciliation

($m)FY18 FY19 FY20 FY21

Underlying EBITDA19.720.418.223.4

Include: Pre-NZ IFRS 16 operating rental lease expense(12.0) (12.4) (12.4) (12.9)

Pre-NZ IFRS 16 Underlying EBITDA7.78.05.810.5

Include: Depreciation and amortisation (Pre-NZ IFRS 16)(3.0)(3.6)(3.7)(4.3)

Include: Net interest expense (Pre-NZ IFRS 16)(0.6)(0.9)(1.2)(0.8)

Include: Current tax expense(0.9)(0.7)(1.0)(2.1)

Include: Income tax impact from Pro forma adjustments0.20.20.3(0.3)

Pre-NZ IFRS 16 Underlying NPAT3.43.00.23.0

Remove: Depreciation and amortisation (excl. NZ IFRS 16

related)

3.03.63.74.2

Include: Maintenance capital expenditure(5.1)(4.6)(4.4)(3.5)

AFFO1.32.0 (0.5)

1

3.7

AFFO outperformance in part due to maintenance capex below historical levels

Refer to Note 2.1 in the 31 March 2021 Annual Report for reconciliation of Underlying profit to Reported net profit after tax–see Appendix attached

1

The +$4.2m change in AFFO in FY2021 is calculated on AFFO for FY2020 of $(0.5)m, which has been revised from the FY2020 AFFO of $0.8m shown in the 10 December 2020 NZX Listing Profile due to a reclassification of the deferred tax on

the FY2020 revaluation of the three owned properties. The impact of this reclassification was an increase of $1.339m in FY2020 current tax and a corresponding decrease of $1.339m in FY2020 deferred tax. There is no impact on AFFO in

any other period and there is no impact going forward.

Capex

maintenance

guidance is

$4.0m

Radius Care
28

Statement of Comprehensive Income

($000)FY20FY21

Revenue

Revenue from contracts with customers113,359121,217

Deferred management fees6711,081

Total revenue114,030122,298

Fair value movement of investment properties(649)2,879

Government subsidy received353794

Interest income4971

Total revenue and other income113,783126,042

Expenses

Employee costs(70,852)(74,457)

Depreciation expense(10,911)(11,552)

Finance costs(10,583)(9,706)

Other expenses(24,770)(28,298)

Total expenses(117,116)(124,013)

Profit / (loss) before income tax(3,333)2,029

Income tax (expense) / benefit 500(324)

Profit / (loss) for the year(2,833)1,705

Other comprehensive income

Items that will not be reclassified subsequently to profit and loss

Revaluation of property, plant and equipment, net of tax5,7081,104

Other comprehensive income for the year5,7081,104

Total comprehensive income 2,8752,809

Radius Care
29

Statement of Financial Position

($000)FY20FY21

Assets

Cash and cash equivalents2,3172,761

Trade and other receivables7,6487,744

Inventories308548

Property, plant and equipment32,30332,896

Right-of-use assets181,431177,170

Investment properties27,83131,675

Deferred tax assets2,0063,635

Intangible assets16,99616,996

Total assets270,840273,425

Liabilities

Trade and other payables14,08614,911

Current tax liabilities7231,135

Borrowings31,42727,212

Deferred management fee9621,178

Refundable occupation right agreements17,51820,591

Lease liabilities185,304184,305

Total liabilities250,020249,332

Net assets20,82024,093

Equity

Share capital4,7365,932

Asset revaluation5,7086,812

Retained earnings10,37611,349

Total equity20,82024,093

Radius Care
30

Statement of Cash flows

($000)FY20FY21

Cash flow from operating activities

Receipts from residents for care fees and village fees113,282122,337

Receipts of government subsidy-1,210

Payments to suppliers and employees(95,436)(101,724)

Proceeds from the sale of Refundable occupation right agreements3,7053,927

Payments for the repurchase of Refundable occupation right agreements-(464)

Interest received4971

Interest paid –borrowings(1,183)(883)

Interest paid –lease liabilities(9,400)(8,823)

Income tax paid (814)(1,744)

Net cash provided by operating activities10,20313,907

Cash flow from investing activities

Proceeds from the sale of property, plant and equipment11454

Payments for the purchase of plant and equipment(11,305)(3,577)

Payments for village developments(3,723)(965)

Net cash used in investing activities(14,914)(4,488)

Cash flows from financing activities

Proceeds from bank borrowings15,120-

Repayments of bank borrowings4,038(4,215)

Repayments of shareholder loans(5,030)-

Principal repayment of lease liabilities(3,035)(4,028)

Dividends paid(225)(732)

Net cash (used in) / provided by financing activities2,792(8,975)

Reconciliation of cash and cash equivalents

Cash and cash equivalents at beginning of the year4,2362,317

Net increase / (decrease) in cash held(1,919)444

Cash and cash equivalents at end of year2,3172,761

Radius Care
31

Reconciliation of NZ GAAP financial measures to non-GAAP financial measures

($000)FY20FY21

Profit/(loss)for the year(2,833)1,705

Adjustments

Non-recurring or infrequent items

Remove: COVID-19 related expenses34653

Remove: Government COVID-19 Subsidy(353)(857)

Remove: One-off listing costs-1,227

Remove: Share based payments-1,464

Structural changes and other

Include: Listed & other company costs(1,084)(714)

Remove: Historical governance costs350417

Include: Income tax impact from adjustments295(270)

Underlying adjustments

Remove: Change in fair value of investment properties649(2,879)

Include: Realised development margins512343

Include: Realised gains on resales-480

Remove: Deferred tax expense(1,533)(1,831)

Underlying Net profit before tax(3,963)(262)

Remove: Depreciation10,91111,552

Remove: Net interest expense10,5349,636

Remove: Current tax expense1,0332,155

Remove: Income tax impact from adjustments(295)270

Underlying EBITDA18,22023,351

Include: Pre-NZ IFRS 16 operating lease expense(12,435)(12,850)

Pre-NZ IFRS 16 Underlying EBITDA5,78510,501

Include: Depreciation (Pre-NZ IFRS 16)(3,700)(4,262)

Include: Net interest expense (Pre-NZ IFRS 16)(1,134)(812)

Include: Current tax expense(1,033)(2,155)

Include: Income tax impact from adjustments295(270)

Pre-NZ IFRS 16 Underlying Net profit after tax2133,002

Remove: Depreciation (excl. NZ IFRS 16 related)3,7004,262

Include: Maintenance capital expenditure(4,400)(3,543)

AFFO(487)3,721

Radius Care
32

$0.1

$0.1

$(0.8)

$(0.2)

$(0.1)

$(0.6)

$(0.7)

$20.4

$18.2

17.0

19.0

21.0

FY19 Pro forma

Underlying EBITDA

Brownfield &

Greenfield

Developments

Bureau Other aged care

operations

DMF and weekly

service fees

Realised Gains on

Resales and

Development

Margin

Support office

personnel costs

Support office

other expenses

FY20 Pro forma

Underlying EBITDA

NZ$m

Aged careRetirement villageGroup support

Historical Pro forma Underlying EBITDA –FY19 to FY20

Note: Extract from the NZX Listing Profile of 10 December 2020

Radius Care
33

Leased facilityLocationCare Beds Units Current lease term Time to next renewal Rights of renewal Time to final expiry Landlord

HeatherleaNew Plymouth55-12 yrs5 yrs3 x 12 yrs41.1 yrsA

Taupaki GablesKumeu60-12 yrs5 yrs3 x 12 yrs41.1 yrsA

Windsor CourtOhaupo76-12 yrs5 yrs3 x 12 yrs41.1 yrsA

Elloughton GardensTimaru86-12 yrs5 yrs3 x 12 yrs41.1 yrsA

KensingtonHamilton96-10 yrs3.2 yrs2 x 10 yrs13.2 yrsB

PeppertreePalmerston North62-10 yrs3.7 yrs2 x 10 yrs13.7 yrsB

St JoansHamilton82-10 yrs4.1 yrs2 x 10 yrs14.1 yrsB

Fulton HomeDunedin93-10 yrs4.6 yrs2 x 10 yrs14.6 yrsB

Arran CourtAuckland102-10 yrs8.3 yrs1 x 10 yrs18.3 yrsB

Potter HomeWhangarei55-20 yrs8.6 yrs2x 15 yrs38.6 yrsC

Rimu ParkWhangarei55-20 yrs8.6 yrs2x 15 yrs38.6 yrsC

WaipunaAuckland86-30 yrs25.9 yrs-25.9 yrsD

Hampton CourtNapier45-10 yrs7.9 yrs-7.9 yrsE

BaycareNorthland45-12 yrs5 yrs3x 12 yrs41.1 yrsF

MatuaTauranga149-30 yrs21.7 yrs-21.7 yrsG

AlthorpTauranga117-15 yrs7.5 yrs3x 10 yrs37.5 yrsH

MillstreamAshburton80-35 yrs30.3 yrs-30.3 yrsI

Millstream ApartmentsAshburton19-5 yrs3.5 yrs2x 5 yrs13.5 yrsI

GlaisdaleHamilton80-15 yrs11.2 yrs2x 15 yrs41.2 yrsJ

HawthorneChristchurch94-10 yrs9.1 yrs2x 10 yrs19.1 yrsK

Total leased1537-n/an/an/an/a

Simple average leased77-15 yrs9.1 yrsn/a27.7 yrs

Owned facility/village

St HelenasChristchurch52-n/an/an/an/an/a

Thornleigh ParkNew Plymouth63-n/an/an/an/an/a

Lexham ParkKatikati63-n/an/an/an/an/a

Windsor Court VillageOhaupo-22n/an/an/an/an/a

Elloughton Grange Village Timaru-54n/an/an/an/an/a

Total owned17876

Total171576

Directory of facilities

Radius Care
34

---

Annual Report
2021

RADIUS RESIDENTIAL

CARE LIMITED

Welcome
We operate 22 aged care facilities across the country with more than

1,700 care beds. We own three of these facilities and lease 19. Radius

Care also owns and operates two retirement villages comprising 76

units. Our core aged care offering is focused on the high acuity and

specialist care segment of the market - being hospital, dementia,

psychogeriatric, physical and intellectual care. In addition, Radius Care

also provides lower acuity rest home level care and as such covers the

full continuum of care across the aged care segment.

Radius Care listed on NZX on 10 December 2020. Whether you were

one of our investors who was a shareholder at that time or have

joined us since, we warmly welcome you. Thank you for putting your

trust in us and joining our journey. Radius Care is focused on offering

exceptional quality services to our residents. By doing this we will

create sustainable long-term value based on a focused strategy and

supported by strong governance.

This is our first Annual Report as an NZX listed company. We have set

out in this report an overview of the key drivers of the Radius Care

business. Updating you on the financial and operational performance

and outlook, you’ll be well placed to assess our performance and our

future.

Radius Residential Care Limited is a specialist health and

aged care provider for elderly and disabled New Zealanders.

We are a New Zealand owned and operated company

committed to providing high-quality clinical care outcomes

for people who require help in their daily lives.

Annual Report 2021
1

This report covers the financial year ended 31 March 2021 and is dated 28 May 2021. The report

has been approved by the Board and is signed on behalf of Radius Residential Care Limited by

Brien Cree, Executive Chairman and Hamish Stevens, Director.

Brien Cree Hamish Stevens

A Day at a Radius Care Facility 2

2021 Highlights and Key Events 4

Our Values 5

Operating and Financial Highlights 6

Executive Chairman’s Letter 8

Interview with the Executive Chairman 12

Chief Executive’s Report 14

Case study: Florence Kiosk 20

Case study: Vaccine Rollout 21

Case study: Caring is Our Calling 22

Directors and Senior Management 23

Consolidated Financial Statements 27

Corporate Governance Statement 74

Other Disclosures 86

Shareholder Information 91

Directory 94

Contents

Radius Residential Care Limited
2

A day

at a Radius

Care facility

Radius Care’s daily activity programmes use a range of

touchpoints to support, challenge and enhance residents’

psychological, spiritual, social, emotional and physical

wellbeing. Sensory enrichment activities such as education

sessions, outings, discussion groups, cooking, beauty

therapy, exercise, gardening and music are standard

offerings at all facilities.

Annual Report 2021
3

During the nationwide Level 4 lockdown enabling residents to keep in touch with

their families was a priority. Radius Care staff taught residents to use Skype, Zoom,

Whatsapp and Facetime on their own and the company’s hardware. When physical

visits were simply not possible, residents’ use of social media platforms for contact

with family and friends became an important and every day activity.

Appointment
of Mary Gardiner and

Hamish Stevens as

independent directors

December

2020

Stuart Bilbrough

returns to Radius Care

as CEO

June

2020

All Radius sites locked

down as a result of

COVID-19 threat

17 March

2020

New Zealand entered

nationwide Level 4

lockdown

26 March

2020

Board approves

decision to undertake

NZX listing

September

2020

NZX Listing

10 December

2020

Payment of FY21

interim dividend

February

2021

Announcement of

exercise of option to

purchase 4.3ha site at

Belfast, Christchurch

April

2021

2021 Highlights

and Key Events

Radius Residential Care Limited

4

Annual Report 2021
5

Caring is our calling

Exceptional People, Exceptional Care

The foundation that every Radius Care facility is built on.

COMMITMENT

Leaders in care

COURAGE

Do the right thing

COMPASSION

Act with empathy

Annual Report 2021

5

Radius Residential Care Limited
6

Financial Highlights

FY2021 Change

Underlying EBITDA

6

$23.4m +$5.1m

Pre-NZ IFRS 16 Underlying EBITDA

6

$10.5m +$4.7m

AFFO

6

$3.7m +$4.2m

Total assets $273.4m +$2.6m

Net interest bearing bank debt $24.5m -$4.7m

Total gross fully imputed dividend declared for year 1.46 cps

Operating Highlights

FY2021 Change

Overall beds (period end)

1

1,715 +11

Bed occupancy (March 21 month)

2

93.4% +1.8%

Underlying EBITDA per Care Bed

3

$19,505 +13.3%

Retirement village units (period end) 76 +3

Staff (period end) 1,560 +58

Revenue composition

Government funded aged care 63.8% -2.0%

Direct private revenue

4

11.0% +2.9%

Indirect private revenue

5

25.2% -0.9%

Operating

and Financial

Highlights

1. Comprises Care Beds occupied, available to be occupied or unavailable due to refurbishment

2. Total occupied Care Bed days divided by total Care Bed days available during the period

3. Underlying EBITDA for aged care divided by average number of Care Beds occupied during the period

4. Reflects full or partial private aged care payments where the resident exceeds means testing threshold

5. Includes accommodation supplements, retirement village revenues, Radius Online Shop revenue and other privately paid

6. These measures are non-GAAP measures. The definitions and calculations of these measures in this report can be found on pages 37 – 39 of this report. The +$4.2m change in

AFFO in FY2021 is calculated on AFFO for FY2020 of $(0.5)m, which has been revised from the FY2020 AFFO of $0.8m shown in the 10 December 2020 NZX Listing Profile due to a

reclassification of the deferred tax on the FY2020 revaluation of the three owned properties. The impact of this reclassification was an increase of $1.339m in FY2020 current tax and a

corresponding decrease of $1.339m in FY2020 deferred tax.

Radius Residential Care Limited

6

Annual Report 2021
7

NEW PLYMOUTH

SitesBedsILUsTotal

Leased155-55

Owned163-63

WAIKATO

SitesBedsILUsTotal

Leased4334-334

Owned1-2222

CANTERBURY

SitesBedsILUsTotal

Leased3279-279

Owned25254106

BAY OF PLENTY

SitesBedsILUsTotal

Leased2266-266

Owned163-63

AUCKLAND

SitesBedsILUsTotal

Leased3248-248

NORTHLAND

SitesBedsILUsTotal

Leased3155-155

NAPIER

SitesBedsILUsTotal

Leased145-45

PALMERSTON NORTH

SitesBedsILUsTotal

Leased162-62

OTAGO

SitesBedsILUsTotal

Leased193-93

Radius Care

at a Glance

SitesAged Care BedsRetirement Villages

aged care

facilities

nationally

comprising

76 units

owned

22

3 owned 19 leased

1,700+2

Denotes leasehold sites

Denotes freehold sites

Employees & Residents

1,700+1,500+

EmployeesBeds

National portfolio with strong

regional performance

Radius Residential Care Limited
8

Letter from

the Chairman

This is the first report for Radius Care as a listed company.

The 2021 financial year will be memorable for two significant

events – the company’s listing on NZX and for the global impact

of COVID-19.

NZX listing

Radius Care listed on NZX on 10 December 2020. The listing

was one of the first direct listings on NZX for some time. Whilst

Radius Care has a clear strategic growth focus around (1) the

purchase of the land and buildings of strategically important

facilities it currently operates, (2) leveraging its existing

Brownfield and Greenfield acquisition capabilities and (3)

undertaking opportunistic value accretive acquisitions of aged

care focused facilities the timing of opportunities is inherently

uncertain. As such, the direct listing allowed Radius Care to

firstly, achieve an NZX listing, and subsequently, focus on its

strategic growth objectives. Our listing documents (being our

Listing Profile and Supplementary Financial Information) are

available in the investor section of the Radius Care website (see

www.radiuscare.co.nz/investors-centre/listing-documents.

Trading on NZX to date has been relatively light, with an

average of about 50,000 shares a day trading between 1

January and 31 March 2021. While our existing shareholders

have been able to enjoy the benefits of a more liquid market

for their shares, most have chosen not to sell at this point.

I am delighted to present the annual report for the year ended 31 March 2021 for Radius

Residential Care Limited.

Annual Report 2021
9

Radius Care

offers high acuity,

specialised care in

New Zealand with a

commitment to and

focus on delivering

compassionate and

outstanding clinical

care outcomes.

COVID-19 response

The start of the 2021 financial year saw New Zealand in

lockdown and unprecedented operating procedures in place

across all of our facilities. Scenario planning and testing

is a regular feature of our operating procedures and risk

mitigation. A pandemic plan had been thoroughly tested and

was activated prior to New Zealand moving to Alert Level 4 on

26 March 2020. We would like to thank our residents, their

families and our suppliers for their complete co-operation with

the procedures that were required to be put in place to keep

all of our residents safe. Our utmost thanks must also go to

our dedicated staff for their professionalism, resilience and

the level of care that was shown for all of those around them

throughout the lockdown periods.

Our market positioning and care strategy

Radius Care offers high acuity, specialised care across New

Zealand with a commitment to and focus on outstanding

clinical care outcomes, delivered with compassion.

We provide a full range of accommodation and care options

from retirement village to rest home care through to high

acuity and specialist care. Services under the latter category

means hospital, dementia, psychogeriatric, physical and

intellectual care. Radius Care provides a broad offering allowing

residents the confidence that they can “age in place” as their

care needs change, however our key focus is on providing

high acuity and specialist care. This greater focus on aged care

and in particular high acuity and specialist care differentiates

Radius Care from other NZX listed aged care and retirement

village operators.

Radius Care is New Zealand’s leading provider in the high

acuity and specialist care segments of the aged care market.

Its strong care reputation has created a clear and defendable

competitive advantage. The high acuity and specialist care

segment is expected to see the greatest increase in Care Bed

demand with an aging population and increased dependency

levels being the key drivers. This is expected to see it continue

to generate the industry’s highest margins per Care Bed.

Strong regulatory and operational requirements create high

barriers to entry for companies that choose to compete

against Radius Care.

Our growth strategy

Whilst historically Radius Care has predominantly leased its

facilities it has a strategic focus of increasing the proportion of

facilities it owns, where it makes strategic sense to do so. For

Radius Residential Care Limited
10

example, Radius Care would consider acquisitions of sites it

operates but does not own if:

• development potential may be constrained by the

landlord;

• to enhance its legal position allowing a Care Suite

(Occupation Right Agreement (ORA) over a Care Bed)

product to be offered;

• where it provides greater control over its cost base; or

• where there are funding benefits

Radius Care currently owns three of the aged care facilities and

both retirement villages that it operates. We lease 19 aged care

facilities. Where the opportunity to purchase any strategically

important leased facilities at an attractive price arises, we will

look to purchase.

We have identified the opportunity to, in time, develop

an additional 144 Care Beds on existing owned facilities.

Brownfield developments provide strong value accretion to

Radius Care as there is nil land cost associated with them

and, as extensions to existing facilities with known catchment

demand, they are generally low risk in nature. Our property

development team is currently undertaking more detailed work

on the Brownfield Development pipeline.

In future developments high acuity and specialist care will

continue to be the core offering at each property. The optimal

Greenfields Development will comprise a boutique integrated

aged care and retirement village in regional or main centres,

accommodating a facility of 100 Care Beds/Care Suites and

100 Retirement Units or more. We will however consider

other value accretive Greenfield Developments that present

themselves but don’t exactly fit this model.

In addition, the aged care market in which Radius Care

operates remains highly fragmented with approximately

50% of the market still owned by small operators. Over its

history Radius Care has acquired 26

7

facilities with 22 of

Letter from the Chairman continued

7. Radius Care sold facilities at Glenbrae, Lester and Seaview and closed

a facility at St Ives following the Christchurch earthquakes.

these retained. We are frequently contacted by smaller

operators seeking to sell their facilities. We will continue to

make acquisitions where opportunities arise that fit with our

strategy and are value accretive.

In order to accelerate the execution of this strategy to drive

our next phase of growth, I became Executive Chairman in

June 2020 and Stuart Bilbrough, who had been Radius Care’s

Chief Financial Officer between 2010 and 2017, returned

as CEO. In his report to you Stuart talks about our next

Greenfields property development which is an example of our

strategy in action.

Dividends

Radius Care’s dividend policy is to target a pay-out ratio

of 50% to 70% of full financial year available funds from

operations (AFFO) with an interim dividend to be paid in

December and a final dividend to be paid in June of each

year. Each dividend will comprise approximately half of the

expected full year dividend. A number of factors will be

considered, including Radius Care’s financial performance,

financial position, market conditions, future funding

requirements and any contractual, legal or regulatory

restrictions on the payment of dividends by Radius Care.

Guidance was provided of a total cash dividend (net of

imputation credits) of between 0.83 and 1.00 cent per share

to be paid for the 2021 financial year, comprising dividends to

be paid in February and June.

A gross fully imputed interim dividend of 0.58 cents per share

was paid on 26 February (being a cash dividend of 0.41 cents

per share with 0.17 cents per share of attaching imputation

credits). A gross fully imputed full year dividend of 1.46 cents

per share (being a cash dividend of 1.05 cents per share with

Annual Report 2021
11

Brien Cree

Executive Chairman and

Managing Director

0.41 cents per share of attaching imputation credits). The

record date is 14 June 2021 and the payment date is the 21

June 2021 for the final dividend.

Our people

I would like to thank my fellow Directors, the Chief Executive

and the management team for their exemplary contribution to

the Company.

On behalf of the Board, I want to acknowledge our 1,500+

employees who have gone above and beyond through this

year, especially in response to the enormous challenges

presented by COVID-19. Continuing to provide high quality

care for our residents through such challenging times,

recognising that our residents include some of New Zealand’s

highest needs patients, was exceptional and showed huge

levels of commitment. Thank you.

Outlook

The Board and management of Radius Care are firmly focused

on continuing our strong performance in FY2022 and remain

focused on our growth strategy. We will continue to ensure

our residents receive exceptional care and ensure day to

day operations are run efficiently and in line with contract

requirements. Where opportunities to expand the business

present themselves, they will be carefully assessed.

Radius Residential Care Limited
12

with Executive Chairman

Brien Cree

Q&A

What brought you into the industry?

I’ve long had a desire to be involved in an industry that adds

value. My path into aged care started when my mother had a

severe stroke and we immediately needed to find care for her.

The care homes we looked at left me thinking there was an

opportunity to offer something considerably better. My first

purchase was a 54 bed aged care facility, Heatherlea, that I

bought in 2003 and Radius still owns it.

And what were you doing before that?

I was involved in property in the 80s and early 90s in

Wellington. I then worked in business broking and specialised

in aged care. Pretty quickly I moved into owning aged care

facilities and it was when my mother became unwell that I

seriously looked at the clear opportunities to offer really good

care. The opportunity to start Radius came next and here I

can combine all my interests – property development and

management, care and interacting with the elderly.

2021 was a year like no other. What are your

standout memories?

A couple of things – the difficulty and stress in making

decisions without any knowledge of what the outcome of

COVID-19 was going to be. I took the decision to lock down our

facilities ahead of other operators. That created a media frenzy

that was a distraction. Looking back now it was clearly the right

thing to do but it was heavily challenged at the time. A week

later everyone else was doing what Radius had already done

and the Prime Minister announced New Zealand was going to

Lockdown Level 4.

Another thing that is still very clear in my mind is the

tremendous support we had from staff. Radius was declared

early on to be offering an Essential Service and that meant

some of the head office team were still coming in to work every

day. We’d have a call with the facilities at the start of every day,

decide the day’s priorities and then start working on them to

ensure our residents continued to receive superb levels of care

and our staff at all of our facilities were as well supported as

possible. I made videos for the staff to keep them in the loop

on what we were doing. The staff that run the facilities and the

staff at the Parnell head office are a fairly close knit team but it

brought us even closer together. I’m so proud of them and the

lengths they went to to uphold the Radius values and put the

residents first.

The NZX listing was also a significant milestone. Fortunately, it

came after the COVID-19 situation had been stabilised and we

had more line of sight as to what was happening and where

New Zealand was going. Listing on NZX is an experience that

happens to very few companies in New Zealand. It was a really

positive way to sign off 2020. While we’re a mature business

we’ve lifted to another level as we prepped for the listing. We’re

structured and ready to grow again.

And even with everything else that was going on we were

able to exercise an option for the new 4.3 ha site in Belfast,

Christchurch. We’re planning for a new integrated aged care

and retirement development with 70 Care Beds, 30 Care Suites

and 94 Units to be constructed.

Annual Report 2021
13

Are there any new areas of business or

extensions of current services that are

appealing?

I’ve been running Radius for 17 years and I know we lead the

sector in new technologies and new processes. Over the next

10 years I think we’ll see Radius being clearly recognised as

the leading aged care provider in New Zealand and setting

the standard by which the industry is judged. Having said that,

we are developing a good model in care suites and boutique

village developments and that’s where we’re going to continue

to operate. Our competitive advantage is in the combination

of care and bricks and mortar. It’s just a matter of finding

appropriate sites. The ideal is a site of 4 to 5 hectares or

more. That gives us enough land to build a large care facility

and boutique village development. The Belfast Christchurch

property will be the second of this model.

What trends are you seeing that might

influence uptake of Radius Care beds?

Care is becoming more complex. Radius Care’s focus on care

has us at the forefront of new initiatives in an industry where

the barriers to entry are continuing to steadily grow. I see more

and more demand for our services, and we’ll be growing to

cater for that.

How do you think 2022 will look different to

an “average” year for Radius Care?

The recent announcement of the removal of DHBs will mean

the start of a simplification of our processes. We currently

work with all of the DHBs and there’s no consistency between

them in their purchasing of services. I think we’ll also see a

continuation of the increase in demand for our services. And

there’s a steady stream of expansion opportunities presenting

themselves. I’m very focussed on our strategic growth pathway

and hope to demonstrate strong progress this year.

What are some of the new technologies

you’ve seen recently that you might

introduce to benefit patients?

Where we decide to adopt new technologies, we’ll do it because

it frees up time for our staff to spend more time with residents.

As an example, we’ve introduced a check-in kiosk for visitors at

all of our sites. You enter your details, your temperature is taken

and you’re sent a QR code to use for the next time you go to

that facility. We’re the first aged care provider to introduce this

system. It makes for an easy and pleasant check-in experience

that doesn’t require staff support.

What’s different about your role as Executive

Chairman from Chief Executive?

As Chairman I look after the strategic direction and long term

growth of the business. Stuart, as CEO, looks after the day to

day operations of Radius Care. We’re a strong team and this

builds on the strengths we each bring to the business.

If you weren’t Chair of Radius Care, what

would you be doing?

I’d be running an aged care business with development

opportunities. I love it and know a lot about it so why would I

do anything else? Keeping on top of making sure our residents

and staff were safe from COVID-19 and listing Radius on NZX

was a major focus in the 2021 financial year. Strategic progress

is a high priority for me alongside indulging in my passion for

fishing, surfing and boating.

Radius Residential Care Limited
14

Chief

Executive’s Report

The 12 months to 31 March 2021 proved to be an incredibly

challenging year. While the NZX listing of Radius Care was a

project that required considerable input from the executive

team, it did not shift the priority that we place on care for our

residents. Their wellbeing is our complete focus 24 hours a day

7 days a week.

COVID-19

Ensuring our facilities run smoothly and safely is always our

top priority and highest commitment. The safety aspect of

that commitment took on an added dimension of importance

during the Government-mandated lockdowns of the past 12

months. Before I rejoined Radius Care in June, the aged care

Stuart Bilbrough

This is the first Radius Care annual report as a listed company and my first annual report as

the Radius Care Chief Executive. I was the company’s Chief Financial Officer from 2010 until

2017 and rejoined in June 2020 as Chief Executive, giving me responsibility for the Company’s

day to day activities. I know the company well and am delighted to be able to guide its journey

on your behalf.

Annual Report 2021
15

industry, all of New Zealand and the whole world was taking

action to combat the COVID-19 pandemic. As Brien highlighted

in his report, it was all hands to the pump and must have been

a crazy time which would successfully result in no cases of

COVID-19 in our facilities.

On Tuesday 17 March 2020, a few days prior to New Zealand

going to Alert Level 4, all of Radius Care’s facilities moved to

“restricted access” mode due to the risk Covid-19 posed to

older adults. This limited visits from anyone who was not a staff

member or resident. As the first aged care provider to restrict

access to their facilities, this initially caused concerns however

with our peers following suit within a day or two, it quickly

became standard across the industry in New Zealand.

It was all hands to

the pump and it must

have been a crazy

time which would

successfully result in no

cases of COVID-19 in our

facilities.


Our aged care operations were deemed to be an essential

service. That enabled management to continue to come to

work at our Auckland-based office to provide support to our

staff working at our facilities. Our operating procedures quickly

moved to daily calls between the executive office and all of our

facilities across New Zealand, rapid responses to the variety

of issues that arose and underpinned by a strong combined

sense of “we’re going to get through this”. The Radius Care

team worked as one and without external support, as we

navigated a rapidly changing environment.

Financial performance

We are pleased to have delivered a strong first result with:

• Underlying EBITDA of $23.4 million, in line with our

guidance of $23.0 million to $23.8 million;

• Pre-NZ IFRS Underlying EBITDA of $10.5 million in line

with our guidance of $10.2 million to $11.0 million; and

• AFFO of $3.7 million, slightly ahead of our guidance of

$2.9 million to $3.5 million

A Financial Report has been included at pages 27 to 73 of this

report and provides an analysis of the financial performance

for the 12 months to 31 March 2021.

At 31 March 2021, Radius Care had net interest bearing bank

debt of $24.5 million, down $0.3 million from $24.8 million as

at 30 November 2020.

Funding mix and occupancy

Radius Care’s revenues have a high proportion of Government

funding. In recent years we have been increasing the

proportion of revenues derived from non-Government

sources, most notably through a material increase in direct

private payments from a combination of accommodation

supplements, and retirement village revenues.

Direct private revenue

Indirect private revenue

Government funded revenue

11.0

%

8.1

%

25.2

%

26.1

%

63.8

%

65.8

%

Radius Care revenue composition over time

Aged care bed monthly average occupancy as at 31 March

2021 was 93.4%, the highest level we have seen at Radius Care.

This was up from 92.7% as at 30 September 2020 and 90.6%

in May 2020. Several of our facilities operated at close to 100%

for a number of months during the year.

Radius Residential Care Limited
16

We manage our bed mix in order to be able to quickly redeploy

beds as specific situations arise that require a shift. Around

710 or 41% of our beds are swing Care Beds which are

available for either rest home or hospital level care depending

on resident needs. This is 22% or 128 beds up on last year but

is indicative of where this is likely to continue to sit in future

years.

For the financial year 2021 2020

Number of Care Beds (period end) 1,715 1,704

Average Care Bed occupancy 92.4% 90.0%

For the 12 months to 31 March 2021 some 11 additional

beds were added to the pool that Radius Care operates. Our

bed portfolio is heavily oriented to the provision of aged care

to the high acuity and specialist care segments. The overall

proportion of high acuity and specialist care beds is 86% of

our overall beds. These types of bed typically generate higher

margins across the industry. This reflects our long term

expectation for the proportion of beds in this segment.

SwingDementiaPhysical and intellectual

Rest HomeHospitalPsychogeriatric

Radius Care operates a significant number of swing

Care Beds which are able to provide rest home or

hospital level care depending on resident needs

14.4

%

26.5

%

32.8

%

49.6

%

10.8

%

11.1

%

5.7

%

0.5

%

5.8

%

1.0

%

41.4

%

Our people

Our day to day operations are heavily reliant on our ability to

continue to attract and retain suitably skilled and experienced

people. Once employed by us, we want to support our staff

to ensure they’re able to offer their very best every day. It’s

important that Radius Care consistently delivers high-quality

service to our residents so it’s also important that an enjoyable

and stimulating work environment is offered to our staff.

Staff retention and turnover improved significantly over 2020.

Our staff turnover rate for the FY21 year for staff working in

our facilities was 32% and has averaged 37% over the past

three years.

Radius Care is an NZ Immigration accredited employer. This

would normally significantly increase the speed with which

staff can be brought on board. Closed borders meant we were

unable to rely on immigrant nurses whereas over the last three

years, around one third of new Radius Care registered nurses

have come through the NZ Immigration pathway. We have

pushed for changes to the immigration arrangements for our

nurses’ families and were delighted to see the Government

recently announce changes to allow the families’ immigration

arrangements to be fast tracked.

Chief Executive’s Report continued

Radius Care (monthly)

Industry average (quarterly)

Jun 19

95%

94%

93%

92%

91%

90%

89%

88%

87%

86%

85%

Sep 19Dec 19Mar 20Jun 20Sep 20Dec 20Mar 21

Occupancy Rates

Occupancy Rate

Annual Report 2021
17

Retirement village sales

Our retirement village business is currently based around villa

style units rather than an apartment products.

Financial period FY20 FY21

Number of Units (period end) 73 76

Number of new Unit sales 8 6

Number of existing Unit resales - 7

Development activity and building

programme

Radius Care operates a nationwide portfolio of aged care

facilities with a focus on both key urban and regional centres. It

also owns and operates two retirement villages, both of which

are co-located with Radius Care aged care facilities, providing a

continuum of care to residents.

Our overall approach to development is to continue to

predominantly look to care facilities as being the anchor of our

business.

As at 31 March 2021 the average time to the next lease renewal

stood at 9.1 years with an average time to expiry of 27.7 years,

assuming all leases continue to be renewed.

Rent increases across the portfolio of leased facilities is based

on a mix of CPI increases and independently assessed market

rent reviews. Rents increased by an average of 4.9% during

FY2021.

Radius Care has a strong track record in undertaking Brownfield

and Greenfield developments. Brownfields is a development on

land that already includes operational aged care or retirement

villages. Greenfields is a development on land that does not

contain any operational aged care or retirement village facilities.

Development work will remain a core part of our growth

strategy.

Our most recent Greenfield development, Elloughton Grange

Village in Timaru, had just one villa unsold and three going

unconditional as at 31 March 2021 of the 54 in the village.

This is an outstanding success for a development for which

construction started in October 2014.

Over the next three years, Radius Care intends to undertake:

• two Brownfield Developments on owned facilities, totalling

approximately 64 Care Beds/Care Suites in aggregate;

• three Brownfield Developments on leased facilities,

totalling approximately 60 Care Beds/Care Suites and 20

Units in aggregate;

• two Greenfield Developments, totalling approximately 200

Care Beds/Care Suites and 200 Units in aggregate. The

Belfast, Christchurch facility (outlined in more detail below)

will be the first of these developments.

In line with this strategy and just after balance date we

announced that Radius Care had exercised its right to acquire

some 4.3 hectares of development land in Belfast, Christchurch

for a Greenfield Development. Resource consent has been

issued by Christchurch City Council for a new integrated aged

care and retirement village facility totalling 70 care beds, 30

care suites and 94 retirement village units to be constructed on

the property.

Settlement of the land is expected to take place in early 2022.

We are currently progressing the final facility design, obtaining

building consents and commencing construction contracting

discussions in relation to this development.

While the retirement village offering is a core part of our growth

strategy, we remain committed to being a predominantly aged

care provider and will not undertake village-only Greenfield

developments. We have a minimum age requirement for

entering our retirement village facilities of 70 years. The average

resident age as at 31 March 2021 was 80.4 years.

Radius Residential Care Limited
18

Stuart Bilbrough

Chief Executive

Outlook

The 2022 financial year has started well for us. We have seen a

continuation of the high occupancy levels experienced through

the last half of the 2021 year.

Industry dynamics are supportive of Radius Care’s overall

business performance in the medium and longer term seeing

continuing growth. Demand for Care Beds, particularly at high

acuity and specialist care levels, is expected to remain strong

as supported by EY’s Aged Residential Care Funding Model

Review undertaken in September 2019.

Radius Care’s operations and portfolio are heavily oriented

to the high acuity and specialist care segments of the aged

care industry. Government spending has historically been a

very significant contributor to Radius Care’s revenue however

private funding is an increasingly important driver of growth in

overall revenue. This provides a clear demand-driven growth

pathway alongside which Radius will continue to expand its

care bed and village offering and deliver compassionate and

outstanding clinical care outcomes.

At the time Radius Care listed on NZX it provided guidance

in relation to three key financial metrics. It has chosen to

again provide guidance in relation to the FY22 year for these

measures. Radius Care does not commit to providing guidance

for future financial periods.

Guidance for the 12 months to 31 March 2022:

• Underlying EBITDA of $23.5m to $25.5m;

• Pre-NZ IFRS 16 Underlying EBITDA of $10.5m to $12.5m;

and

• AFFO of $3.7m to $4.7m.

An update on the 2022 year will be given at the Annual

Meeting.

Chief Executive’s Report continued

Annual Report 2021
19

Annual Report 2021

19

Case Studies

Radius Residential Care Limited
20

Innovative IT

Radius Care’s custom-built self-check in kiosk.

COVID-19’s arrival in New Zealand saw Radius Care take an industry leading

response in quickly installing practical restrictions to visitors to ensure residents

were kept protected from the virus. A new self-check in kiosk was developed,

custom-built for us to keep our facilities safe, secure and protected from

COVID-19 and other transmissible viruses. The kiosk became affectionately

known as Florence.

Prompted by the additional restrictions on visitation during the COVID-19

pandemic, the kiosk combines the visitor’s health and safety register with a

health questionnaire and temperature check.

When a visitor enters the Radius Care facility they will:

• See a tablet on a pedestal to check in

• Enter standard details about the visit such as their name and who they are

visiting

• Fill out a COVID-19 health questionnaire

• Place their fist, palm down, under the temperature scanner to be

accurately temperature checked.

The software will give the green light for ‘safe visitors’ to enter. However, if their

temperature is elevated or answers to health questions spark an issue, the

screen will refer them to the receptionist. This allows Radius Care staff to get

more detailed information and make an informed decision around visitation.

Pilot tested at Radius St Joans, visitors can pre-register online ahead of time to

receive a QR code. When they arrive, perhaps during a short lunch break, they

simply scan the QR code and undertake a quick temperature check before

proceeding.

Units will be installed throughout Radius Care facilities by the end of 2021.

Looking ahead, the health questionnaire is adaptable to any COVID-strand,

dangerous flu variant, or transmissible virus that New Zealand encounters.

The kiosks will greatly reduce paperwork which is currently required to be

collected and stored for 10 years. A larger facility could receive up to 100 visitors

a day, who would each need to complete two forms. The cumulative impact is

an immense amount of paperwork.

Problem

The immense amount

of paperwork to keep

facilities safe, secure

and protected from

COVID-19 and other

transmissable viruses.

Solution

Radius Care’s

custom-built self-check

in kiosk to combine

visitor’s health and

safety register with a

health questionnaire

and temperature check.

Result

Units will be installed

throughout Radius Care

facilities by the end of

2021.

The kiosk prototype being tested at

Radius St Joans in Hamilton.

Annual Report 2021
21

Vaccine Education

Radius Care’s proactive approach.

The Pfizer/BioNTech vaccine is the best way to protect residents

and staff from the most severe symptoms of COVID-19. It

allows facilities nationwide to reduce their exposure risk as the

borders begin to open.

Our Head of Infection Control, Corrie Bronkhurst, was confident

that much like the annual flu vaccination campaign, Radius

Care would manage the COVID-19 vaccination rollout

effectively.

However, rumours swirled when the Pfizer/BioNTech vaccine

first reached New Zealand shores, and there was a risk that

low uptake – especially amongst our staff or residents – would

leave the people we care for vulnerable to the virus.

Radius Care took a proactive approach, undertaking a

comprehensive internal communications plan which

included posters, videos, and brochures with essential, factual

information for staff to understand the vaccination ahead of

being offered it. Staff continue act as trusted influencers to

those around them.

Facilities work closely with DHBs to book in vaccination dates,

and on the day, facilities distribute stickers to vaccinated

staff and residents to highlight an individual’s contribution to

protecting the Radius community.

The uptake amongst both staff and residents is high, with

many facilities reporting around 90% uptake of the vaccine. By

taking a one team approach to encourage all of the Radius

Community to take the vaccine – staff, residents, family and

friends – we aim to provide the safest care for residents.

Problem

The misinformation

and rumours regarding

the safety of the Pfizer/

BioNTech vaccine.

Solution

Create an internal

communication

program filled with

factual information

to inform residents

and staff before the

vaccination is offered.

Result

High vaccination

uptake of residents

and staff.

Elloughton Gardens staff in Timaru received their

second vaccination in May 2021

Radius Residential Care Limited
22

Caring is

our calling

Commitment, courage and compassion are the

three values that all Radius Care staff live each

day. We’re committed to providing the best

possible care; have the courage to advocate for our

residents; and knowing that compassion is the most

important part of our role.

The fact that over 140 staff members have worked at Radius Care

for over 10 years is testimony to a supportive and challenging work

environment. This support includes regular in-house training and

ongoing skills development which ensures our staff are updated

on the latest health care practices and feel confident in their role.

Examples of this are:

Radius Care employs more than 1500 people,

and all our staff – Management, Nurses,

Health Care Assistants, Cleaners, Cooks – are

highly qualified and committed to providing

the best in aged care. Neethu Roji and Nofo

Nauma are examples of staff who were

supported in their career progression by

management.

A talented Registered Nurse originally

from India, Neethu has through sheer

determination and hard work progressed

from a Health Care Assistant to Facility

Manager at Radius St Helenas – in less

than five years! Neethu is very passionate

about looking after people, both staff and

the residents, and is proud to be part of

the excellent team at the 52-bed facility in

Christchurch.

Neethu Roji

Facility Manager

After being encouraged by her manager at

Radius Fulton in Dunedin, Nofo enrolled at

New Zealand Tertiary College to complete

the New Zealand Certificate in Health

and Wellbeing to further progress her

career. Nofo says that: “It’s so rewarding

contributing to a team; bringing out the

best in myself and my colleagues to fulfil

our goals and see positive results in the

healthcare setting.”

Nofa Mauma

Health Care Assistant

Pure Wellness

The once a year wellbeing month sees facilities across the

country offering complimentary wellness initiatives including

physio appointments, pilates and Zumba classes, steps

challenge and a healthy soup available all day for staff.

Rhythm of Leadership

The nine-month programme for Clinical Managers, Facility

Managers and Support Office staff provides everyone with the

opportunity to be the best version of themselves.

Value Cards

Staff who show great examples of value-led work are rewarded

with presents such as special tokens, prezzie cards or a coffee

vouchers, to value and recognise staff effort throughout the year.

Cap Course

Radius Care regularly assists healthcare assistants to have

overseas qualifications officially recognised in New Zealand.

NZQA Level 2 & 3

Radius Care also offers financial and practical assistance

for all cleaning staff towards obtaining the NZQA Level 2 & 3

qualification. This not only helps their career but improves their

pride in what they do.

Annual Report 2021
23

Board of Directors

Directors and

Senior Management

Radius Care’s Directors

and Senior Management

Brien Cree

Executive Chairman and

Managing Director

Brien Cree is the founding shareholder

of Radius Care and has been Managing

Director from the company’s inception

in 2003. Brien has built the Radius

Care’s property portfolio from nothing

to its current 22 aged care facilities and

two retirement villages. As Executive

Chairman and Managing Director, Brien

is focused on the formulation and

execution of Radius Care’s strategic

growth objectives.

Brien has more than 30 years’

experience in the aged care sector. He

is a board member of the NZACA and

past board member of the Retirement

Villages Association.

Duncan Cook

Non-Executive Director

LLB

Duncan Cook has been a director

of Radius Care since 2010, and

worked with Radius Care’s founders

to establish, structure and grow

Radius Care’s business. Duncan is a

partner at Sharp Tudhope Lawyers

(Tauranga and Auckland) and has

over 30 years’ experience in practice.

His key areas of practice are mergers

and acquisitions, and turnaround and

restructuring. Duncan is a member of

the New Zealand Law Society, Institute

of Directors New Zealand (Inc) and

Restructuring Insolvency & Turnaround

Association New Zealand Incorporated.

Duncan has governance experience

across a range of industry sectors,

including fishing, exports and housing

construction. He has volunteered on

the boards of the Tauranga Chamber

of Commerce and agencies associated

with economic development in the

Tauranga region.

Board of Directors

Radius Care’s Board currently comprises:

Bret Jackson

Non-Executive Director

BCom (Honours),

MBA (Harvard Business School)

Bret Jackson has been a director of

Radius Care since 2014. Bret is an

experienced business professional

with over two decades of business

experience. Bret is a co-founder

of Knox Investment Partners (a

leading private equity manager)

and has been a Managing Director

of Knox Investment Partners since

2005 (focusing on deal origination,

strategy and value creation). Bret

has represented Knox Investment

Partners on the board of every

portfolio investment made by it and is

currently Chairman of AAM Group in

Australia. Bret is also a past President

of the Harvard Business School Alumni

Association of New Zealand. Previously

Bret held corporate roles at Mobil

Oil New Zealand, as a management

consultant at Boston Consulting Group

(Sydney and London) and has founded

and successfully operated his own

private businesses.

2. RADIUS CARE AND WHAT IT DOES

44 NZX LISTING PROFILE | RADIUS RESIDENTIAL CARE LIMITED

Brien Cree is the founding shareholder of Radius Care

and has been Managing Director from the company’s

inception in 2003. Brien has built the Radius Care’s

property portfolio from nothing to its current 22 aged

care facilities and two retirement villages. As Executive

Chairman and Managing Director, Brien is focused on

the formulation and execution of Radius Care’s strategic

growth objectives.

Brien has more than 30 years’ experience in the aged

care sector. He is a board member of the NZACA and past

board member of the Retirement Villages Association.

Duncan Cook has been a director of Radius Care since 2010,

and worked with Radius Care’s founders to establish, structure

and grow Radius Care’s business. Duncan is a partner at Sharp

Tudhope Lawyers (Tauranga and Auckland) and has over 30 years’

experience in practice.

His key areas of practice are mergers and acquisitions, and

turnaround and restructuring. Duncan is a member of the New

Zealand Law Society, Institute of Directors New Zealand (Inc) and

Restructuring Insolvency & Turnaround Association New Zealand

Incorporated.

Duncan has governance experience across a range of industry

sectors, including fishing, exports and housing construction.

He has volunteered on the boards of the Tauranga Chamber of

Commerce and agencies associated with economic development in

the Tauranga region.

Radius Care’s Directors

and Senior Management

Brien Cree

Executive Chairman and

Managing Director

Brien Cree is the founding shareholder

of Radius Care and has been Managing

Director from the company’s inception

in 2003. Brien has built the Radius

Care’s property portfolio from nothing

to its current 22 aged care facilities and

two retirement villages. As Executive

Chairman and Managing Director, Brien

is focused on the formulation and

execution of Radius Care’s strategic

growth objectives.

Brien has more than 30 years’

experience in the aged care sector. He

is a board member of the NZACA and

past board member of the Retirement

Villages Association.

Duncan Cook

Non-Executive Director

LLB

Duncan Cook has been a director

of Radius Care since 2010, and

worked with Radius Care’s founders

to establish, structure and grow

Radius Care’s business. Duncan is a

partner at Sharp Tudhope Lawyers

(Tauranga and Auckland) and has

over 30 years’ experience in practice.

His key areas of practice are mergers

and acquisitions, and turnaround and

restructuring. Duncan is a member of

the New Zealand Law Society, Institute

of Directors New Zealand (Inc) and

Restructuring Insolvency & Turnaround

Association New Zealand Incorporated.

Duncan has governance experience

across a range of industry sectors,

including fishing, exports and housing

construction. He has volunteered on

the boards of the Tauranga Chamber

of Commerce and agencies associated

with economic development in the

Tauranga region.

Board of Directors

Radius Care’s Board currently comprises:

Bret Jackson

Non-Executive Director

BCom (Honours),

MBA (Harvard Business School)

Bret Jackson has been a director of

Radius Care since 2014. Bret is an

experienced business professional

with over two decades of business

experience. Bret is a co-founder

of Knox Investment Partners (a

leading private equity manager)

and has been a Managing Director

of Knox Investment Partners since

2005 (focusing on deal origination,

strategy and value creation). Bret

has represented Knox Investment

Partners on the board of every

portfolio investment made by it and is

currently Chairman of AAM Group in

Australia. Bret is also a past President

of the Harvard Business School Alumni

Association of New Zealand. Previously

Bret held corporate roles at Mobil

Oil New Zealand, as a management

consultant at Boston Consulting Group

(Sydney and London) and has founded

and successfully operated his own

private businesses.

2. RADIUS CARE AND WHAT IT DOES

44 NZX LISTING PROFILE | RADIUS RESIDENTIAL CARE LIMITED

Brien CreeDuncan Cook

Executive

Chairman and

Managing Director

Non Executive Director

LLB

Radius Residential Care Limited
24

Directors continued

Bret Jackson has been a director of Radius Care since 2014.

Bret is an experienced business professional with over two

decades of business experience. Bret is a co-founder of Knox

Investment Partners (a leading private equity manager) and

has been a Managing Director of Knox Investment Partners

since 2005 (focusing on deal origination, strategy and value

creation). Bret has represented Knox Investment Partners

on the board of every portfolio investment made by it and

is currently Chairman of AAM Group in Australia. Bret is also

a past President of the Harvard Business School Alumni

Association of New Zealand.

Bret held corporate roles at Mobil Oil New Zealand, as a

management consultant at Boston Consulting Group (Sydney

and London) and has founded and successfully operated his

own private businesses.

Mary Gardiner was appointed as an independent director

of Radius Care in December 2020. She is an Independent

Director and Chair of the Audit and Risk Committee of

Southern Cross Pet Insurance, Chair of Netball Northern

Zone and trustee of Mangere Mountain Education Trust, an

Auckland Council controlled organisation.

Mary has previously been Chair of Auckland Netball Centre

and Badminton NZ. Her commercial experience includes roles

as Chief Financial Officer of Instant Finance and Radius Health

Group, and Governance Risk Manager at Air New Zealand,

following a career focused primarily in financial services with

KPMG in New Zealand, Germany and Australia.

Mary is a Chartered member of the Institute of Directors,

Fellow of Governance New Zealand and is a New Zealand

Fellow Chartered Accountant.

Tim Sumner has been a director of Radius Care since 2014.

Tim is a New Zealand Chartered Accountant and finance

professional with over two decades of financial services

experience. He started his career with KPMG (Auckland and

Moscow) and then moved into banking and private equity

with Credit Suisse (London and New York). Tim is a co-founder

of Knox Investment Partners and has worked as a Managing

Director of Knox Investment Partners since 2005, focusing on

deal structuring and execution and fund administration.

Hamish Stevens was appointed as an Independent Director of

Radius Care in December 2020. Hamish is an Auckland based

independent director having held directorships in both the

listed and private company sectors since 2010. Hamish is also

currently Chair of Evolve Education Group, East Health Services

and Pharmaco and a director of Marsden Maritime Holdings,

Northport, Pacific Radiology Group and Counties Power. Prior

to his governance career Hamish held senior finance positions

with Heinz Wattie, Tip Top Ice Cream and DB Breweries.

Hamish is a qualified chartered accountant and a chartered

fellow of the Institute of Directors.

Bret Jackson

Mary Gardiner

Timothy Sumner

Hamish Stevens

Non-Executive Director

BCom (Honours), MBA

(Harvard Business School)

Independent Director

BCom, FCA, FCIS, CMInstD

Non-Executive Director

BCom, DipGrad, CA

Independent Director

MCom (Honours), MBA,

CA, CFInstD

Annual Report 2021
25

Senior Management

Radius Care’s senior management team currently comprises:

Stuart Bilbrough was appointed Chief Executive Officer

of Radius Care in June 2020, following successful roles

in the healthcare industry. He was Chief Financial Officer

at Radius Care from 2010 to 2017. Stuart has over 30

years’ experience in finance roles in industries including

healthcare, fast moving consumer goods (FMCG), logistics,

telecommunications and financial services. Notable companies

include PricewaterhouseCoopers, Fonterra, Deutsche Bank

and American Express. Stuart is a New Zealand Chartered

Accountant and holds an MBA with distinction from Massey

University. Stuart is a board member of the New Zealand

Underwater Association Inc.

Steven Heesen joined Radius Care in 2007 and heads up the

Radius Care commercial services team.

He has over 20 years’ experience in hospitality management

and over 16 years’ experience in the aged care sector.

His disciplines include all property matters, procurement,

marketing, hospitality and information services. Steven was

trained in Europe and has a business management degree.

Jane Smart was appointed Chief Operations Officer of Radius

Care in February 2011. She has over 30 years’ experience

in healthcare and extensive experience in the aged care

sector. Jane has spent most of her career in leadership and

management positions.

Michelle Slabber joined Radius Care in 2016.

Michelle has nearly 25 years’ experience in finance roles in

various industries including healthcare and financial services.

Michelle trained with PricewaterhouseCoopers in South Africa

and is a New Zealand Chartered Accountant.

Stuart Bilbrough

Steven Heesen

Jane Smart

Michelle Slabber

Chief Executive

Officer

BCom, MBA

(Distinction), CA

General Manager,

Commercial Services

Bachelor of International

Hospitality & Hotel

Management (Hons)

Chief Operations Officer

BSc Physiotherapy,

Dip.Business Administration,

MBS

General Manager, Finance

BCom (Hons), CA

Radius Residential Care Limited
26

Senior Management continued

Margaret Paramore joined Radius Care as General Manager

of People and Culture early 2021. Margaret has 25 years’

experience in a variety of industries including sales, marketing,

market research, and learning and development. She has

worked in a number of different industries such as fast moving

consumer goods (FMCG), over the counter medicines (OTC),

pharmaceuticals, and primary care. Notable companies

include GlaxoSmithKline, Roche, Smith and Nephew and

Nielsen. Margaret has worked extensively abroad in the United

Kingdom, Ireland and Europe and has recently returned home

to New Zealand.

Gared Thomas completed a Bachelor of Business, majoring

in Management at AUT in 2010. Gared joined Radius Care in

2019 and is responsible for all Radius property development

across New Zealand. Gared has over 20 years of construction

experience in various disciplines, including starting and

growing a successful weather tightness business which he sold

in 2015. He is passionate about delivering our village and care

home residents with high-quality, well designed, and enjoyable

spaces to live.

Sam Carey completed a Bachelor of Business, majoring in

Marketing and International Business at AUT in 2008. He

subsequently travelled through Europe and North America

looking to test his trade. In 2011 Sam was employed to start up

in-house marketing at Radius. He now oversees the national

brand strategy, regional campaigns and PR. Since 2015

Sam was an integral part of developing the newest revenue

generator for the company, the Radius Online Shop – www.

radiusshop.co.nz. Outside of work Sam loves all things sports

and is an avid competitor in Squash and Golf. He is a current

member of the Remuera Rackets Club Board Committee.

Margaret

Paramore

Gared Thomas

Sam Carey

General Manager,

People and Culture

Bachelor of Science;

Postgraduate Diploma in Marketing

General Manager,

Village and

Development

Bachelor of Business

General Manager,

Marketing and Retail

Bachelor of Business

Consolidated Statement of Comprehensive Income 28
Consolidated Statement of Changes in Equity 29

Consolidated Statement of Financial Position 30

Consolidated Statement of Cash Flows 31

Notes to the Consolidated Financial Statements 34

Independent Auditor's Report 67



Financial

Statements

Contents

Annual Report 2021

27

Radius Residential Care Limited
28

2021 2020

Note $’000 $’000

Revenue

Revenue from contracts with customers 2.2 121,217 113,359

Deferred management fees 2.2 1,081 671

Total revenue 122,298 114,030

Fair value movement of investment properties 3.1 2,879 (649)

Government subsidy received 794 353

Interest income 71 49

Total revenue and other income 126,042 113,783

Expenses

Employee costs (74,457) (70,852)

Depreciation expense 2.3 (11,552) (10,911)

Finance costs 2.3 (9,706) (10,583)

Other expenses 2.3 (28,298) (24,770)

Total expenses (124,013) (117,116)

Profit/(loss) before income tax 2,029 (3,333)

Income tax (expense)/ benefit 5.1 (324) 500

Profit /(loss) for the year 1,705 (2,833)

Other comprehensive income

Items that will not be reclassified subsequently to profit and loss

Revaluation of property, plant and equipment, net of tax 3.2 1,104 5,708

Other comprehensive income for the year 1,104 5,708

Total comprehensive income 2,809 2,875

Earnings per share

Basic and diluted earnings per share (cents per share) 4.2 0.97 (22.66)

The above Consolidated Statement of Comprehensive Income should be read in conjunction with the accompanying notes.

Statement of

Comprehensive Income

CONSOLIDATED

For the year ended 31 March 2021

Annual Report 2021
29

Asset

Contributed Revaluation Retained Total

Equity Reserve Earnings Equity

Note $’000 $’000 $’000 $’000

Balance as at 1 April 2019 4,736 - 13,434 18,170

Loss for the year - - (2,833) (2,833)

Other comprehensive income for the year 3.2 - 5,708 - 5,708

Total comprehensive income for the year - 5,708 (2,833) 2,875

Transactions with owners:

Dividends paid 4.1 - - (225) (225)

Total transactions with owners - - (225) (225)

Balance as at 31 March 2020 4,736 5,708 10,376 20,820

Balance as at 1 April 2020 4,736 5,708 10,376 20,820

Profit for the year - - 1,705 1,705

Other comprehensive income for the year 3.2 - 1,104 - 1,104

Total comprehensive income for the year - 1,104 1,705 2,809

Transactions with owners:

Share issue 4.1 1,196 - - 1,196

Dividends paid 4.1 - - (732) (732)

Total transactions with owners 1,196 - (732) 464

Balance as at 31 March 2021 5,932 6,812 11,349 24,093

The above Consolidated Statement of Changes in Equity should be read in conjunction with the accompanying notes.

Statement of

Changes in Equity

CONSOLIDATED

For the year ended 31 March 2021

Radius Residential Care Limited
30

2021 2020

Note $’000 $’000

Assets

Cash and cash equivalents 2,761 2,317

Trade and other receivables 5.3 7,744 7,648

Inventories 548 308

Property, plant and equipment 3.2 32,896 32,303

Right-of-use assets 3.4 177,170 181,431

Investment properties 3.1 31,675 27,831

Deferred tax assets 5.1 3,635 2,006

Intangible assets 5.2 16,996 16,996

Total assets 273,425 270,840

Liabilities

Trade and other payables 5.4 14,911 14,086

Current tax liabilities 1,135 723

Borrowings 4.3 27,212 31,427

Deferred management fee 3.3 1,178 962

Refundable occupation right agreements 3.3 20,591 17,518

Lease liabilities 3.4 184,305 185,304

Total liabilities 249,332 250,020

Net assets 24,093 20,820

Equity

Share capital 4.1 5,932 4,736

Asset revaluation reserve 4.1 6,812 5,708

Retained earnings 11,349 10,376

Total equity 24,093 20,820

The Board of Directors of the Company authorised these consolidated financial statements for issue on 25 May 2021.

For and on behalf of the Board

Brien Cree - Chair, Board of Directors Hamish Stevens - Chair, Audit and Risk Committee


The above Consolidated Statement of Financial Position should be read in conjunction with the accompanying notes.

Statement of

Financial Position

CONSOLIDATED

As at 31 March 2021

Annual Report 2021
31

2021 2020

$’000 $’000

Cash flows from operating activities

Receipts from residents for care fees and village fees 122,337 113,282

Receipts of government subsidy 1,210 -

Payments to suppliers and employees (101,724) (95,436)

Proceeds from the sale of Refundable occupation right agreements 3,927 3,705

Payments for the repurchase of Refundable occupation right agreements (464) -

Interest received 71 49

Interest paid - borrowings (883) (1,183)

Interest paid - lease liabilities (8,823) (9,400)

Income tax paid (1,744) (814)

Net cash provided by operating activities 13,907 10,203

Cash flows from investing activities

Proceeds from the sale of property, plant and equipment 54 114

Payments for the purchase of plant and equipment (3,577) (11,305)

Payments for village developments (965) (3,723)

Net cash used in investing activities (4,488) (14,914)

Cash flows from financing activities

Proceeds from bank borrowings - 15,120

Repayment of bank borrowings (4,215) (4,038)

Repayment of shareholder loans - (5,030)

Principal repayment of lease liabilities (4,028) (3,035)

Dividends paid (732) (225)

Net cash (used in)/provided by financing activities (8,975) 2,792

Reconciliation of cash and cash equivalents

Cash and cash equivalents at beginning of the year 2,317 4,236

Net increase/(decrease) in cash held 444 (1,919)

Cash and cash equivalents at end of year 2,761 2,317

The above Consolidated Statement of Cash Flows should be read in conjunction with the accompanying notes.

Statement of

Cash Flows

CONSOLIDATED

For the year ended 31 March 2021

Radius Residential Care Limited
32

2021 2020

$’000 $’000

Reconciliation of profit/(loss) for the year to net cash provided by operating activities

Profit/(loss) for the year 1,705 (2,833)

Adjustments for non-cash items

Depreciation 11,552 10,911

Share based payments 1,196 -

Net (gain)/loss on disposal of property, plant and equipment (26) 91

Fair value adjustment to investment properties (2,879) 649

Fair value adjustment to financial instruments - (42)

Movement in deferred tax (1,831) (1,533)

Changes in operating assets and liabilities

- Trade and other receivables and other assets (79) (465)

- Inventories (240) (140)

- Trade and other payables and other liabilities 798 482

- Current tax liabilities 412 220

- Refundable occupation rights agreements 3,299 2,863

Net cash provided by operating activities 13,907 10,203

The above Consolidated Statement of Cash Flows should be read in conjunction with the accompanying notes.

Statement of

Cash Flows

continued

CONSOLIDATED

For the year ended 31 March 2021

Annual Report 2021
33

Reconciliation of liabilities arising from financing activities

Liabilities arising from financing activities are liabilities for which cash flows are, or will be, classified as ‘cash flows from financing

activities’ in the statement of cash flows. Changes in the carrying amount of such liabilities, which comprise bank borrowings and lease

liabilities, are summarised below.

Lease

Borrowings Liabilities Total

$’000 $’000 $’000

Balance as at 1 April 2020 31,427 185,304 216,731

- Repayment of bank borrowings and lease liabilities (4,215) (4,028) (8,243)

Total changes from financing cash flows (4,215) (4,028) (8,243)

Non-cash changes

- Remeasurements - 3,029 3,029

Balance as at 31 March 2021 27,212 184,305 211,517

Balance as at 1 April 2019 25,375 191,903 217,278

- Proceeds from bank borrowings 15,120 - 15,120

- Repayment of bank borrowings and lease liabilities (9,068) (3,035) (12,103)

Total changes from financing cash flows 6,052 (3,035) 3,017

Non-cash changes

- Remeasurements - (3,564) (3,564)

Balance as at 31 March 2020 31,427 185,304 216,731

The above Consolidated Statement of Cash Flows should be read in conjunction with the accompanying notes.

Statement of

Cash Flows

continued

CONSOLIDATED

For the year ended 31 March 2021

Radius Residential Care Limited
34

For the year ended 31 March 2021

Notes to the Consolidated

Financial Statements

1. General Information

1.1 Basis of Preparation

(i) Reporting Entity

The consolidated financial statements are for Radius Residential Care Limited (‘the Company’) and its subsidiaries (together ‘the

Group’).

The Group provides rest home and hospital care of the elderly along with development and operation of integrated retirement villages

in New Zealand.

(ii) Statutory Basis and Statement of Compliance

Radius Residential Care Limited is a limited liability company, incorporated and domiciled in New Zealand. It is registered under the

Companies Act 1993 and is a FMC Reporting Entity in terms of Part 7 of the Financial Markets Conduct Act 2013. The Company is listed

on the NZX Main Board (“NZX”). The consolidated financial statements have been prepared in accordance with the requirements of the

NZX, and Part 7 of the Financial Markets Conduct Act 2013.

These consolidated financial statements have been prepared in accordance with Generally Accepted Accounting Practice in New

Zealand (‘NZ GAAP’), except for Note 2.1: Non-GAAP Underlying Net Profit after tax (“Underlying Profit”) and Non-GAAP AFFO

(“Available Funds from Operations”), which is presented in addition to NZ GAAP compliant information. They comply with New Zealand

equivalents to International Financial Reporting Standards (‘NZ IFRS’), International Financial Reporting Standards (‘IFRS’) and other

applicable New Zealand Financial Reporting Standards, as appropriate for for-profit entities. The Group is a Tier 1 for-profit entity in

accordance with XRB A1 Application of the Accounting Standards Framework.

The consolidated financial statements have been prepared on a going concern basis, which contemplates continuity of normal

business activities and the realisation of assets and the settlement of liabilities in the ordinary course of business.

The balance sheet for the Group is presented on the liquidity basis where the assets and liabilities are presented in the order of their

liquidity.

(iii) Functional and Presentation Currency

The consolidated financial statements are presented in New Zealand dollars which is the Group’s functional currency. All amounts

have been rounded to the nearest thousand, unless otherwise indicated.

(iv) Measurement Basis

These consolidated financial statements have been prepared under the historical cost convention, with the exception of investment

properties (note 3.1) and land and buildings included within property, plant and equipment (note 3.2).

(v) Key Estimates and Judgements

The Board of Directors and Management are required to make judgements, estimates and assumptions in applying the accounting

policies. The estimates and associated assumptions are based on experience and other factors that are believed to be reasonable

under the circumstances, the results of which form the basis of making the judgements. Actual results may differ from the estimates,

judgements and assumptions made by the Board of Directors and Management.

Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the

period in which the estimate is revised and in any future periods affected.

Annual Report 2021
35

The areas involving a higher degree of judgement or complexity, or areas where assumptions and estimates are significant to the

consolidated financial statements are described in the following notes:

• Valuation of investment properties (note 3.1)

• Valuation of land and buildings (note 3.2)

• Lease extension and termination options & incremental borrowing rates (note 3.4)

• Impairment testing of goodwill (note 5.2)

• Impairment testing of right-of-use assets (note 3.4)

• Recognition of deferred tax (note 5.1)

In March 2020, the World Health Organization declared an ongoing global outbreak of a novel coronavirus (‘COVID-19’) as a pandemic.

In response, the New Zealand Government implemented a range of public health and economic measures to mitigate the impact

of the COVID-19 pandemic. Whilst the COVID-19 pandemic and measures implemented have lowered overall economic activity, the

Group’s earnings, cash flow and financial position have not been impacted since the outbreak began and up to the date of the signing

of these consolidated financial statements. The Directors have assessed the impact of COVID-19 on these judgements and estimates

and concluded that limited changes are necessary. This is primarily due to the Group being classified as a provider of essential

services.

It is not possible to estimate the impact of the COVID-19 pandemic’s short and long-term effects. As at the date of the signing of these

consolidated financial statements, all reasonably known and available information with respect to the COVID-19 pandemic, has been

taken into consideration and all reasonably determinable adjustments have been made in preparing these consolidated financial

statements.

(vi) Comparative Information

During the current year, Management has simplified the consolidated financial statements to provide more relevant information that

is easier to understand. Consequently, certain comparative information has been re-ordered, re-labelled; or where considered non-

essential or immaterial, has been removed.

In the 2020 consolidated financial statements:

• the Group presented segment reporting information, however, this was not in accordance with how operating results are

reported to the Groups’ chief operating decision maker, and was included for consistency with retirement village and aged care

listed peers in New Zealand; and

• cash flows from the sale and repurchase from refundable occupation right agreements are now included as part of cash flows

from operating activities instead of cash flows from investing activities.

(vii) New and Amended Accounting Standards and Interpretations

All mandatory new standards, amendments and interpretations to existing standards that came into effect during the current

accounting period have been adopted in the current year. None of these have had a material impact on the Group. The Group

has not early adopted any standards, amendments or interpretations to existing standards that are not yet effective. They are

not expected to have a material impact on the Group. There are a number of new standards and amendments to standards and

interpretations that are not yet effective for the year beginning 1 April 2021. None of these have been identified as having a material

effect on the Group’s consolidated financial statements in the future.

Radius Residential Care Limited
36

Notes to the Consolidated Financial Statements continued

(viii) Segment Reporting

An operating segment is a component of an entity that engages in business activities which earn revenue and incur expenses and

where the chief operating decision maker reviews the operating results on a regular basis and makes decisions on resource allocation.

The Group operates in one operating segment being the provision of aged care in New Zealand. The chief operating decision maker,

the Board of Directors, reviews the operating results on a regular basis and makes decisions on resource allocation based on the

review of Group results and cash flows as a whole. The nature of the services provided and the type and class of residents have similar

characteristics within the operating segment. The Ministry of Health is a significant customer of the Group as disclosed in note 2.2, as

the Group derives care fee revenue in respect of eligible Government subsidised aged care residents. No other customers individually

contribute a significant proportion of the Group’s revenue. All revenue earned and assets held are in New Zealand.

1.2 Accounting Policies

Accounting policies which are relevant to understanding the consolidated financial statements are disclosed in each of the applicable

notes. They have been applied on a consistent basis across all periods presented in these consolidated financial statements.

Other relevant policies are provided as follows:

(i) Goods and Services Tax (GST)

Revenues, expenses and purchased assets are recognised net of the amount of GST, except where the amount of GST incurred is

not recoverable from the Inland Revenue Department (‘IRD’). In these circumstances the GST is recognised as part of the cost of

acquisition of the asset or as part of an item of the expense. Receivables and payables in the consolidated statement of financial

position are shown inclusive of GST.

Cash flows are presented in the consolidated statement of cash flows on a net basis, except for the GST component of investing and

financing activities, which are disclosed as operating cash flows.

(ii) Measurement of Fair Value

For financial reporting purposes, ‘fair value’ is the price that would be received to sell an asset, or paid to transfer a liability, in an

orderly transaction between market participants (under current market conditions) at the measurement date, regardless of whether

that price is directly observable or estimated using another valuation technique.

When estimating the fair value of an asset or liability, the Group uses valuation techniques that are appropriate in the circumstances

and for which sufficient data is available to measure fair value, maximising the use of relevant observable inputs and minimising the

use of unobservable inputs. Inputs to valuation techniques used to measure fair value are categorised into three levels according to

the extent to which the inputs are observable:

• Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the

measurement date.

• Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either

directly or indirectly.

• Level 3 inputs are unobservable inputs for the asset or liability.

Further information about the assumptions made in measuring fair values is included in notes 3.1, 3.2, 4.1 and 5.2.

(iii) Government Grants

Government grants and subsidies to the Group are not recognised until there is reasonable assurance that the Group will comply

with the conditions attached to them and that the grants will be received. Government grants are recognised in profit or loss on a

systematic basis over the periods in which the Group recognises as expenses the related costs for which the grants are intended to

compensate. Grants relating to expense items are recognised as income over the periods necessary to match the grant to the costs

they are compensating.

Annual Report 2021
37

2. Operating Performance

2.1 Non-GAAP financial measures: Non-GAAP Underlying Net Profit after tax (“Underlying Profit”) and Non-GAAP

Available Funds from Operations (“AFFO”)

Underlying Profit and AFFO are non-GAAP (non-Generally Accepted Accounting Practice) financial measures and differ from NZ GAAP,

NZ IFRS and IFRS Net Profit after Tax and Net cash provided by Operating Activities, respectively. Underlying Profit and AFFO do not

have a standardised meaning prescribed by NZ GAAP (Generally Accepted Accounting Practice in New Zealand) and so may not be

comparable to similar financial information and measures presented by other entities. The Group uses Underlying Profit and AFFO,

with other measures, to monitor financial performance and for shareholder dividend determination considerations. The Group uses

these measures consistently across reporting periods.

The Group believes that these non-GAAP financial measures, which are not considered to be a substitute for or superior to NZ GAAP,

NZ IFRS and IFRS measures, provide stakeholders with additional helpful information on the performance of the business. The non-

GAAP measures are consistent with how the business performance is planned and reported within the internal management reporting

to the Board and Audit and Risk Committee. Underlying Profit and AFFO are prepared in accordance with the basis of preparation

described below.

Underlying Profit

Underlying Profit is a non-GAAP measure of financial performance and considered in the determination of shareholder dividends.

The calculation of Underlying Profit requires a number of estimates to be approved by the Directors in its preparation. Both the

methodology and the estimates may differ among other entities in the retirement village and aged care sector. Underlying Profit does

not represent cash flow generated during the period.

Basis of preparation: Underlying Profit

The Group calculates Underlying Profit by making the following adjustments to reported Net Profit after Tax:

Adjustments

Non-recurring or infrequent items

1. COVID-19 related expenses. As part of the response to COVID-19, the Group incurred additional expenses, including personal

protective equipment (PPE) costs and expenses in relation to additional sick leave and isolation leave from April 2020 to

September 2020. The Group required staff to take a COVID-19 test before returning to work following any sick leave or isolation

leave, to ensure the safety of residents and staff in the aged care facilities.

2. Government COVID-19 related subsidy. As with other aged care providers in New Zealand, the Group received funding during

the year ended 31 March 2021 from the New Zealand Government in relation to the increased costs associated with COVID-19

which covered higher staff and PPE costs.

3. One-off listing costs. Costs incurred with the compliance listing on the NZX on 10 December 2020.

4. Share based payments. Shares were issued to employees and service providers as part of the compliance listing (note 4.1).

Structural changes and other

1. NZ listed & other listed entity related costs. Following its listing the Group incurred costs associated with operating in a listed

environment in respect of Directors’ fees (including the additional independent Directors recently appointed to the Group),

audit costs, listing fees, share registry fees, enhanced shareholder reporting costs and additional Director & Officer insurance

costs. From the date of listing, the Group also incurred a fee of 3.5% per annum of annual rental and outgoings in relation to the

personal guarantee in place with one landlord.

2. Historical governance costs. These relate to nonrecurring historical Directors, consulting and management fees previously

incurred by the Group but now replaced by NZ Listed and other listed entity related costs.

The effect of these adjustments is to present the Group as if it has been listed for the current and comparative year.

Radius Residential Care Limited
38

Notes to the Consolidated Financial Statements continued

Income tax

Included is the potential income tax impact of the above adjustments (described under non-recurring or infrequent items and

structural changes and other above). An effective tax rate of 28% has been assumed, where applicable.


Underlying adjustments

Underlying adjustments allow for direct comparison to other NZX listed aged care and retirement village operators and include:

• The removal of changes in the fair value of investment properties relating to the Group’s owned retirement villages (Elloughton

Grange Village and Windsor Lifestyle Estate Village).

• Inclusion of realised development margins on the cash settlement of the first sale of new Occupation Right Agreements (ORA)

Units following development.

• Inclusion of realised gains on Unit resales. Realised gains are calculated as the net cash flow received by the Group on the cash

settlement of the resale of pre-existing ORA Units (i.e. the difference between the value of the ORA licence payment received

from the incoming resident and the ORA licence payment previously received from the outgoing resident). Realised gains are net

of incurred refurbishment costs. The margin on the repurchase of legacy units under a unit title subsequently sold under an ORA

contract is also included. Note, no adjustment is made for differences between accrued deferred management fees (DMF) and

actual cash DMF realised.

• Removal of deferred tax expenses including those related to the application of NZ IFRS 16 Leases, where applicable.

AFFO

AFFO is a non-GAAP measure of available cash used by the Group to indicate the level of shareholder dividend it may pay.

Basis of preparation: AFFO

AFFO is calculated from Pre-NZ IFRS 16 Underlying Profit by removing Pre-NZ IFRS 16 depreciation and amortisation and instead

including maintenance capital expenditure. Pre-NZ IFRS 16 Underlying Profit is used as the starting point for this calculation as it

reflects the Pre-NZ IFRS 16 operating rental lease expense which largely represents the actual cash lease payment made, rather than

the NZ IFRS 16 equivalent which instead includes depreciation on right-of-use assets and interest expense on lease liabilities, which

materially exceed the actual cash operating rental lease expense payments.

Annual Report 2021
39

Reconciliation of NZ GAAP financial measures to non-GAAP financial measures

2021 2020

$’000 $’000

Profit/(loss) for the year 1,705 (2,833)

Adjustments

Non-recurring or infrequent items

Remove: COVID-19 related expenses 653 34

Remove: Government COVID-19 Subsidy (857) (353)

Remove: One-off listing costs 1,227 -

Remove: Share based payments 1,464 -

Structural changes and other

Include: Listed & other company costs (714) (1,084)

Remove: Historical governance costs 417 350

Include: Income tax impact from adjustments (270) 295

Underlying adjustments

Remove: Change in fair value of investment properties (2,879) 649

Include: Realised development margins 343 512

Include: Realised gains on resales 480 -

Remove: Deferred tax expense (1,831) (1,533)

Underlying Net profit before tax (262) (3,963)

Remove: Depreciation 11,552 10,911

Remove: Net interest expense 9,636 10,534

Remove: Current tax expense 2,155 1,033

Remove: Income tax impact from adjustments 270 (295)

Underlying EBITDA 23,351 18,220

Include: Pre-NZ IFRS 16 operating lease expense (12,850) (12,435)

Pre-NZ IFRS 16 Underlying EBITDA 10,501 5,785

Include: Depreciation (Pre-NZ IFRS 16) (4,262) (3,700)

Include: Net interest expense (Pre-NZ IFRS 16) (812) (1,134)

Include: Current tax expense (2,155) (1,033)

Include: Income tax impact from adjustments (270) 295

Pre-NZ IFRS 16 Underlying Net profit after tax 3,002 213

Remove: Depreciation (excl. NZ IFRS 16 related) 4,262 3,700

Include: Maintenance capital expenditure (3,543) (4,400)

AFFO 3,721 (487)

Radius Residential Care Limited
40

Notes to the Consolidated Financial Statements continued

2.2 Revenue

Revenue from contracts with customers

Revenue from care and village fees and recoveries income is recognised in accordance with NZ IFRS 15 Revenue from Contracts with

Customers (“NZ IFRS 15”). Deferred management fees and rental income are considered leases under NZ IFRS 16 Leases (“NZ IFRS 16”),

and are therefore excluded from the scope of NZ IFRS 15. None of the Group’s revenue, as defined by NZ IFRS 15, contains significant

financing components.

Care and village fees and recoveries income

The Group derives revenue from the provision of residential care and related services. Rest home, hospital and service fee charges

are governed by the individual care admission agreement with each care resident. The resident incurs a daily care fee charged per the

agreement, as set by the Government each year. Care fees are recognised net of any rebates to residents.

The Group derives care fee revenue in respect of eligible Government subsidised aged care residents who receive rest home,

dementia or hospital level care. Government aged care subsidies received from the Ministry of Health included in care fees and village

services amounted to $78,019k (2020: $72,483k).

There are no elements of variable consideration of significant financing component associated with care and village fees and

recoveries income.

Village fees are detailed within each resident’s occupation right agreement and relate to the operating costs of the village. Revenue is

recognised based on the daily or weekly fees charged, reflecting the period a resident has occupied a unit.

The performance obligation of providing the care and village services is satisfied over time, as the customer simultaneously receives

and consumes the benefits of the service as it is provided. Billing and revenue recognition are generally done during the same period

that the performance obligation is satisfied. Payments received in advance are recorded on the statement of financial position as a

contract liability and subsequently recognised through profit or loss when the services are rendered.

Lease income

Deferred management fees

Occupation Right Agreements (ORAs) confer the right to occupancy of a retirement unit and are considered leases under NZ IFRS 16

Leases.

A management fee is payable by the residents of the Group’s independent living units for the right to share in the use and enjoyment

of common facilities. The management fee is calculated as a percentage of the ORA amount and accrues either daily, monthly or

annually for a set period, based on the terms of the individual contracts. The current ORAs accrue management fees at rates ranging

from 6.67% to 10% per annum.

The management fee is payable in cash by the resident at the time of repayment (to the resident) of the refundable ORA amount due.

The Group has the right to set-off of the refundable occupation right agreement amount and the management fee receivable.

At year end, the management fee receivable that has yet to be recognised through profit or loss as management fee revenue is

recognised as a deferred management fee liability in the statement of financial position.

Key accounting estimates and judgements

Deferred management fees are recognised as revenue on a straight-line basis. This requires Management to estimate the period of

occupancy for independent living units. The expected periods of tenure, being based on historical results, experience and industry

averages, are estimated at 8 years (2020 : 8 years).

Annual Report 2021
41

2.3 Expenses

Accounting policy

Operating expenses are recognised on an accrual basis.

Interest expense is measured in accordance with the effective interest method.

2021 2020

Note $’000 $’000

Depreciation of property, plant and equipment:

- buildings 3.2 249 33

- motor vehicles 3.2 140 155

- furniture, fixtures and fittings 3.2 3,037 2,703

- information technology 3.2 746 737

- medical equipment 3.2 90 72

4,262 3,700

Depreciation of right-of-use assets:

- buildings 3.4 7,290 7,211

7,290 7,211

Total depreciation 11,552 10,911

Finance costs:

- interest - bank 883 1,183

- interest - lease liabilities 8,823 9,400

Total finance costs 9,706 10,583

Other expenses:

Fees paid to Auditors

Audit and review of consolidated financial statements 154 60

Assurance engagement to report on the compilation of

Pro forma financial information included in a listing profile 21 -

Tax compliance services 90 41

Total fees paid to auditor 265 101

Facility operating expenses 20,039 18,967

Listing costs 1,227 -

Operating rental expenses relating to low value and short-term leases 69 53

Directors’ fees 410 107

Donations and sponsorships 14 14

(Gain)/loss on sale of property, plant and equipment (26) 91

Gain on derivative financial instruments - (42)

Other expenses (no items of individual significance) 6,300 5,479

Total other expenses 28,298 24,770

Radius Residential Care Limited
42

Notes to the Consolidated Financial Statements continued

3. Property Assets

3.1 Investment Properties

Accounting policy

Investment properties include completed freehold land and buildings, freehold development land and buildings under development

comprising independent living units and common facilities, provided for use by residents under the terms of a Occupation Right

Agreement (ORA). Investment properties are held for long term yields and are not occupied by the Group.

Investment properties are initially recognised at cost. After initial recognition, investment properties are measured at fair value. Gains

or losses arising from a change in the fair value of investment properties are recognised in profit or loss.

Land acquired with the intention of constructing investment properties are classified as investment properties from the date of

acquisition.

Rental income from investment properties, being deferred management fees, is accounted for as described in note 2.2.

When the use of a property changes such that it is reclassified as property, plant and equipment, its fair value at the date of

reclassification becomes its cost for subsequent accounting.

2021 2020

$’000 $’000

Investment properties

Opening carrying amount 27,831 23,727

Development expenditure 338 3,057

Development expenditure transfer - (3,221)

Net fair value gain/(loss) 2,879 (649)

Occupation right agreements settled (4,894) -

Occupation right agreements entered 5,421 3,705

Purchases 100 187

Transferred from property, plant and equipment - 1,025

Closing carrying amount 31,675 27,831

A reconciliation between the valuation and the amount recognised on the Consolidated Statement of Financial Position as investment

properties is as follows:

Notes

Valuation of operator’s interest 8,345 6,215

Refundable occupation right agreements 3.3 20,591 17,518

Deferred management fee 3.3 1,178 962

Unsold units 1,561 3,136

31,675 27,831

Annual Report 2021
43

Valuation process and key inputs

The Group’s investment properties are valued on an annual basis by CBRE Limited (CBRE), an independent valuer. CBRE is registered

with the Property Institute of New Zealand, employs registered valuers and has appropriate recognised professional qualifications and

recent experience in the location and category of properties being valued.

Fair value as determined by CBRE is adjusted for assets and liabilities already recognised in the Consolidated Statement of Financial

Position which are also reflected in the discounted cash flow model. The valuation of investment properties is then grossed up for

cash flows relating to refundable occupation right agreements, which are recognised separately in the Consolidated Statement of

Financial Position (refer also note 3.3).

Retirement villages under development

The cost of retirement villages includes directly attributable construction costs and other costs necessary to bring the retirement

villages to working condition for their intended use. These other costs include professional fees and consents, borrowing costs

during the build period and head office costs directly related to the construction of the retirement villages. Where costs are

apportioned across more than one asset, the apportionment methodology is determined by considering the nature of the cost. The

borrowing costs capitalised during the period was $49k (2020: $130k). The related borrowing costs were solely for the villages under

development.

If the fair value of investment properties under development and construction cannot be reliably determined but it is expected the fair

value of the property can be reliably determined when construction is complete, then investment properties under construction will

be measured as cost less any impairment, until either its fair value can be reliably determined or construction is complete. Impairment

is determined by considering the value of work in progress and Management’s estimate of the value of the investment properties on

completion.

Unsold units

Any developed but not yet sold units (unsold units) is valued based on recent comparable transactions, adjusted for disposal costs,

holding costs and an allowance for profit and risk. This represents the fair value of the Group’s interest in unsold units at reporting date.

Key accounting estimates and judgements

As the fair value of investment properties is determined using inputs that are significant and unobservable, the Group has categorised

investment properties as Level 3 under the fair value hierarchy in accordance with NZ IFRS 13 Fair Value Measurement.

Valuation uncertainty

As at the 31 March 2021 valuation date, the valuers, CBRE, have included a valuation uncertainty clause in their valuation reports

as a result of the COVID-19 pandemic. This clause highlights the difficulties in undertaking valuations due to the absence of, or

limited relevant transactional evidence that demonstrates current market pricing. Therefore, less certainty and a higher degree of

caution should be attached to the point estimate valuations. This represents an increase in the significant estimation uncertainty

in the valuation of investment properties. Given the valuation uncertainty, the valuers have recommended in their reports that the

valuations of the properties be kept under frequent review. As at the 31 March 2020 valuation date, the valuers CBRE, had included a

similar clause in their valuation reports, however it was highlighted as a “material” valuation uncertainty on the basis that there was an

absence of relevant transactional evidence that demonstrates current market pricing.

Significant unobservable inputs

The significant unobservable input used in the fair value measurement of the Group’s development land is the value per square metre

assumption. Increases in the value per square metre rate result in the corresponding increases in the total valuation.

The significant unobservable inputs used in the fair value measurement of the Group’s portfolio of completed investment properties

are the discount rate and the property growth rate.

Radius Residential Care Limited
44

Notes to the Consolidated Financial Statements continued

The following assumptions have been used to determine fair value:

Inter-relationship

between the key inputs

and fair value measurement

Significant input Description 2021 2020

Discount rate The pre-tax discount rate A significant increase/(decrease)

in the discount rate would result

in a significantly (lower)/higher

fair value measurement 15.75% - 18.0% 16.0% - 18.25%

Property price Anticipated annual property A significant increase/(decrease)

growth rate price growth over the cash in the Property price growth rate

flow period 0 - 4 years would result in a significantly

higher/(lower) fair value

measurement 2.0% - 2.5% -2.0% - 3.0%

Property price Anticipated annual property A significant increase/(decrease)

growth rate price growth over the cash in the Property price growth rate

flow period 5+ years would result in a significantly

higher/(lower) fair value

measurement 3.0% 3.0%

Due to the valuation uncertainty disclosed, the range of reasonably possible changes to key assumptions is uncertain and could be

significantly greater than the ranges used in the sensitivity analysis.

Sensitivities

Adopted Value

of Operator’s Interest Discount Rate Property Growth Rate

As at 31 March 2021 +0.5% -0.5% +0.5% -0.5%

Valuation $000’s 8,345

Difference $000’s (320) 280 515 (515)

Difference % -3.8% 3.4% 6.2% -6.2%

Adopted Value

of Operator’s interest Discount Rate Property Growth Rate

As at 31 March 2020 +0.5% -0.5% +0.5% -0.5%

Valuation $000’s 6,215

Difference $000’s (235) 255 398 (423)

Difference % -3.8% 4.1% 6.4% -6.8%

The stabilised occupancy is a key driver of the CBRE valuation. A significant increase/(decrease) in the occupancy period would result in

a significant lower/(higher) fair value measurement.

Significant input

2021 2020

Stabilised occupancy period 8.4yrs - 8.7yrs 8.3yrs - 8.6yrs

Current ingoing price, for subsequent resales of ORA’s, is a key driver of the CBRE’s valuation. A significant increase/(decrease) in the

ingoing price (as driven by the property growth rates) would result in a significantly higher/(lower) fair value measurement.

Annual Report 2021
45

3.2 Property, Plant and Equipment

Accounting policy

Property, plant and equipment is measured at cost or fair value less, where applicable, any accumulated depreciation and any

accumulated impairment losses.

Cost includes expenditures that are directly attributable to the acquisition of the asset. The cost of self constructed assets includes the

cost of materials and direct labour and any other costs directly attributable to bringing the asset to a working condition for its intended

use. Purchased software that is integral to the functionality of the related equipment is capitalised as part of that equipment.

Subsequent costs are added to the carrying amount of an item of plant and equipment when that cost is incurred if it is probable that

the future economic benefits embodied with the item will flow to the Group and the cost of the item can be measured reliably. All

other costs are recognised in the profit or loss as an expense as incurred. The costs of the day to day servicing of property, plant and

equipment are recognised in profit or loss as incurred.

Freehold land and buildings are measured at revalued amounts, being the fair value at the date of the revaluation, less any

subsequent accumulated depreciation and any accumulated impairment losses. At each reporting date the carrying amount of each

asset is reviewed to ensure that it does not differ materially from the asset’s fair value at reporting date. Where necessary, the asset is

revalued to reflect its fair value.

Increases in the carrying amounts arising on revaluation of land and buildings are recognised in other comprehensive income and

accumulated in equity. To the extent that the increase reverses a decrease of the same asset previously recognised in profit or

loss, the increase is recognised in profit or loss. Decreases that offset previous increases of the same asset are recognised in other

comprehensive income; all other decreases are recognised in profit or loss.

Leasehold improvements are depreciated over the shorter of either the unexpired period of the lease or the estimated useful lives of

the improvements.

Land is not depreciated. The depreciable amount of all other property, plant and equipment is depreciated using the straight line

method over their estimated useful lives commencing from the time the asset is held available for use, consistent with the estimated

consumption of the economic benefits embodied in the asset.


Category Useful Life Range

- Buildings 10 - 50 years

- Motor vehicles 3 - 5 years

- Furniture, fixtures and fittings 5 - 10 years

- Information technology 3 - 4 years

- Medical equipment 5 - 7 years

The assets’ residual values and useful lives are reviewed, and adjusted if appropriate, at each balance date. No depreciation is charged

in the year of sale for all assets other than buildings in which case depreciation is charged to the earlier of the date of classification to

held for sale or the date of sale.

Assets are assessed for impairment whenever events or circumstances arise that indicate the asset may be impaired. An asset’s

carrying amount is written down immediately to its recoverable amount if the asset’s carrying amount is greater than its estimated

recoverable amount. Impairment losses in respect of individual assets are recognised immediately in profit or loss unless the asset

is measured at a revalued amount, in which case the impairment loss is treated as a revaluation decrease and is recognised in other

comprehensive income to the extent that it does not exceed the amount in the revaluation surplus for the same asset.

Gains and losses on disposals are determined by comparing the net disposal proceeds with the carrying amount of the asset. These

are included in the profit or loss.

Radius Residential Care Limited
46

Notes to the Consolidated Financial Statements continued

Furniture

Land and Motor Fixtures & Information Medical

$000’s Buildings Vehicles Fittings Technology Equipment Total

Year ended 31 March 2021

Opening net book value 17,265 297 12,905 1,637 199 32,303

Additions 3 205 2,633 587 150 3,578

Net amount of revaluation

increments less decrements* 1,307 - - - - 1,307

Disposals - (1) (21) (5) (3) (30)

Depreciation (249) (140) (3,037) (746) (90) (4,262)

Closing net book value 18,326 361 12,480 1,473 256 32,896

Year ended 31 March 2021

Cost 115 1,212 34,380 4,766 647 41,120

Valuation 18,225 - - - - 18,225

Accumulated depreciation (14) (851) (21,900) (3,293) (391) (26,449)

Net book value 18,326 361 12,480 1,473 256 32,896


Furniture

Land and Motor Fixtures & Information Medical

$000’s Notes Buildings Vehicles Fittings Technology Equipment Total

Year ended 31 March 2020

Opening net book value 3,954 514 12,467 1,774 177 18,886

Additions 104 101 3,448 633 94 4,380

Additions through purchase

of new land and buildings 6,925 - - - - 6,925

Net amount of revaluation

increments less decrements* 7,047 - - - - 7,047

Disposals - (163) (14) (33) - (210)

Depreciation (33) (155) (2,703) (737) (72) (3,700)

Transfer to investment properties 3.1 (732) - (293) - - (1,025)

Closing net book value 17,265 297 12,905 1,637 199 32,303

Year ended 31 March 2020

Cost 127 1,282 31,772 4,183 500 37,864

Valuation 17,150 - - - - 17,150

Accumulated depreciation (12) (985) (18,867) (2,546) (301) (22,711)

Net book value 17,265 297 12,905 1,637 199 32,303

* The revaluation noted in the Consolidated Statement of Comprehensive Income differs from the above due to deferred tax, refer to note 5.1.

Annual Report 2021
47

Valuations

Three of the Group’s properties, St Helenas, Thornleigh Park and Lexham Park, which are included in land and buildings were revalued

on 31 March 2021 to $18,225k from a carrying value prior to revaluation of $16,918k resulting in a revaluation gain of $1,307k. (2020:

Two of the Group’s properties, St Helenas and Thornleigh Park, which are included in land and buildings were revalued on 31 March

2020 to $10,225k from a carrying value prior to revaluation of $3,208k resulting in a revaluation gain of $7,047k. The remaining

property included in land and buildings, Lexham Park, was purchased on 31 July 2019 for $6,925k. LVC Limited (LVC) was involved in

providing valuation services for the purchase of Lexham Park. The valuer confirmed that the purchase price as at 31 July 2019 was

materially consistent with its fair value as at 31 March 2020).

The fair values of the three revalued land and buildings on freehold land have been determined by reference to independent

valuations obtained as at 31 March 2021. These valuations were undertaken by a Property Institute of New Zealand registered valuer,

LVC. LVC, an external independent valuation company employing registered valuers, have appropriate recognised professional

qualifications and recent experience in the location and category of properties being valued. LVC Limited determined the fair value of

land and buildings on freehold land using the direct comparison approach and capitalisation of market income approaches.


Valuation uncertainty

As at the 31 March 2021 valuation date, the valuers, LVC, have included a valuation uncertainty clause in their valuation reports as

a result of the COVID-19 pandemic. This clause highlights the difficulties in undertaking valuations due to the absence of relevant

transactional evidence that demonstrates current market pricing. Therefore, less certainty and a higher degree of caution should

be attached to the point estimate valuation. This represents an increase in the significant estimation uncertainty in the valuation of

the properties. Given the valuation uncertainty, the valuers have recommended in their reports that the valuations of the properties

be kept under frequent review. As at the 31 March 2020 valuation date, the valuers, LVC, had included a similar clause in their

valuation reports, however it was highlighted as a “material” valuation uncertainty on the basis that there was an absence of relevant

transactional evidence that demonstrated current market pricing.

Key accounting estimates and judgements

Property measurements are categorised as Level 3 (2020: Level 3) of the fair value measurement hierarchy as the fair value is

determined using inputs that are unobservable.

Significant unobservable inputs

The significant unobservable input used in the fair value measurement of the Group’s land and buildings is the capitalisation rate

applied to earnings. A significant decrease/(increase) in the capitalisation rate would result in significantly higher/(lower) fair value

measurement.

Sensitivities

Adopted Value Capitalisation Rate

As at 31 March 2021 +0.5% -0.5%

Valuation $000’s 18,225

Difference $000’s 1,318 (1,318)

Difference % 7.2% -7.2%

As at 31 March 2020 +0.5% -0.5%

Valuation $000’s 17,150

Difference $000’s 1,217 (1,217)

Difference % 7.1% -7.1%

Radius Residential Care Limited
48

Notes to the Consolidated Financial Statements continued

3.3 Refundable Occupation Right Agreements

Accounting policy

Occupation Right Agreements (ORAs) confer the right to occupy a retirement unit and are considered leases under NZ IFRS 16

Leases.

A new resident is charged a refundable security deposit, on being issued the right to occupy one of the Group’s units, which is

refunded to the resident subject to a new ORA for the unit being issued to an incoming resident, net of any amount owing to the

Group. The Group has a legal right to set off any amounts owing to the Group by a resident against that resident’s security deposit.

Such amounts include management fees, rest home and hospital fees, service fees and village fees. As the refundable occupation right

is repayable to the resident upon vacating the unit (subject to a new ORA for the unit being issued to an incoming resident), the fair

value is equal to the face value, being the amount that can be refunded.

The right of residents to occupy the investment properties of the Group is protected by the statutory supervisor restricting the ability

of the Group to fully control these assets without undergoing a consultation process with all affected parties.

A resident is charged a village contribution fee in consideration for the right to occupy one of the Group’s units:

• for Windsor Lifestyle Estate Limited, to a maximum of 21% of the entry payment; and

• for Elloughton Grange Village Limited, to a maximum of 30% of the entry payment.

The village contribution is payable by the resident on termination of the ORA. Village contribution is recognised as deferred

management fees, note 2.2. The management fee receivable is recognised in accordance with the terms of the resident’s ORA.

The deferred management fee represents the difference between the management fees receivable under the ORA and the portion of

the management fee accrued which is recognised on a straight-line basis over the longer of the term specified in a resident’s ORA or

the average expected occupancy for the relevant accommodation i.e. 8 years (2020 : 8 years).

The management fee recognised in the Consolidated Statement of Comprehensive Income represents income earned in line with the

average expected occupancy.

As a refundable occupation license payment is repayable to the resident upon termination (subject to a new ORA being issued to an

incoming resident), the fair value is equal to the face value, being the amount that can be demanded.

The expected maturity of the refundable obligations to residents is beyond 12 months.

2021 2020

$’000 $’000

Refundable Occupation Right Agreements

Refundable occupation license payments 24,125 20,350

Less: Management fee receivable (per contract) (3,534) (2,832)

20,591 17,518

Reconciliation of Management Fees recognised under NZ IFRS and per ORA

Management fee receivable (per contract) (3,534) (2,832)

Deferred management fee 1,178 962

Management fee receivable (per NZ IFRS) (2,356) (1,870)

Annual Report 2021
49

3.4 Leases

Accounting policy

At the commencement date of a lease (other than leases of 12 months or less and leases of low value assets), the Group recognises a

lease asset representing its right to use the underlying asset and a lease liability representing its obligation to make lease payments.

Right-of-use assets

Right-of-use assets are initially recognised at cost, comprising the amount of the initial measurement of the lease liability, any lease

payments made at or before the commencement date of the lease, less any lease incentives received, any initial direct costs incurred

by the Group, and an estimate of costs to be incurred by the Group in dismantling and removing the underlying asset, restoring the

site on which it is located or restoring the underlying asset to the condition required by the terms and conditions of the lease.

Subsequent to initial recognition, lease assets are measured at cost (adjusted for any remeasurement of the associated lease liability),

less accumulated depreciation and any accumulated impairment loss. Right-of-use assets are assessed for impairment whenever

events or circumstances arise that indicate the asset may be impaired. An asset’s carrying amount is written down immediately to its

recoverable amount if the asset’s carrying amount is greater than its estimated recoverable amount.

Right-of-use assets are depreciated over the shorter of the lease term and the estimated useful life of the underlying asset, consistent

with the estimated consumption of the economic benefits embodied in the underlying asset.

Lease liabilities

Lease liabilities are initially recognised at the present value of the future lease payments (i.e., the lease payments that are unpaid at

the commencement date of the lease). These lease payments are discounted using the interest rate implicit in the lease, if that rate

can be readily determined, or otherwise using the Group’s incremental borrowing rate.

Subsequent to initial recognition, lease liabilities are measured at the present value of the remaining lease payments (i.e., the lease

payments that are unpaid at the reporting date). Interest expense on lease liabilities is recognised in profit or loss (as a component

of finance costs). Lease liabilities are remeasured to reflect changes to lease terms, changes to lease payments and any lease

modifications not accounted for as separate leases.

Variable lease payments not included in the measurement of lease liabilities are recognised as an expense when incurred.

Leases of 12 months or less and leases of low value assets

Lease payments made in relation to leases of 12 months or less and leases of low value assets (for which a lease asset and a lease

liability has not been recognised) are recognised as an expense on a straight line basis over the lease term.

Key accounting estimates and judgements

Extension and termination options are included in a number of leases across the Group. These terms are used to maximise the

operational flexibility of contracts. The majority of extension and termination options are exercisable only by the Group and not by the

respective lessor. In determining the lease term management considers all facts and circumstances that lead to an economic incentive

to exercise an extension option or not exercise a termination option. Extension options or periods after termination options are

only included in the lease term if the lease is reasonably certain to be exercised. This assessment is reviewed if a significant event or

significant change in circumstances occurs which effects this assessment and that is within the Group’s control. All extension options

have been assumed for the calculations of the Groups’ lease liabilities.

The lease payments are discounted using the interest rate implicit in the lease. If that rate cannot be readily determined, which is

generally the case for leases in the Group, the lessee’s incremental borrowing rate is used, being the rate that the individual lessee

would have to pay to borrow the funds necessary to obtain an asset of similar value to the right-of-use asset in a similar economic

environment with similar terms, security and conditions. The weighted average incremental borrowing rates applied by the Group is

5% (2020: 5%). No new leases were entered into during the year (2020: none) and no leases were modified or cancelled during the

year (2020: one was cancelled).

Radius Residential Care Limited
50

Notes to the Consolidated Financial Statements continued

2021 2020

$’000 $’000

(a) Right-of-use assets

Land and Buildings under lease 191,603 188,574

Accumulated depreciation (14,433) (7,143)

Total carrying amount of right-of-use assets 177,170 181,431

Reconciliations

Reconciliation of the carrying amount of lease assets at the beginning and end of the financial year:

Land and buildings

Opening carrying amount 181,431 192,205

Additions - 1,393

Depreciation (7,290) (7,211)

Remeasurements 3,029 1,861

Disposals - (6,817)

Closing carrying amount 177,170 181,431

(b) Lease liabilities

Current

Land and buildings 4,051 3,907

Non-current

Land and buildings 180,254 181,397

184,305 185,304

(c) Lease expenses and cash flows

Interest expense on lease liabilities 8,823 9,400

Depreciation expense on right-of-use assets 7,290 7,211

Cash outflow in relation to leases 12,850 12,435

(d) Maturity analysis - contractual undiscounted cash flows:

- Not later than 1 year 12,933 12,710

- Later than 1 year and not later than 5 years 52,035 51,105

- Later than 5 years 292,002 300,654

356,970 364,469

Annual Report 2021
51

4. Shareholder Equity and Funding

4.1 Shareholder Equity and Reserves

Accounting policy

Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new shares are shown in equity as a

deduction, net of tax, from the proceeds.

The grant date fair value of equity settled share-based payment arrangements granted to employees is recognised as an expense, with

a corresponding increase in equity.

2021 2020

Shares $’000 Shares $’000

Share Capital

Authorised, issued and fully paid up capital 176,495,000 5,932 12,500,000 4,736

Total contributed equity 176,495,000 5,932 12,500,000 4,736

Movements

Opening balance of ordinary shares issued 12,500,000 4,736 12,500,000 4,736

Share split 162,500,000 - - -

Shares issued to employees and service providers 1,495,000 1,196 - -

Closing balance of ordinary shares issued 176,495,000 5,932 12,500,000 4,736


All ordinary shares are authorised and rank equally with one vote attached to each fully paid ordinary share. The shares have no par

value. The Group incurred no transaction costs issuing shares during the period (2020:$nil).

Share split

On 8 December 2020 the Group undertook a 14:1 split of existing ordinary shares prior to listing on the NZX.

Shares issued to employees and service providers

Shares $’000

On 10 December 2020 the Company issued 1,245,000 new ordinary shares as follows:

838,750 shares (@ $0.80 per share) were issued to employees

as share based payments.* 838,750 671

250,000 shares (@ $0.80 per share) were issued to Duncan Cook, Director

for legal services rendered to the group and for services provided in connection

with the Company’s listing on the NZX.*


250,000 200

156,250 shares (@ $0.80 per share) were issued to Tom Wilson for consultancy

services rendered to the Group and for services provided to the Group in

connection with the Company’s listing on the NZX.*


156,250 125

1,245,000 996

Also on 10 December 2020, 250,000 (@ $0.80 per share) ordinary shares were issued to

Harmos Horton Lusk Limited in consideration for $200,000 of legal services

provided to the Group in connection with the Company’s listing on the NZX.* 250,000 200

1,495,000 1,196

Radius Residential Care Limited
52

Notes to the Consolidated Financial Statements continued

* On 10 December 2020 when the Group listed, 1,245,000 new shares were issued at $0.80 per share which was determined to be the

fair value on issuance by the Board of Directors. This value was derived by using a market approach valuation technique. The technique

used was the multiples method utilising comparable company analysis. This involved comparing the Group’s implied enterprise value

/ underlying earnings before interest, tax depreciation and amortisation to its retirement village and aged care listed peers in New

Zealand. The valuation was assessed using independent advisor reports prepared to assist the Directors in establishing the share price.

As the fair value of shares issued as share based payments was determined using inputs that are significant and unobservable, the

Group has categorised these inputs as Level 3 under the fair value hierarchy in accordance with NZ IFRS 13 Fair Value Measurement. The

significant unobservable inputs used in the fair value measurement of the Group’s shares was the market multiples applied. A significant

increase/(decrease) in the market multiples would result in a significantly higher/(lower) fair value measurement.

The total share based payments expense recognised for the year ended 31 March 2021 was $996k (refer to subtotal above) and a

further $468k in PAYE, totalling $1,464k.

Dividends

Dividend distributions to shareholders are recognised as a liability in the period in which dividends are declared. On 5 February 2021

a dividend of $0.00576031 per share (fully imputed) was declared and was paid on 26 February 2021 (2020: On 28 June 2019, a

dividend of $0.0180 per share (fully imputed) was declared and was paid on 28 June 2019).

Asset Revaluation Reserve

The asset revaluation reserve is used to record the revaluation of freehold land and buildings.

4.2 Earnings per share

Basic and diluted

Basic earnings per share is calculated by dividing the (loss)/profit after tax of the Group by the weighted average number of ordinary

shares outstanding during the year. Diluted earnings per share is calculated by adjusting the weighted average number of ordinary

shares outstanding to assume conversion of all dilutive potential ordinary shares. As at 31 March 2021, there were no shares with a

dilutive effect (31 March 2020: none) and therefore basic and diluted earnings per share were the same.

2021 2020 2020*

Profit/(Loss) after tax ($’000) 1,705 (2,833) (2,833)

Weighted average number of ordinary shares outstanding (‘000s) 175,455 12,500 175,000

Cents per share 0.97 (22.66) (1.62)

* As described above a 14:1 share split took place on 8 December 2020, the Group has also presented the basic earnings per share for

the year ended 31 March 2020 taking into consideration this share split.

4.3 Borrowings

Accounting policy

Borrowings are initially recognised at fair value, including transaction costs incurred. Borrowings are subsequently measured at

amortised cost. Any difference between the proceeds (net of transaction costs) and the redemption amount is recognised in the

Statement of Comprehensive Income over the period of the borrowings, using the effective interest method.

Specific borrowing costs directly attributable to the acquisition, construction or production of qualifying assets, which are assets that

necessarily take a substantial period of time to get ready for their intended use or sale, are added to the cost of those assets, until

such a time as the assets are substantially ready for their intended use. Other borrowing costs are recognised in the Statement of

Comprehensive Income in the period in which they are incurred. The borrowing costs capitalised during the period was $49,000 (2020:

$130,000). The related borrowing costs were solely for the villages under development (note 3.1).

Annual Report 2021
53

2021 2020

$’000 $’000

Secured Liabilities

Current

Bank Loans 1,000 500

Non-Current

Bank Loans 26,212 30,927

27,212 31,427

Terms and conditions and assets pledged as security

Effective

Current Non-current Facility interest Expiry

Limit rate date

$’000 $’000 $’000 %

31 March 2021

Committed Cash Advance - 17,387 18,000 2.01% 29 April 2023

Committed Cash Advance - 9,825 9,825 1.76% 29 July 2023

- 27,212 27,825

31 March 2020


Committed Cash Advance - 19,583 19,583 2.10% 29 April 2021

Revolving Committed Cash Advance - 2,019 3,000 2.18% 3 June 2021

Committed Cash Advance - 9,825 9,825 2.56% 29 July 2022

- 31,427 32,408

Security

The bank loans of the Group are guaranteed by certain Group entities and secured by mortgages over the Group’s care centre

freehold land and buildings and rank second behind the Statutory Supervisors when the land and buildings are classified as

investment property and investment property under development.

As at 31 March 2021 the balance of the bank loans over which the properties are held as security is $9,825k (31 March 2020:

$11,844k), the total commitment as at 31 March 2021 is $9,825k (31 March 2020: $12,825k).

Other

The Group has a Corporate Banking Overdraft Facility Agreement with ASB Bank Limited (ASB) for $1.5m (2020: $1.5m) that has an

expiry date on 31 March 2049 (2020: 31 March 2049). This facility bears interest at an effective interest rate of 3.75% (2020: 4.04%)

and is secured over the assets of the Group and guaranteed by certain Group entities. At reporting date this overdraft facility was not

drawn (2020:$Nil).

Financing arrangements

Under the Group’s bank loan arrangements with ASB, the Group must comply with externally imposed banking covenant. These

covenants are tested and reported to the ASB on a quarterly basis. During the year ended 31 March 2021, the Group complied with

all externally imposed banking covenant requirements to which it is subject (2020: complied with all). The Group has agreed with

its banks that the calculation of Adjusted EBITDA (Earnings Before Interest, Tax, Depreciation and Amortisation) and Net Interest, for

the purposes of the financial covenants, shall continue to be based on the accounting treatment in use before the introduction and

adoption of NZ IFRS 16 Leases.

Radius Residential Care Limited
54

Notes to the Consolidated Financial Statements continued

5. Other Disclosure

5.1 Income Tax

Accounting policy

Current income tax expense or credit is the tax payable on the current period’s taxable income based on the applicable income tax

rate adjusted by changes in deferred tax assets and liabilities.

Deferred tax assets and liabilities are recognised for temporary differences at the applicable tax rates when the assets are expected

to be recovered or liabilities are settled. Deferred tax liabilities are not recognised if they arise from the initial recognition of goodwill.

Deferred income tax is also not recognised if it arises from the initial recognition of an asset or liability in a transaction other than a

business combination that at the time of the transaction affects neither accounting nor taxable profit or loss.

Deferred tax assets are recognised for deductible temporary differences and unused tax losses only if it is probable that future taxable

amounts will be available to utilise those temporary differences and losses.

Current and deferred tax balances attributable to amounts recognised directly in equity are also recognised directly in equity.

Key accounting estimates and judgements

Deferred tax on Investment Property

Deferred tax on investment property is assessed on the basis that the asset value will be realised through use (“Held for Use”).

An initial recognition exemption has been applied to newly developed village sites in accordance with NZ IAS 12, Income Taxes.

The Group’s ORAs comprise two distinct cash flows (being an ORA deposit upon entering the unit and the refund of this deposit upon

exit). In determining the tax base of investment property, the Group considered whether taxable cash flows are received at the end of

the ORA period (i.e. upon refund of the ORA deposit by way of set off on exit by a resident) or at the beginning of the ORA period (i.e.

at time of the receipt of the ORA deposit). The Group has carefully evaluated all the available information and considers it appropriate

to recognise and measure the tax base and associated deferred tax based on the taxable cash flows being receivable at the end of the

ORA period as this best represents the Group’s contractual entitlement.

In calculating deferred tax under the Held for Use methodology, the Group has made significant judgements to determine taxable

temporary differences. The carrying value of the Group’s investment property is determined on a discounted cash flow basis and

includes cash flows that are both taxable and non-taxable in the future. The Group has recognised deferred tax on the cash flows with

a future tax consequence being DMF as provided by CBRE, to the extent that it arises from depreciable components (i.e. buildings)

of the investment property. The Group uses the valuers’ valuations to estimate the apportionment of cash flows arising from the

depreciable (i.e. buildings) and non-depreciable components (i.e. land).

2021 2020

$’000 $’000

(a) Components of tax expense/(benefit)

Current tax 2,155 1,033

Deferred tax (1,831) (1,533)

324 (500)

Annual Report 2021
55

2021 2020

$’000 $’000

(b) Income tax reconciliation

The prima facie tax payable on profit before tax is reconciled to the income tax expense as follows:

Prima facie income tax payable on profit before tax at 28.0% 568 (933)

Permanent differences (443) 268

Under provision for income tax in prior year 223 165

Other (24) -

Income tax expense/(benefit) attributable to profit 324 (500)

(c) Deferred tax

Deferred tax relates to the following:

Non-current asset

Deferred tax assets

The balance comprises:

Lease liabilities 51,605 51,885

Provisions 1,970 1,408

Deferred management fee income 765 659

54,340 53,952

Deferred tax liabilities

The balance comprises:

Property, plant and equipment 1,098 1,145

Right-of-use assets 49,607 50,801

50,705 51,946

Net deferred tax assets 3,635 2,006

(d) Deferred income tax revenue comprises

Through profit/(loss) included in income tax expense

(Increase)/decrease in deferred tax assets (388) 1,677

Decrease in deferred tax liabilities (1,443) (3,210)

(1,831) (1,533)

Through other comprehensive income

Increase in deferred tax liabilities 202 1,339

Through other comprehensive income included in revaluation of property,

plant and equipment 202 1,339

Increase in deferred tax liabilities (1,629) (194)

Deferred tax assets are recognised for deductible temporary differences as Management considers that it is probable that future

taxable profits will be available to utilise those temporary differences.

Radius Residential Care Limited
56

Notes to the Consolidated Financial Statements continued

2021 2020

$’000 $’000

(e) Imputation credits available for use in subsequent periods

Balance at the beginning of the year 4,104 3,380

Dividends paid (285) (88)

New Zealand tax payments, net of refunds 1,744 814

Other debits (14) (2)

Balance at the end of the year 5,549 4,104


5.2 Intangible Assets

Accounting policy

Goodwill

Goodwill represents the future economic benefits arising from other assets acquired in a business combination that are not

individually identifiable or separately recognised. Goodwill is initially recognised at an amount equal to the excess of: (a) the aggregate

of the consideration transferred, the amount of any non controlling interest, and the acquisition date fair value of the acquirer’s

previously held equity interest (in the case of a step acquisition), over (b) the net fair value of the identifiable assets acquired and

liabilities assumed. For accounting purposes, such measurement is treated as the cost of goodwill at that date.

Goodwill is not amortised, but is tested for impairment annually, or more frequently if events or changes in circumstances indicate that

it might be impaired. Subsequent to initial recognition, goodwill is measured at cost less any accumulated impairment losses.

2021 2020

$’000 $’000

Goodwill at cost 16,996 16,996

Key accounting estimates and judgements

Goodwill has been assessed as having indefinite useful lives, as there is no foreseeable limit to the period over which the asset is

expected to generate net cash inflow for the Group.

Goodwill is allocated to twenty individual CGUs within the residential care business (various acquired residential care facilities).

Corporate office cash flows incurred by the Group as a whole cannot be allocated to individual CGUs on a reasonable basis. Therefore,

these cash flows and related corporate assets are impairment tested at the overall Group level.

The recoverable amount of CGUs as at reporting date has been determined based on its fair value less costs of disposal, determined

using discounted cash flows (2020: based on its value-in-use, determined by discounting the future cash flows to be generated from

its continuing use of the CGU) that includes Management’s estimates based on past performance and its expectation for the future

performance for up to 3 years. These estimates are based on budgeted projections of occupancy levels, sales growth and changes

to cost structures. Cash flows from performance thereafter are estimated using a standard growth rate deemed to be reasonable by

Management.

Annual Report 2021
57

The key assumptions used for discounted cash flows (2020: value-in-use) calculations are as follows:

• The year 1 forecast cash flows are based on Management forecasts approved by the Board of Directors

• The year 2 and 3 forecast cash flow period growth rate used in the calculations was 3.0% (2020: 3.0%)

• The cash flow period used in the calculations was 3 years (2020: 3 years)

• The pre-tax discount rate applied in the calculations was between 12.6% and 13.3% (2020: pre-tax 18.1%)

• The terminal growth rate applied in the calculations was 2.0% (2020: 2.0%)

• Occupancy projections vary between CGUs based on actual and expected occupancy rates.

Management believes that no reasonably possible changes in any of the above key assumptions would cause the carrying value of the

goodwill to be materially lower than its recoverable amount.

Care CGUs Recoverable Amount

The recoverable amount of the individual care sites as at 31 March 2021 has been determined based on fair value less costs of

disposal, determined using discounted cash flows. As the recoverable amount of individual care sites was determined using inputs

that are significant and unobservable, the Group has categorised these inputs as Level 3 under the fair value hierarchy in accordance

with NZ IFRS 13 Fair Value Measurement. The significant unobservable inputs used in the fair value measurement of the recoverable

amount of the Group’s individual care sites were as described above, year 1 to 3 forecast cash flows, a pre-tax discount rate, a terminal

growth rate and occupancy projections based on actual and expected occupancy rates.

• A significant increase/(decrease) in the forecast cash flows, terminal growth rate, and occupancy projections and rates,

assumptions would result in a significantly higher/(lower) fair value measurement.

• A significant increase/(decrease) in the pre-tax discount rate would result in a significantly (lower)/higher fair value measurement.


5.3 Trade and Other Receivables

Accounting policy

Trade receivables are amounts due from residents and Government agencies in the ordinary course of business and are recognised

initially at fair value being the transaction price plus any transaction costs. Subsequent to initial recognition, receivables from

contracts with customers are measured at amortised cost and are tested for impairment.

2021 2020

$’000 $’000

Current

Trade receivables 6,945 7,097

Allowance for credit losses (722) (688)

6,223 6,409

Grant receivable - 353

NZX listing bond 75 -

Prepayments 522 492

Accrued Income 10 6

Development costs 777 207

7,607 7,467

Non-current

Prepayments 5 17

Accrued Income 132 164

137 181

7,744 7,648

Radius Residential Care Limited
58

Notes to the Consolidated Financial Statements continued

Recognition, measurement and judgements in applying accounting policies

When measuring expected credit losses (‘ECL’) the Group uses reasonable and supportable forward looking information, which is

based on assumptions for future movement of different economic drivers and how these drivers will affect each other.

The expected credit losses on trade receivables are estimated using a provision matrix by reference to past default experience of

the debtors and an analysis of the debtors’ current financial positions, adjusted for factors that are specific to the debtors, general

economic conditions of the industry in which the debtors operate and an assessment of both the current as well as the forecast

direction of conditions at the reporting date.

The Group has the following financial assets subject to the application of the expected credit loss model:

• Trade receivables from care operations for the provision of care fees revenue for rest home and hospital fees. These are split

between private amounts owed by residents and amounts due from agencies such as the Ministry of Health and Accident

Compensation Corporation.

• Trade receivables from village operations for the provision of weekly service fees and occupation licence payment receivables.

These are receivable from residents.

The following table provides information about the risk profile of trade receivables from contracts with residents and Government

agencies using a provision matrix. The information in the below table does not distinguish between resident or product types as the

Group’s historical credit loss experience does not show different patterns for different resident or product types.

12-month expected credit losses

Days past due

Not past due 31-60 61-90 91 and over Total

2021

Estimated total gross carrying amount at default (‘$000) 5,152 434 246 1,113 6,945

Expected credit loss rate (%) 0.3% 0.5% 2.9% 62.7% 10.4%

Expected credit loss rate (‘$000) 16 2 7 697 722

2020

Estimated total gross carrying amount at default (‘$000) 4,280 754 357 1,706 7,097

Expected credit loss rate (%) 0.4% 0.5% 3.6% 38.3% 9.7%

Expected credit loss rate (‘$000) 18 4 13 653 688

5.4 Trade and Other Payables

Accounting policy

Trade payables are recognised initially at fair value less transaction costs and subsequently measured at amortised costs using the

effective interest method.

Employee benefits

(i) Short-term employee benefit obligations

Liabilities arising in respect of wages and salaries, annual leave and other employee benefits (other than termination benefits)

expected to be settled wholly before twelve months after the end of the reporting period are measured at the (undiscounted)

amounts based on remuneration rates which are expected to be paid when the liability is settled.

Annual Report 2021
59

(ii) Long-term employee benefit obligations

The provision for other long-term employee benefits, including obligations for long service leave and annual leave, which are not

expected to be settled wholly before twelve months after the end of the reporting period, are measured at the present value of the

estimated future cash outflow to be made in respect of the services provided by employees up to the reporting date.

When the Group does not have an unconditional right to defer settlement for at least twelve months after the reporting date, those

employee entitlements are presented as current. All other long-term employee benefit obligations are presented as non-current

liabilities.

(iii) Retirement benefit obligations: Defined contribution superannuation plan

The Group makes superannuation contributions to the employee’s defined contribution superannuation plan of choice in respect

of employee services rendered during the year. These superannuation contributions are recognised as an expense in the same

period when the related employee services are received. The Group’s obligation with respect to employee’s defined contributions

entitlements is limited to its obligation for any unpaid superannuation guarantee contributions at the end of the reporting period.

2021 2020

$’000 $’000

Current

Unsecured liabilities

Trade creditors 3,893 4,574

GST payable 714 690

Other payable 33 11

Accrued expenses 926 610

Annual leave 5,339 4,219

Other employee entitlements 3,846 3,822

Deferred government grants income 160 160

14,911 14,086


5.5 Related Party Transactions

Subsidiaries are entities controlled by the Group. The Group controls an entity when it is exposed to, or has rights to, variable returns

from its involvement with the entity and has the ability to affect those returns through its power over the entity.

The financial statements of subsidiaries are prepared for the same reporting period as the parent entity, using consistent accounting

policies. Adjustments are made to bring into line any dissimilar accounting policies which may exist.

All intercompany transactions and balances are eliminated. The subsidiaries are consolidated from the date the Group gains control

until the date on which control ceases.

Radius Residential Care Limited
60

Notes to the Consolidated Financial Statements continued

Subsidiaries

The following are the Group’s subsidiaries

Ownership interests

and voting rights

Class of

Name of Entity Principal Activities 2021 2020 shares

Radius Arran Court Limited Lessee entity for Radius Arran Court facility 100% 100% Ordinary

Windsor Lifestyle Estate Limited Operating entity for Windsor retirement village 100% 100% Ordinary

Radius Care Limited (non-trading) Dormant 100% 100% Ordinary

Elloughton Grange Village Limited Operating entity for Elloughton retirement village 100% 100% Ordinary

Radius Care Holdings Limited Property owning entity for St Helenas,

Thornleigh Park and Lexham Park facilities 100% 100% Ordinary

On 1 May 2020, Radius Health Limited, a wholly owned subsidiary of the Group was amalgamated into Radius Residential Care Limited.

All subsidiaries are incorporated in New Zealand and have a balance date of 31 March.

Key management personnel compensation and other related parties

Key management personnel are all executives with the authority for the strategic direction and management of the Group.


Related Party Relationship

Brien Cree Director and Ultimate Shareholder

Duncan Cook Director and Shareholder

Bret Jackson Director and Ultimate Shareholder

Timothy Sumner Director and Ultimate Shareholder

Mary Gardiner Director

Hamish Stevens Director

Wave Rider Holdings Limited Shareholder

Knox Radius LP Shareholder

Knox Fund IV AUD LP Shareholder

Knox Fund IV NZD LP Shareholder

Sharp Tudhope Lawyers Limited Consultant (Duncan Cook)

Cibus Catering Limited Common Director (Brien Cree)

Valhalla Capital Limited Common Director (Brien Cree)

Harmos Horton Lusk Limited Shareholder

Tom Wilson Shareholder

Time Capital NZ Limited Director (Tom Wilson)

Annual Report 2021
61

2021 2020

$’000 $’000

Directors’ remuneration and expenses 410 107

Dividends to director related entities 523 225

Key Management personnel salaries and other short term employee benefits 1,294 880

Key Management personnel dividends 3 -

2,230 1,212

Other related parties

Trade creditors

- Cibus Catering Limited 86 54

Trade debtors

- Cibus Catering Limited 7 7

Legal Fees

- Sharp Tudhope Lawyers Limited 149 63

- Duncan Cook - Share based payments 299 -

- Harmos Horton Lusk Limited 547 -

- Harmos Horton Lusk Limited - Share based payments 200 -

2021 2020

$’000 $’000

Personal guarantee fee

- Brien Cree 85 -

Management fee expense

- Knox Radius LP - 83

Catering services

- Cibus Catering Limited 4,777 4,872

Consulting fees

- Time Capital NZ Limited (since Tom Wilson became a shareholder) 33 -

- Tom Wilson - share based payments 125 -

Purchase of property, plant and equipment

- Valhalla Capital - Ashburton Laundry Assets - 550

Assignment of an agreement for the purchase of land from a Director

Brien Cree (Director) and the Group are party to an agreement (“the Assignment Agreement”), whereby, Brien has agreed to assign to

the Group his rights under an agreement for sale and purchase of real estate (“Land SPA”), to acquire a circa 4.3 hectare development

property at Main North Road, Belfast, Christchurch (‘the development property’) from an unrelated third party.

Radius Residential Care Limited
62

Notes to the Consolidated Financial Statements continued

The purchase price under the Land SPA is $5.8m, of which a non-refundable deposit of $300k had already been paid by Brien, with the

balance payable on the date of settlement, being 16 April 2021.

The Assignment Agreement also requires the Group to pay the Brien an additional $400k on 16 April 2021, for preserving the

development opportunity for the Group and for taking the risk on resource consent being obtained at a time that the Group was not

able to respond to the opportunity the land presented.

A condition of the Assignment Agreement was approval of the transaction by the Board of the Group by 2 April 2021. On 2 April 2021

the Board (excluding Brien as an interested director) exercised its right to approve the Assignment Agreement and the Group now

holds the rights to acquire the development property. The Board approved the Assignment Agreement on 2 April 2021, as the Group

had obtained:

• resource consent and funding for the development of an integrated aged care facility and retirement village on the property; and

• an independent valuation had confirmed that the property’s fair value after resource consent exceeded the purchase price of the

property (including the additional $400k consideration payable to Brien).

The Group paid Brien for the $300k non-refundable deposit in July 2020 and the additional $400k on 16 April 2021.

The balance of the purchase price under the SPA amounting to $5.5m is payable to the third party vendor on settlement, which will be

completed when the title of the property is issued. It is currently expected that title will be issued prior to 31 March 2022.


5.6 Financial Risk Management

The Group is exposed to the following financial risks in the normal course of business:

(a) Credit risk

(b) Liquidity risk

(c) Interest rate risk

The Board of Directors reviews and agrees on policies for managing each of these risks as summarised below:

2021 2020

Note $’000 $’000

Financial Assets

Amortised cost

Cash and cash equivalents 2,761 2,317

Trade receivables 5.3 6,223 6,409

Total assets 8,984 8,726

Financial Liabilities

Amortised cost

Trade and other payables 5.4 5,566 5,885

Lease liabilities 3.4 184,305 185,304

Borrowings 4.3 27,212 31,427

Refundable occupation right agreements 3.3 20,591 17,518

Total liabilities 237,674 240,134

(a) Credit Risk

Credit risk is the risk that one party to a financial instrument will cause a financial loss for the other party by failing to discharge an

obligation.

The Group’s exposure to credit risk, or the risk of counterparties defaulting arises mainly from cash at bank, trade and other

receivables.

Annual Report 2021
63

The maximum exposure to credit risk, excluding the value of any collateral or other security, at reporting date, of recognised financial

assets is the carrying amount of those assets, net of any provisions for impairment of those assets, as disclosed in the consolidated

statement of financial position and notes to consolidated financial statements.

The Group has no significant concentrations of credit risk. The Group’s trade receivables represent distinct trading relationships with

each of its residents and various Government agencies. The only large trade receivables relate to residential care subsidies which are

receivable in aggregate from various District Health Boards and Work and Income New Zealand. These entities are not considered a

credit risk.

The Group does not have any material credit risk exposure to any single counterparty or group of counterparties under financial

instruments entered into by the Group.

(i) Cash deposits and other receivables

Credit risk for cash deposits is managed by holding all cash deposits with high credit rating financial institutions, i.e. major registered

New Zealand banks.

(ii) Trade receivables

Credit risk with respect to trade receivables is limited due to the large number of customers which qualify for Ministry of Health

funding in relation to payment of our services. Amounts owed by the residents are generally unsecured. Credit risk is managed

through the use of admission agreements for all residents, which gives contractual rights to the Group in relation to security and

collection of debts in circumstances where there is no entitlement to Ministry of Health funding. All admissions are reviewed to ensure

a duly completed admission agreement is available. The loss allowance for expected credit losses of trade receivables is provided in

note 5.3. As the Group undertakes transactions with a large number of customers and regularly monitors payment in accordance with

credit terms, the financial assets that are neither past due nor impaired, are expected to be received in accordance with the credit

risk.

(b) Liquidity risk

Liquidity risk is the risk that an entity will encounter difficulty in meeting obligations associated with financial liabilities.

The Group has liquidity risk with respect to its repayment obligations of financial liabilities.

The Group maintains a rolling 90 day forecast of daily cash flows to ensure it will have sufficient liquidity to meet its liabilities as they

fall due. This is linked to a monthly rolling forecast which provides directional liquidity expectations for a minimum of a further twelve

months.

The Group has a bank facility which is subject to certain covenant clauses, whereby it is required to meet certain key performance

indicators. This bank facility is provided by the ASB Bank.

The following table outlines the Group’s remaining contractual maturities for non-derivative financial instruments. The amounts

presented in the table are the undiscounted contractual cash flows of the financial liabilities allocated to time bands based on the

earliest date on which the Group can be required to pay:


Less than Between Between Over

1 year 1 and 2 years 2 and 5 years 5 years

$’000 $’000 $’000 $’000

2021

Trade and other payables 5,566 - - -

Lease liabilities 12,933 12,988 39,047 292,002

Borrowings - - 27,212 -

Refundable occupation right agreements* 20,591 - - -

39,090 12,988 66,259 292,002

Radius Residential Care Limited
64

Notes to the Consolidated Financial Statements continued

Less than Between Between Over

1 year 1 and 2 years 2 and 5 years 5 years

$’000 $’000 $’000 $’000

2020

Trade and other payables 5,885 - - -

Lease liabilities 12,710 12,723 38,382 300,654

Borrowings - 21,602 9,825 -

Refundable occupation right agreements* 17,518 - - -

36,113 34,325 48,207 300,654

* The refundable ORAs are repayable to the resident on vacation of the unit or on the termination of the occupation right agreement and subsequent resale of the unit. The

expected maturity of the refundable ORAs is shown in note 3.3.

c) Interest rate risk

The Group is exposed to interest rate risk in relation to its interest earning cash deposits and its interest bank borrowings. Interest

rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate as a result of changes in market

interest rates. The Group manages its interest rate risk by maintaining a mix of variable rate and fixed rate borrowings, and by utilising

interest rate swap contracts.


Interest rates on cash at bank are subject to market risk in the event of changes in interest rates. As these securities are carried at net

market value, the effective interest rate is reflected in the market price. Interest rates on non-current bank borrowings are generally

subject to review annually or at shorter intervals, and interest rates on current borrowings can be reviewed at the lender’s discretion.

The following table outlines that Group’s exposure to interest rate risk in relation to future cash flows and the effective weighted

average interest rates on classes of financial assets and financial liabilities:

Total

Interest Non-interest carrying Weighted average

bearing bearing amount effective interest rate

2021 $’000 $’000 $’000

Financial Instruments

Financial assets

Cash 2,761 - 2,761 0.0% Fixed

Financial liabilities

Bank and other loans (27,212) - (27,212) 1.9% Fixed

Lease liabilities (184,305) - (184,305) 5.0% Fixed

(211,517) - (211,517)

Annual Report 2021
65

Total

Interest Non-interest carrying Weighted average

bearing bearing amount effective interest rate

2020 $’000 $’000 $’000

Financial Instruments

Financial assets

Cash 2,317 - 2,317 0.0% Fixed

Financial liabilities

Bank and other loans (31,427) - (31,427) 2.3% Fixed

Lease liabilities (185,304) - (185,304) 5.0% Fixed

(216,731) - (216,731)


No other financial assets or financial liabilities are expected to be exposed to interest rate risk.

Sensitivity

If interest rates were to increase/decrease by 100 basis points from the rates prevailing at the reporting date, assuming all other

variables remain constant, then the impact of profit for the year and equity would be as follows:

2021 2020

$’000 $’000

+ / - 100 basis points

Impact on profit after tax (272) (314)

Impact on equity (196) (226)

5.7 Contingent Liabilities

Lester Heights business

On 26 June 2013, the Group entered into an agreement to sell the Lester Heights business. The sale was settled on 31 August 2013.

One of the conditions of sale is that in the event that the new business owner defaults on the rental payments, the Group is required

to guarantee the rent. For the years ended 31 March 2019 and 2020, no amounts were paid, but in the event that a default occurs, the

potential cost to the Group is an annual rent of $238k per annum until 2029. The Group will likely assume operations at this facility, in

the event of a default.

Other

There were no other material contingent liabilities at reporting date (2020:Nil).

5.8 Commitments

There were no material commitments at reporting date (2020: Nil).

Radius Residential Care Limited
66


67



/HYHO4XHHQ6WUHHW$XFNODQG

32%R[$XFNODQG

1HZ=HDODQG

T:

F: 

E:

DXFNODQG#EDNHUWLOO\VUQ]

W:ZZZEDNHUWLOO\VUQ]



INDEPENDENT AUDITOR’S REPORT

To the Shareholders of Radius Residential Care Limited

Report on the Audit of the Consolidated Financial Statements

Opinion

We have audited the consolidated financial statements of Radius Residential Care Limited and its subsidiaries

('the Group') on pages 28 to 66, which comprise the consolidated statement of financial position as at 31 March

2021, and the consolidated statement of comprehensive income, consolidated statement of changes in equity

and consolidated statement of cash flows for the year then ended, and notes to the consolidated financial

statements, including significant accounting policies.

In our opinion, the accompanying consolidated financial statements present fairly, in all material respects, the

consolidated financial position of the Group as at 31 March 2021, and its consolidated financial performance

and its consolidated cash flows for the year then ended in accordance with New Zealand Equivalents to

International Financial Reporting Standards ('NZ IFRS') and International Financial Reporting Standards ('IFRS').

Our report is made solely to the Shareholders of the Group. Our audit work has been undertaken so that we

might state to the Shareholders of the Group those matters we are required to state to them in an auditor’s

report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume

responsibility to anyone other than the Shareholders of the Group as a body, for our audit work, for our report

or for the opinions we have formed.

Basis for Opinion

We conducted our audit in accordance with International Standards on Auditing (New Zealand) ('ISAs (NZ)').

Our responsibilities under those standards are further described in the Auditor’s Responsibilities for the Audit of

the Consolidated Financial Statements section of our report. We are independent of the Group in accordance

with Professional and Ethical Standard 1 (Revised) International Code of Ethics for Assurance Practitioners

(including International Independence Standards) (New Zealand) issued by the New Zealand Auditing and

Assurance Standards Board and the International Ethics Standards Board for Accountants’ Code of Ethics for

Professional Accountants (including International Independence Standards) (‘IESBA Code’), and we have fulfilled

our other ethical responsibilities in accordance with these requirements and the IESBA Code. We believe that

the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Other than in our capacity as auditor and provider of other assurance services, our firm carries out other

assignments for Radius Residential Care Limited and its subsidiaries in the area of taxation compliance

services. The provision of these other services has not impaired our independence.

Notes to the Consolidated Financial Statements continued

5.9 Events subsequent to reporting date

Assignment of an agreement for the purchase of land from a Director

On 2 April 2021 the Board (excluding Brien Cree) exercised its right to approve an Assignment Agreement between the Group and

Brien Cree and now holds the rights under an agreement for sale and purchase of real estate to acquire 4.3 hectare development

property for a purchase price of $5.8m. Refer to Note 5.5 for the detailed disclosure.

Dividends

On 25 May 2021, the Board declared a final dividend of $0.00888048 per share (fully imputed), that will be paid on 21 June 2021.

Other

There has been no other matter or circumstance, which has arisen since 31 March 2021 that has significantly affected or may

significantly affect:

(a) the operations, in financial years subsequent to 31 March 2021, of the Group, or

(b) the results of those operations, or

(c) the state of affairs, in financial years subsequent to 31 March 2021, of the Group.

Annual Report 2021
67


67



/HYHO4XHHQ6WUHHW$XFNODQG

32%R[$XFNODQG

1HZ=HDODQG

T:

F: 

E:

DXFNODQG#EDNHUWLOO\VUQ]

W:ZZZEDNHUWLOO\VUQ]



INDEPENDENT AUDITOR’S REPORT

To the Shareholders of Radius Residential Care Limited

Report on the Audit of the Consolidated Financial Statements

Opinion

We have audited the consolidated financial statements of Radius Residential Care Limited and its subsidiaries

('the Group') on pages 28 to 66, which comprise the consolidated statement of financial position as at 31 March

2021, and the consolidated statement of comprehensive income, consolidated statement of changes in equity

and consolidated statement of cash flows for the year then ended, and notes to the consolidated financial

statements, including significant accounting policies.

In our opinion, the accompanying consolidated financial statements present fairly, in all material respects, the

consolidated financial position of the Group as at 31 March 2021, and its consolidated financial performance

and its consolidated cash flows for the year then ended in accordance with New Zealand Equivalents to

International Financial Reporting Standards ('NZ IFRS') and International Financial Reporting Standards ('IFRS').

Our report is made solely to the Shareholders of the Group. Our audit work has been undertaken so that we

might state to the Shareholders of the Group those matters we are required to state to them in an auditor’s

report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume

responsibility to anyone other than the Shareholders of the Group as a body, for our audit work, for our report

or for the opinions we have formed.

Basis for Opinion

We conducted our audit in accordance with International Standards on Auditing (New Zealand) ('ISAs (NZ)').

Our responsibilities under those standards are further described in the Auditor’s Responsibilities for the Audit of

the Consolidated Financial Statements section of our report. We are independent of the Group in accordance

with Professional and Ethical Standard 1 (Revised) International Code of Ethics for Assurance Practitioners

(including International Independence Standards) (New Zealand) issued by the New Zealand Auditing and

Assurance Standards Board and the International Ethics Standards Board for Accountants’ Code of Ethics for

Professional Accountants (including International Independence Standards) (‘IESBA Code’), and we have fulfilled

our other ethical responsibilities in accordance with these requirements and the IESBA Code. We believe that

the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Other than in our capacity as auditor and provider of other assurance services, our firm carries out other

assignments for Radius Residential Care Limited and its subsidiaries in the area of taxation compliance

services. The provision of these other services has not impaired our independence.

Radius Residential Care Limited
68

68

Key Audit Matters

Key audit matters are those matters that, in our professional judgement, were of most significance in our audit

of the consolidated financial statements of the current year. These matters were addressed in the context of

our audit of the consolidated financial statements as a whole, and in forming our opinion thereon, and we do

not provide a separate opinion on these matters.

Key audit matter How our audit addressed the key audit matter

Impairment testing of Goodwill

As

disclosed in Note 5.2 of the Group’s

consolidated financial statements, the Group

has goodwill of $17.0m allocated across 20

cash-generating units (‘CGUs’) as at 31

March 2021.

Goodwill was significant to our audit due to

the size of the asset and the subjectivity,

complexity and uncertainty inherent in the

measurement of the recoverable amount of

these CGUs for the purpose of the required

annual impairment test. The measurement of

a CGUs recoverable amount includes the

assessment and calculation of its ‘fair value

less costs of disposal’.

Management has completed the annual

impairment test for all CGUs as at 31 March

2021.

This annual impairment test involves

complex and subjective estimation and

judgement by Management on the future

performance of the CGUs, discount rates

applied to the future cash flow forecasts, the

terminal growth rates, costs of disposal and

future market and economic conditions.


Management has also engaged an external

valuation expert to assist in the annual

impairment testing.


Our audit procedures among others included:

•Understanding and evaluating the Group’s internal controls relevant to the

accounting estimates used to determine the recoverable value of the

Group’s CGUs.

•Evaluating Management’s determination of the Group’s CGUs base

d on

our understanding of the nature of the Group’s business and the economic

environment in which the segments operate. We also analysed the internal

reporting of the Group to assess how CGUs are monitored and reported.

•Evaluating the competence, capabilities, objectivity and expertise of

Management's external valuation expert and the appropriateness of the

expert's work as audit evidence for the relevant assertions.

•Challenging Management’s assumptions and estimates used

to

determine the recoverable value of the Group’s CGUs, including those

relating to forecasted revenue, costs, capital expenditure, discount rates,

by adjusting for future events and corroborating the key market-related

assumptions to external data

(including considering the impact of the

COVID-19 pandemic).

Procedures included:

oEvaluating the logic of the ‘fair value less costs of disposal’

calculations supporting Management’s annual impairment test

and testing the mathematical accuracy of these calculations;

oEvaluating Management’s process regarding the preparation and

review of forecasts

(balance sheet, income statement, and cash

flow statement);

oComparing forecasts used in the calculations to Board approved

forecasts;

oEvaluating the accuracy of the Group’s forecasting to actual

historical performance;

oEvaluating the forecast growth assumptions;

oEvaluating the inputs to the calculation of the discount rates

applied;

oEngaging our own internal valuation experts to evaluate the logic

of the ‘fair value less costs of disposal’ calculations and the inputs

to the calculations of the discount rates applied;

oEvaluating the forecasts, inputs and any underlying assumptions

with a view to identifying Management bias;

oEvaluating Management’s sensitivity analysis for reasonably

possible changes in key assumptions; and

oPerforming sensitivity analysis for reasonably possible changes in

key assumptions, the two main assumptions being: the discount

rate and forecast growth assumptions.

•Evaluating the related disclosures (including the accounting policies and

accounting estimates) about goodwill assets in the Group’s consolidated

financial statements.


69

Key audit matter How our audit addressed the key audit matter

Valuation of investment properties and freehold land

and buildings

As respectively disclosed in Notes 3.1 and 3.2 of the

Group’s consolidated financial statements, as at 31

March 2021, the Group has: investment properties

(operated by the Group as retirement villages) totalling

$31.7m; and

freehold land and buildings totalling

(operated by the Group for provision of care services)


$18.2m. For the purpose of this key audit matter, the

Group’s investment properties and freehold land and

buildings, when referred to, together or collectively as ‘the

properties’).


Investment properties and freehold land and buildings

were significant to our audit due to the size of the assets

and the subjectivity, complexity and uncertainty inherent

in estimating the fair value of the investment properties

and freehold land and buildings.

Management has engaged independent external valuers

(‘the Valuers’) to determine the fair value of the Group’s

investment properties and freehold land and buildings as

at 31 March 2021. The Valuers performed their work in

accordance with the International Valuation Standards

and the Australia and New Zealand Valuation and

Property Standards, NZ IFRS 13 Fair Value Measurement

and NZ IAS 40 Investment Property or NZ IAS 16 Property,

plant and equipment, respectively. The Valuers engaged

by the Group have appropriate experience in the sector in

which the Group operates.

For each investment property, the Valuers took into

account property specific information such as the income

generated by departures and the re-sale of independent

living units. They then applied assumptions in relation to,

the timing of unit re-sale, the length of occupancy of

existing residents, the price paid by new residents, price

movements, type of Occupancy Right Agreement,

discount rate, growth rate and terminal yield. The Valuer

also considered the individual characteristics of each

village, its location, its nature, its resident profile and the

expected future cash flows for that particular village.


For each freehold land and building property, the Valuers

took into account property specific information such as

capitalisation rates and earnings per care bed. The

Valuers also considered the individual characteristics of

each property, its location, and its nature.


The Group has adopted the assessed values determined

by the Valuers.

As at valuation date, the Valuers have included a

valuation uncertainty clause in their reports as a result of

the COVID-19 pandemic. This clause highlights the

difficulties in undertaking valuations due to the absence

of or limited relevant transactional evidence that

demonstrates current market pricing. Therefore, less

certainty and a higher degree of caution, should be

attached to the point estimate valuation.

This represents an increase in the significant estimation

uncertainty in the valuation of investment properties.

Given the valuation uncertainty, the Valuers have

recommended in their reports that the valuations of the

properties be kept under frequent review.


Our audit procedures among others included:

•Understanding and evaluating the Group’s internal controls

relevant to the accounting estimates used to determine the

fair value of the Group’s investment properties and freehold

land and buildings.

•Reading the external valuation reports for the Group’s

investment properties and freehold land and buildings as at

31 March 2021.

•Confirming that the valuation approaches for the properties

were in accordance with NZ IFRS 13 and NZ IAS 40 or NZ

IAS 16, respectively, and suitable for determining the fair

value of the Group’s investment properties and freehold land

and buildings as at 31 March 2021.

•Evaluating the competence, capabilities, objectivity and

expertise of Management's external valuation expert and the

appropriateness of the expert's work as audit evidence for

the relevant assertions.

•Agreeing property related data provided by Management to

the Valuers, to the Group’s records.

•Engaging our own external property valuation expert to

assist in understanding and evaluating the following, based

on their specialist knowledge from performing and reviewing

valuations of similar properties, known relevant transactional

evidence and available market data:

othe work and findings of the Group’s external valuation

expert engaged by Management;

o

the Group’s valuation methods and assumptions to

assist us in challenging the appropriateness of

valuation methods and assumptions used by

Management; and

othe acceptable range of values considered reasonable

to evaluate Management’s adopted valuation

estimate.

•Evaluating the selection of valuation methods, inputs and

assumptions with a view to identifying Management bias.

•Evaluating the related disclosures (including the accounting

policies and accounting estimates) about the investment

properties and freehold land and buildings which are

included in the Group’s consolidated financial statements

including disclosure on the valuation uncertainty as a result

of the COVID-19 pandemic.

Annual Report 2021
69

69

Key audit matter How our audit addressed the key audit matter

Valuation of investment properties and freehold land

and buildings

As respectively disclosed in Notes 3.1 and 3.2 of the

Group’s consolidated financial statements, as at 31

March 2021, the Group has: investment properties

(operated by the Group as retirement villages) totalling

$31.7m; and

freehold land and buildings totalling

(operated by the Group for provision of care services)


$18.2m. For the purpose of this key audit matter, the

Group’s investment properties and freehold land and

buildings, when referred to, together or collectively as ‘the

properties’).


Investment properties and freehold land and buildings

were significant to our audit due to the size of the assets

and the subjectivity, complexity and uncertainty inherent

in estimating the fair value of the investment properties

and freehold land and buildings.

Management has engaged independent external valuers

(‘the Valuers’) to determine the fair value of the Group’s

investment properties and freehold land and buildings as

at 31 March 2021. The Valuers performed their work in

accordance with the International Valuation Standards

and the Australia and New Zealand Valuation and

Property Standards, NZ IFRS 13 Fair Value Measurement

and NZ IAS 40 Investment Property or NZ IAS 16 Property,

plant and equipment, respectively. The Valuers engaged

by the Group have appropriate experience in the sector in

which the Group operates.

For each investment property, the Valuers took into

account property specific information such as the income

generated by departures and the re-sale of independent

living units. They then applied assumptions in relation to,

the timing of unit re-sale, the length of occupancy of

existing residents, the price paid by new residents, price

movements, type of Occupancy Right Agreement,

discount rate, growth rate and terminal yield. The Valuer

also considered the individual characteristics of each

village, its location, its nature, its resident profile and the

expected future cash flows for that particular village.


For each freehold land and building property, the Valuers

took into account property specific information such as

capitalisation rates and earnings per care bed. The

Valuers also considered the individual characteristics of

each property, its location, and its nature.


The Group has adopted the assessed values determined

by the Valuers.

As at valuation date, the Valuers have included a

valuation uncertainty clause in their reports as a result of

the COVID-19 pandemic. This clause highlights the

difficulties in undertaking valuations due to the absence

of or limited relevant transactional evidence that

demonstrates current market pricing. Therefore, less

certainty and a higher degree of caution, should be

attached to the point estimate valuation.

This represents an increase in the significant estimation

uncertainty in the valuation of investment properties.

Given the valuation uncertainty, the Valuers have

recommended in their reports that the valuations of the

properties be kept under frequent review.


Our audit procedures among others included:

•Understanding and evaluating the Group’s internal controls

relevant to the accounting estimates used to determine the

fair value of the Group’s investment properties and freehold

land and buildings.

•Reading the external valuation reports for the Group’s

investment properties and freehold land and buildings as at

31 March 2021.

•Confirming that the valuation approaches for the properties

were in accordance with NZ IFRS 13 and NZ IAS 40 or NZ

IAS 16, respectively, and suitable for determining the fair

value of the Group’s investment properties and freehold land

and buildings as at 31 March 2021.

•Evaluating the competence, capabilities, objectivity and

expertise of Management's external valuation expert and the

appropriateness of the expert's work as audit evidence for

the relevant assertions.

•Agreeing property related data provided by Management to

the Valuers, to the Group’s records.

•Engaging our own external property valuation expert to

assist in understanding and evaluating the following, based

on their specialist knowledge from performing and reviewing

valuations of similar properties, known relevant transactional

evidence and available market data:

othe work and findings of the Group’s external valuation

expert engaged by Management;

o

the Group’s valuation methods and assumptions to

assist us in challenging the appropriateness of

valuation methods and assumptions used by

Management; and

othe acceptable range of values considered reasonable

to evaluate Management’s adopted valuation

estimate.

•Evaluating the selection of valuation methods, inputs and

assumptions with a view to identifying Management bias.

•Evaluating the related disclosures (including the accounting

policies and accounting estimates) about the investment

properties and freehold land and buildings which are

included in the Group’s consolidated financial statements

including disclosure on the valuation uncertainty as a result

of the COVID-19 pandemic.

Radius Residential Care Limited
70

70

Key audit matter How our audit addressed the key audit matter

Valuation and completeness of lease

liabilities and right-of-use assets

As disclosed in Note 3.4 of the Group’s

consolidated financial statements, the Group

has lease liabilities of $184.3m, and, right-of-

use assets of $177.2m as at 31 March 2021.


Lease liabilities and right-of-use assets are

significant to our audit due to the size of the

assets and liabilities and the subjectivity,

complexity and uncertainty inherent in the

application of NZ IFRS 16 Leases and the

assumptions required by Management for the

calculations of the lease balances and interest

and depreciation expenses.


Management has completed calculations of

the lease balances for all leases for the year

ended, and as at 31 March 2021.

These calculations require estimates regarding

the lease term and the incremental borrowing

rates. In addition, Management has exercised

their judgement in determining the

recoverability of right-of-use assets. No

impairment has been determined.


Our audit procedures among others included:

•Understanding and evaluating the Group’s internal controls relevant to

the accounting estimates used to determine the expected term of the

Group’s leases and applicable incremental borrowing rates.

•Evaluating Management’s process relating to the identification,

recording, recognition and measurement of leases within the scope of

NZ IFRS 16.

•For all leases:

oAgreeing key inputs in the lease calculation to the underlying

lease agreement(s);

oRecalculating the lease liability and right-of-use assets based on

the key inputs noted above and comparing our recalculations to

the balances recognised by the Group; and

oChecking the appropriateness of the classification of the lease

liability between current and non-current based on the remaining

term of the lease.

•For all existing leases, evaluating Management’s calculations for the

subsequent measurement of the leases, including lease modifications

and rent revisions.

•Evaluating the completeness of identified lease contracts by checking

that all leased facilities were included in the calculation.

•Evaluating Management’s estimates regarding terms of the leases and

Management’s consideration of options to extend or terminate the

leases (including considering the impact of the COVID-19 pandemic).

•Evaluating Management’s assessment of the incremental borrowing

rates applied to individual leases or portfolios of leases.

•Evaluating the inputs and any underlying assumptions with a view to

identifying Management bias.

•Evaluating Management’s assessment of any indicators of impairment

for the right of use assets in accordance with NZ IAS 36 Impairment of

Assets (including considering the impact of the COVID-19 pandemic).

•Evaluating the disclosures (including the accounting policies and

accounting estimates) related to leases which are included in the

Group’s consolidated financial statements.

Other Matter - Non-NZ GAAP financial measures

Note 1(ii) of the consolidated financial statements describes that the consolidated financial statements include

the presentation of two non-NZ GAAP (non-Generally Accepted Accounting Practice in New Zealand) financial

measures in Note 2.1, which are presented in addition to NZ GAAP (Generally Accepted Accounting Practice in

New Zealand) financial measures. These two non-NZ GAAP financial measures are not defined under the

requirements of NZ GAAP, NZ IFRS and IFRS. Our opinion is not modified in respect of this matter.

Other Information

The Directors are responsible for the other information. The other information comprises the information

included in the Group’s annual report for the year ended 31 March 2021 (but does not include the consolidated

financial statements and our auditor’s report thereon).

71

Our opinion on the consolidated financial statements does not cover the other information and we do not

express any form of audit opinion or assurance conclusion thereon.

In connection with our audit of the consolidated financial statements, our responsibility is to read the other

information and, in doing so, consider whether the other information is materially inconsistent with the

consolidated financial statements or our knowledge obtained in the audit, or otherwise appears to be materially

misstated.

If, based on the work we have performed, we conclude that there is a material misstatement of this other

information, we are required to report that fact. We have nothing to report in this regard.

Responsibilities of the Directors for the Consolidated Financial Statements

The Directors are responsible on behalf of the Group for the preparation and fair presentation of the

consolidated financial statements in accordance with NZ IFRS and IFRS, and for such internal control as the

Directors determine is necessary to enable the preparation of the consolidated financial statements that are

free from material misstatement, whether due to fraud or error.

In preparing the consolidated financial statements, the Directors are responsible on behalf of the Group for

assessing the Group’s ability to continue as a going concern, disclosing, as applicable, matters related to going

concern and using the going concern basis of accounting unless the Directors either intend to liquidate the

Group or to cease operations, or have no realistic alternative but to do so.

Auditor’s Responsibilities for the Audit of the Consolidated Financial Statements

Our objectives are to obtain reasonable assurance about whether the consolidated financial statements as a

whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that

includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit

conducted in accordance with ISAs (NZ) will always detect a material misstatement when it exists.

Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they

could reasonably be expected to influence the economic decisions of users taken on the basis of these

consolidated financial statements.

As part of an audit in accordance with ISAs (NZ), we exercise professional judgement and maintain professional

scepticism throughout the audit. We also:

ƒIdentify and assess the risks of material misstatement of the consolidated financial statements, whether

due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit

evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a

material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve

collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

Annual Report 2021
71

71

Our opinion on the consolidated financial statements does not cover the other information and we do not

express any form of audit opinion or assurance conclusion thereon.

In connection with our audit of the consolidated financial statements, our responsibility is to read the other

information and, in doing so, consider whether the other information is materially inconsistent with the

consolidated financial statements or our knowledge obtained in the audit, or otherwise appears to be materially

misstated.

If, based on the work we have performed, we conclude that there is a material misstatement of this other

information, we are required to report that fact. We have nothing to report in this regard.

Responsibilities of the Directors for the Consolidated Financial Statements

The Directors are responsible on behalf of the Group for the preparation and fair presentation of the

consolidated financial statements in accordance with NZ IFRS and IFRS, and for such internal control as the

Directors determine is necessary to enable the preparation of the consolidated financial statements that are

free from material misstatement, whether due to fraud or error.

In preparing the consolidated financial statements, the Directors are responsible on behalf of the Group for

assessing the Group’s ability to continue as a going concern, disclosing, as applicable, matters related to going

concern and using the going concern basis of accounting unless the Directors either intend to liquidate the

Group or to cease operations, or have no realistic alternative but to do so.

Auditor’s Responsibilities for the Audit of the Consolidated Financial Statements

Our objectives are to obtain reasonable assurance about whether the consolidated financial statements as a

whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that

includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit

conducted in accordance with ISAs (NZ) will always detect a material misstatement when it exists.

Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they

could reasonably be expected to influence the economic decisions of users taken on the basis of these

consolidated financial statements.

As part of an audit in accordance with ISAs (NZ), we exercise professional judgement and maintain professional

scepticism throughout the audit. We also:

ƒIdentify and assess the risks of material misstatement of the consolidated financial statements, whether

due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit

evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a

material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve

collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

Radius Residential Care Limited
72

72

ƒObtain an understanding of internal control relevant to the audit in order to design audit procedures that

are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness

of the Group’s internal control.

ƒEvaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates

and related disclosures made by management.

ƒConclude on the appropriateness of the use of the going concern basis of accounting by the Directors and,

based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions

that may cast significant doubt on the Group’s ability to continue as a going concern. If we conclude that

a material uncertainty exists, we are required to draw attention in our auditor’s report to the related

disclosures in the consolidated financial statements or, if such disclosures are inadequate, to modify our

opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor’s report.

However, future events or conditions may cause the Group to cease to continue as a going concern.

ƒEvaluate the overall presentation, structure and content of the consolidated financial statements, including

the disclosures, and whether the consolidated financial statements represent fairly the underlying

transactions and events in a manner that achieves fair presentation.

ƒObtain sufficient appropriate audit evidence regarding the financial information of the entities or business

activities within the Group to express an opinion on the consolidated financial statements. We are

responsible for the direction, supervision and performance of the group audit. We remain solely responsible

for our audit opinion.

We communicate with the Directors regarding, among other matters, the planned scope and timing of the audit

and significant audit findings, including any significant deficiencies in internal control that we identify during

our audit.

We also provide the Directors with a statement that we have complied with relevant ethical requirements

regarding independence, and to communicate with them all relationships and other matters that may

reasonably be thought to bear on our independence, and where applicable, related safeguards.

From the matters communicated with the Directors, we determine those matters that were of most significance

in the audit of the consolidated financial statements of the current year and are therefore the key audit matters.

We describe these matters in our auditor’s report unless law or regulation precludes public disclosure about

the matter or when, in extremely rare circumstances, we determine that a matter should not be communicated

in our report because the adverse consequences of doing so would reasonably be expected to outweigh the

public interest benefits of such communication.



73

Matters Relating to the Electronic Presentation of the Audited Consolidated Financial Statements

This audit report relates to the consolidated financial statements of Radius Residential Care Limited and its

subsidiaries for the year ended 31 March 2021 included on Radius Residential Care Limited ’s website. The

Directors of Radius Residential Care Limited are responsible for the maintenance and integrity of Radius

Residential Care Limited ’s website. We have not been engaged to report on the integrity of Radius Residential

Care Limited ’s website. We accept no responsibility for any changes that may have occurred to the

consolidated financial statements since they were initially presented on the website.

The audit report refers only to the consolidated financial statements named above. It does not provide an

opinion on any other information which may have been hyper linked to or from these consolidated financial

statements. If readers of this report are concerned with the inherent risks arising from electronic data

communication they should refer to the published hard copy of the audited consolidated financial statements

and related audit report dated 25 May 2021 to confirm the information included in the audited consolidated

financial statements presented on this website.

Legislation in New Zealand governing the preparation and dissemination of consolidated financial statements

may differ from legislation in other jurisdictions.

The engagement partner on the audit resulting in this independent auditor’s report is S Patel.

BAKER TILLY STAPLES RODWAY AUCKLAND

Auckland, New Zealand

25 May 2021

Annual Report 2021
73

73

Matters Relating to the Electronic Presentation of the Audited Consolidated Financial Statements

This audit report relates to the consolidated financial statements of Radius Residential Care Limited and its

subsidiaries for the year ended 31 March 2021 included on Radius Residential Care Limited ’s website. The

Directors of Radius Residential Care Limited are responsible for the maintenance and integrity of Radius

Residential Care Limited ’s website. We have not been engaged to report on the integrity of Radius Residential

Care Limited ’s website. We accept no responsibility for any changes that may have occurred to the

consolidated financial statements since they were initially presented on the website.

The audit report refers only to the consolidated financial statements named above. It does not provide an

opinion on any other information which may have been hyper linked to or from these consolidated financial

statements. If readers of this report are concerned with the inherent risks arising from electronic data

communication they should refer to the published hard copy of the audited consolidated financial statements

and related audit report dated 25 May 2021 to confirm the information included in the audited consolidated

financial statements presented on this website.

Legislation in New Zealand governing the preparation and dissemination of consolidated financial statements

may differ from legislation in other jurisdictions.

The engagement partner on the audit resulting in this independent auditor’s report is S Patel.

BAKER TILLY STAPLES RODWAY AUCKLAND

Auckland, New Zealand

25 May 2021

Radius Residential Care Limited
74

Corporate

Governance

Statement

The Board of Radius Residential Care

Limited (Radius Care, the Company) is

committed to ensuring that the Company

meets best practice governance

principles and maintains the highest

ethical standards by conducting our

business safely and ethically and within

the legal and regulatory framework, so

we can deliver the best outcomes for our

residents, their families, shareholders,

employees, customers and suppliers, and

the communities in which we operate.

This Corporate Governance Statement provides an overview of the Company’s governance framework. It is structured to follow the

NZX Corporate Governance Code (NZX Code) and discloses the practices relating to the NZX Code’s recommendations.

The Board regularly reviews the Company’s corporate governance structures against the eight principle recommendations in the

Code, and considers that during the period from its listing to 31 March 2021 its practices and procedures substantially met NZX Code

recommendations. Any differences, where recommendations of the NZX Code have not been followed are set on page 85 of this

annual report.

The Company’s governance policies are available on its website, see www.radiuscare.co.nz/investors-centre/governance.

The Radius Care Board approved this Corporate Governance Statement on 25 May 2021.

For detailed information on the Group’s corporate

governance policies, practices and processes please refer to

the Investors section on the Radius Care website:


www.radiuscare.co.nz/investors-centre/governance

This contains the following documents:

Constitution

Charters

• Board Charter

• Audit and Risk Committee Charter

• Remuneration and Human Resources Committee Charter

Policies

• Code of Conduct

• External Auditor Independence Policy

• Financial Product Trading Policy

• Fraud Policy

• Market Disclosure Policy

• Whistleblower Policy

Annual Report 2021
75

Principle 1. Code of ethical behaviour

Directors should set high standards of ethical behaviour, model this behaviour and hold management accountable for these

standards being followed throughout the organisation.

Code of Conduct

The Company’s ethical standards are included in the Company’s Code of Conduct and the Board Charter.

Radius Care commits to high ethical standards in all dealings undertaken by the Group’s directors, employees and suppliers. We are a

New Zealand owned and operated company that is committed to providing quality rest home and private hospital care. Our business

spans healthcare, cultural and regulatory boundaries, and our directors and management understand that high ethical standards

deliver the best outcomes for our residents, their families, employees, shareholders, suppliers and customers, and communities.

Our commitment to ethical dealings is captured by the Company’s core brand attribute “Exceptional People, Exceptional Care” and in

the Code of Conduct and Board Charter.

The Radius Care Code of Conduct outlines how directors and employees are to consistently act with honesty and integrity.

The Code of Conduct will be reviewed by the Board every two years.

Annual Report 2021

75

Radius Residential Care Limited
76

Corporate Governance continued

Trading in Financial Products

Radius Care also has a Financial Product Trading Policy, prohibiting the direct or indirect dealing of the Company’s financial products

when holding inside information, and setting out a duty of confidentiality that protects the dissemination and use of confidential

company information. The Financial Product Trading Policy also defines black-out periods during which certain restricted persons are

prohibited in trading in Radius Care shares unless provided by a specific exemption by the Radius Care Chair or Chief Executive (CEO).

Principle 2. Board composition and performance

To ensure an effective board, there should be a balance of independence, skills, knowledge, experience and perspectives.

Responsibilities of the Board

The Board has overall responsibility for all decision making within Radius Care. Day-to-day management of the Company, including

being the company’s principal representative, is delegated to the CEO. The Boards’ functions are set out in the Board Charter and

include:

• Establishing corporate objectives and strategies

• Reviewing and approving the strategic, business, risk, and financial plans prepared by management.

• Monitoring performance against these plans.

• Appointing, providing counsel to and reviewing the performance of the CEO.

• Approving major investments and divestments.

• Ensuring ethical behaviour by the Company, Board, management and employees.

• Assessing its own effectiveness in carrying out its functions.

• Ensuring timely and transparent stakeholder and market communication.

The Board monitors these matters by receiving reports and plans from management, maintaining an active programme of divisional

visits and through its annual work programme.

The Board uses committees to address certain issues that require detailed consideration by members of the Board who have

specialist knowledge and experience. The Board retains ultimate responsibility for the functions of its committees and determines

their responsibilities.

The Board has a statutory obligation to reserve responsibility for certain matters.

Details of the Radius Care Board’s role, composition, responsibilities, operation, policies and committees are provided in the Board

Charter.

Director nomination, appointment and reappointment

The Board is responsible for the process of appointment and reappointment of Directors, who are elected by Shareholders. The Board

identifies candidates to be nominated or re-elected as a Director through a procedure outlined in the Board Charter.

The Board is comprised of Directors who have a mix of skills, knowledge, experience and diversity to adequately discharge its

responsibilities and add value to Radius Care.

Letter of appointment

All Directors have entered into a written agreement with Radius Care setting out the terms of their appointment.

Annual Report 2021
77

Board composition

Directors

As at 31 March 2021 and the date of this Annual Report, the Board comprised of the following six Directors:

Brien Cree Chair, Executive Director Appointed August 2003

Duncan Cook Executive Director Appointed July 2010

Bret Jackson Non-Executive Director Appointed September 2014

Timothy Sumner Non-Executive Director Appointed September 2014

Mary Gardiner Independent Director Appointed December 2020

Hamish Stevens Independent Director Appointed December 2020

Four of the Directors are non-executive Directors. The Board has considered which of the Directors are Independent Directors for the

purposes of the NZX Listing Rules and has determined that, as at 31 March 2021, two Directors are Independent Directors, including

the Chair of the Audit Committee. The factors relevant to determining whether a Director is an Independent Director are the criteria in

the NZX Listing Rules for Director independence, having regard to the factors described in the NZX Corporate Governance Code that

may impact Director independence.

The Company’s Constitution specifies that the Board shall have a minimum of three directors; at least two Directors shall be ordinarily

resident in New Zealand; and while the Company is Listed, it shall have not less than the minimum number of Independent Directors

prescribed by the Listing Rules.

A profile of each Director is available on the Radius Care website (www.radiuscare.co.nz) at pages 23 – 24 of this report. The profiles

include information on the skills, experience and background of each Director. Radius Care complies with Listing Rule 2.1.1(c) (namely

“at least two Directors must be Independent Directors”). Having only recently listed on NZX in December 2020, it does not yet comply

with NZX Code Recommendation 2.8 that a majority of the Board should be Independent Directors. Radius Care aims to comply with

this Recommendation in the medium term.

Ownership of Radius Care shares by Directors is encouraged rather than being a requirement. Directors’ ownership interests are

disclosed at page 89.

At this stage the Board does not have a tenure policy however it is committed to a regular refreshment programme to introduce new

perspectives, skills, attributes and experience. A formal evaluation will be undertaken in FY2022 which will identify any skills gap that

should be addressed over the next one to two years.

Interests Register

The Board maintains an Interests Register. Any Director who is interested in a transaction with the Company must immediately

disclose to the Board the nature, monetary value and extent of the interest. A Director who is interested in a transaction may attend

and participate at a Board meeting at which the transaction is discussed but may not be counted in the quorum for that meeting or

vote in respect of the transaction, unless it is one in respect of which Directors are expressly required by the Companies Act 1993 to

sign a certificate. Particulars of entries made in the Interests Register for the year ended 31 March 2021 are included in the Director

Disclosures section on page 86.

Diversity

The Board seeks diversity in the skills, attributes, perspectives and experience of its members across a broad range of criteria so as to

represent the diversity of shareholders, business types and regions in which it operates. Diversity, both at Board level and throughout

the Company, is actively considered and reviewed by the Board. A formal Diversity Policy will be adopted by the Board in FY2022.

Radius Care recruits, promotes and compensates on the basis of merit, regardless of gender, ethnicity, religion, age, nationality, sexual

orientation, union membership or political opinion. A fundamental tenet of the Company’s values is Exceptional people, Exceptional

Care together with: Commitment: Leaders in care; Courage: Do the right thing; Compassion: Act with empathy.

Radius Residential Care Limited
78

Corporate Governance continued

Responsibility for workplace diversity and the setting of measurable objectives is held by the Remuneration and Human Resources

Committee.

The following table reports gender composition of the Board and officers as at 31 March 2021. Radius Care has determined that the

category of Officers comprises the members of its senior management team.

As at 31 March 2021 As at 31 March 2020

Position Female Male Female Male

Director 1 (17%) 5 (83%) - 4 (100%)

Officers 3 (43%) 4 (57%) 2 (40%) 3 (60%)

Director training

The Board ensures that there is appropriate training available to all Directors to enable them to remain current on how best to

discharge their responsibilities and keep up to date on changes and trends in areas relevant to their work. Directors are provided with

industry information and receive copies of appropriate Company documents to enable them to perform their role. In addition, visits to

Radius Care’s facilities, briefing from senior management and key advisors to Radius Care are arranged for Directors. Where training is

undertaken at the Company’s expense, directors are expected to brief the Board on key learnings.

The Board also ensures that new Directors are appropriately introduced to Management and the businesses.

Board Performance Evaluation

The Board undertakes an annual assessment of Board, director and committee performance, seeking assistance, as required, from

external advisors.

Principle 3 – Board Committees

The Board should use committees where this will enhance its effectiveness in key areas, while still retaining Board responsibility.

Board Committees

The Board currently has two committees – the Audit and Risk Committee and the Remuneration and Human Resources Committee.

The Board may set up ad-hoc committees when required to efficiently and effectively carry out key governance functions, while

retaining ultimate responsibility for all decisions and actions.

Each Committee focuses on specific areas of governance and together they strengthen the Board’s oversight of the Company.

Committee membership is reviewed annually. Each Committee has a written charter that is approved by the Board, which sets out its

mandate. The charters are reviewed annually with any proposed changes recommended to the Board for approval. The charters are

available at www.radiuscare.co.nz/investors-centre/governance.

Each Committee has an annual work programme of matters to be addressed over the following 12 month period. Included in the work

programme is an annual review of performance against the Committee charter and objectives for the year. The Committee’s review

findings are reported to the Board.

Standing committees of the Board

Audit and Risk Committee

CompositionRolesMembers

• At least three members of the Board;

a majority of members must be

independent.

• At least one member who has an

accounting or financial background.

• Committee Chair appointed by the Board;

must be an independent director; not the

Chair of the Board.

Responsibility for:

• External financial reporting;

• Internal control environment;

• Business Assurance / Internal Audit

and external audit functions;

• Risk management.

Hamish Stevens (Chair)

Mary Gardiner

Tim Sumner

Annual Report 2021
79

The Committee met on one occasion during the period from listing on 10 December 2020 to 31 March 2021.

Remuneration and Human Resources Committee

CompositionRolesMembers

• At least three members of the Board.

• Committee Chair appointed by the Board;

must be a non-executive director; not the

Chair of the Board.

Responsibility for:

• Establishment of remuneration

policies and practices for the CEO,

Key Management, and Directors;

• Oversee remuneration-setting and

review; and

• Oversee the management of human

resources activities.

Duncan Cook (Chair)

Mary Gardiner

Bret Jackson

The Committee did not meet during the period from listing on 10 December 2020 to 31 March 2021. Radius Care does not currently

fully comply with NZX Code Recommendation 3.3 given that the Remuneration and Human Resource Committee does not currently

comprise of a majority of Independent Directors.

Meeting Attendance by Officers

Officers and other employees only attend Committee meetings at the invitation of the relevant Committee.

The CEO and General Manager, Finance are regularly invited to attend Audit and Risk Committee meetings.

Attendance at Meetings

Director attendance at Board and Committee meetings during the period from 10 December 2020 when Radius Care listed on NZX to

31 March 2021 are set out below.

Board, Audit and Risk Committee, Remuneration and Human Resources Committee

Board Audit & Risk Committee Remuneration & Human

Resources Committee

Eligible to Eligible to Eligible to

attend Attended attend Attended attend Attended

Brien Cree 3 3

Duncan Cook 3 3 0 0

Mary Gardiner 3 3 1 1 0 0

Bret Jackson 3 3 0 0

Hamish Stevens 3 3 1 1

Tim Sumner 3 3 1 1

No separate Nomination Committee

The Board has decided not to have a separate Nomination Committee as Director appointments are considered by the Board as a

whole, as further disclosed in Principle 2 above.

Takeover offer protocols

In the event a takeover offer is received, the Board would engage legal and financial experts to provide advice on procedure. Forward

takeover protocols will be developed and adopted in FY2022.

Radius Residential Care Limited
80

Principle 4 – Reporting and Disclosure

The Board should demand integrity in financial and non-financial reporting, and in the timeliness and balance of corporate

disclosures.

Shareholder Communications and Market Disclosure

The Board is committed to providing timely, orderly, consistent, accurate, and credible information in accordance with legal and

regulatory requirements to enable orderly behaviour in the market. The Board believes objective disclosure is fundamental to building

shareholder value and earning the confidence of the investment community.

The Company has in place a written Market Disclosure Policy designed to ensure this occurs. The policy includes procedures intended

to ensure that disclosure is made in a timely and balanced manner and in compliance with the NZX Listing Rules, such that the

Board is able to fulfil its obligation to keep investors and the market informed through a timely, clear, and balanced approach that

communicates all information which may have a material effect on the price of Radius Care’ shares, whether it is positive or negative, in

accordance with the NZX Listing Rules.

Procedures are set out in the Policy to guide Directors, officers and employees on the appropriate steps to take if they become aware

of any information that may be material that is not generally available to the market. All NZX and media releases are subject to an

agreed sign off procedure which requires approval from the Chair of the Board or CEO. Significant market announcements, including

the preliminary announcement of the half year and full year results, the consolidated financial statements for those periods, and any

advice of a change in earnings forecast are approved by the Board.

Directors consider at the end of each Board meeting whether there is any material information that should be disclosed to the market.

Financial and Non-Financial Reporting

The Board is committed to ensuring integrity and timeliness in its financial reporting and in providing information to the market

and shareholders. A programme of clear, meaningful, timely and effective communications with shareholders is centred around a

comprehensive set of information regarding the Company’s operations and results being available primarily in its six monthly and full

year reports, in ad hoc releases lodged with NZX and also on its website.

The Audit and Risk Committee oversees the quality and integrity of external financial reporting including the accuracy, completeness,

balance and timeliness of financial statements. It reviews interim and annual financial statements and makes recommendations to the

Board concerning accounting policies, areas of judgement, compliance with financial reporting standards, stock exchange and legal

requirements, and the results of the external audit.

All interim and full-year consolidated financial statements are prepared in accordance with relevant financial standards.

Principle 5 - Remuneration

The remuneration of directors and executives should be transparent, fair and reasonable.

Director Remuneration

In accordance with best practice corporate governance, the structure of Director remuneration is separate and distinct from the

remuneration of the CEO and other officers, and is reviewed on an annual basis.

The Board intends to review Director remuneration annually to ensure the Company’s Directors are fairly remunerated for their

services and level of skill and experience required to fulfil the role is recognised. They have no entitlement to any performance-based

remuneration or participation in any share-based incentive schemes.

Each Director receives a base fee for services as a Director of the Company and an additional fee is also paid for being a member of

the Board Committees. The payment of an additional fee recognises the additional time commitment and specific skills required by

each Director who serves on those Committees. All Directors are also entitled to be reimbursed for costs associated with carrying out

their duties.

Corporate Governance continued

Annual Report 2021
81

Fees paid to the Directors of the Company (in their capacity as director) for year ended 31 March 2021 were as follows:


Fees for serving

on Remuneration

Fees for serving and Human

on Audit and Risk Resources Total

Directors Base fee Committee Committee Remuneration

Brien Cree $52,083 $52,083

Duncan Cook $113,333 $4,000 $117,333

Mary Gardiner $30,000 $2,000 $2,000 $34,000

Bret Jackson $82,083 $2,000 $84,083

Hamish Stevens $30,000 $4,000 $34,000

Tim Sumner $82,083 $2,000 $84,083

As of listing, Brien Cree as Executive Chairman of Radius Care did not receive any fees in his capacity as a Director. The fees paid to

Brien Cree in the table above were paid in the period prior to Radius Care’s listing on 10 December 2020.

The fees for directors of Radius Care (in their capacity as directors) that applies from the date of listing on NZX have been fixed as a

total pool of up to $800,000 per annum. In FY2022, the total fees payable to directors of Radius Care (in their capacity as directors) is

expected to be $522,000 excluding the Executive Chairman / Managing Director.

Position Fees per annum

Chair Nil

Directors (other than the Chair) $90,000

Committee Chair $12,000

Committee members $6,000

Remuneration of the CEO

The remuneration of the CEO currently comprises fixed remuneration that is based on the scale and complexity of the role, market

relativities, qualifications and experience. Other benefits, including Kiwisaver and a carpark, are included in fixed remuneration.

Radius Care does not currently have any short-term incentive (STI) or long-term incentive (LTI) arrangements in place for the CEO, and

accordingly no such payments were made in the FY2021 year. Stuart Bilbrough did however receive a one-off issue of 187,500 shares

having a value of $150,000 in connection with the successful listing of Radius Care in FY2021. The Board intends to establish STI and

LTI arrangements for the CEO in FY2022.

Radius Residential Care Limited
82

CEO Remuneration Paid

Share based

Salary

1

$ Benefits

2

$ Subtotal $ payments $ Total $

Stuart Bilbrough* FY2021 339,231 14,577 353,808 150,000 503,808

Brien Cree^ FY2021 880,598 29,981 910,579 - 910,579

Brien Cree FY2020 827,899 28,400 856,299 - 856,299

1 Actual salary paid includes holiday pay paid as per NZ legislation.

2 Benefits include Kiwisaver and car park.

* The CEO was employed on 8 June 2020.

^ In his capacity as Managing Director of Radius Care in the 12 months to 31 March 2021.

Employees’ Remuneration

All employees are employed by Radius Care. The number of employees and former employees, not in relation to being a Director of

Radius Care, who received remuneration and other benefits the value of which exceeded $100,000 during the financial year ended 31

March 2021 is set out in the table of remuneration bands below.

The remuneration figures shown in the “Remuneration” column include all monetary payments actually paid during the course of the

year ended 31 March 2021. The table does not include amounts paid after 31 March 2021 that relate to the year ended 31 March

2021.


Remuneration Number of employees

$910,000 - $919,999 1

$350,000 - $359,999 1

$300,000 - $309,999 1

$200,000 - $209,999 1

$170,000 to $179,999 1

$150,000 to $159,999 1

$140,000 to $149,999 3

$130,000 to $139,999 7

$120,000 to $129,999 1

$110,000 to $119,999 3

$100,000 to $109,999 9

Corporate Governance continued

Annual Report 2021
83

Principle 6 – Risk Management

Directors should have a sound understanding of the material risks faced by the issuer and how to manage them. The Board should

regularly verify that the issuer has appropriate processes that identify and manage potential and material risks.

The Board is responsible for ensuring that key business risks are identified, and that appropriate controls and responses are in place

to effectively manage those risks. The Board considers risk management an important governance function to protect stakeholders

and optimise shareholder value.

The Board composition includes Directors with long-term experience in the care sector and with senior-level governance experience.

The Board’s complementary skill set and understanding of the core business have allowed it to implement strategies to mitigate risk

such as those associated with the COVID-19 pandemic.

The Board retains ultimate oversight of risk management, with the Audit and Risk Committee delegated with responsibility for ensuring

that the Company’s risk management framework is appropriate and that it appropriately identifies, assesses, manages and monitors

risks.

The Committee’s responsibilities in relation to risk include:

• assessing the effectiveness of, and monitor compliance with, the risk management framework;

• identifying areas for fulsome review on significant risks for inclusion in the agenda of the responsible Board and/or Board

Committee meeting;

• reporting to the Board on progress with risk management work; and

• reviewing and recommending policies for Board approval.

Risk management is an integral part of Radius Care’s business. The Board requires management to prepare a risk management

framework incorporating a risk register. This approach is intended to embed a comprehensive, holistic, Group-wide culture of risk

awareness in senior management and in decision makers across the business, supported by a consistent method of identifying,

assessing, controlling, monitoring and reporting Radius Care’s existing and potential risks.

The framework is used to identify those situations and circumstances in which the Company may be materially at risk and for which

risk mitigation activities are appropriate. The objectives of the framework are to:

• Provide a consistent and structured way to identify, assess and manage risk across the Company;

• Ensure the Company manages the risks it faces in achieving its objectives; and

• Ensure staff and management are aware of and meet their responsibilities to identify, evaluate and treat the risks that may

prevent or restrict the Company from achieving its objectives.

Risk management is a standing item on the agenda for Audit and Risk Committee meetings, with detailed reports provided by

management.

Insurance

Radius Care has insurance policies in place covering most areas where risk to its assets and business can be insured at a reasonable

cost.

Radius Residential Care Limited
84

Principle 7 – Auditors

The Board should ensure the quality and independence of the external audit process.

External Auditor

Radius Care’s Audit and Risk Committee Charter outlines the Company’s commitment to an independent audit process that provides

shareholders and the market with objective, robust, clear and timely financial reporting. The Committee’s responsibilities are to:

• Monitor the independence and effectiveness of the external auditors;

• Make recommendations to the Board on the appointment and termination of the external auditors;

• Approve the external audit terms of engagement, audit partner rotation, and audit fee;

• Review the annual audit plan of the external auditors;

• Review and approve non-audit services performed by the external auditor in accordance with the External Auditor Independence

Policy;

• Review the External Auditor Independence Policy on a regular basis; and

• Ensure the Key Audit Partner is rotated at least every five years.

The Audit and Risk Committee in consultation with management and the external auditor reviews the efficiency and effectiveness of

the external audit process, and provides a formal channel of communication between the Board, senior management and the external

auditor.

Radius Care’s external auditor is Baker Tilly Staples Rodway. Baker Tilly Staples Rodway has confirmed independence to the Audit and

Risk Committee and that its independence was not compromised during the reporting period.

The External Auditor Independence Policy is available at www.radiuscare.co.nz/investors-centre/governance.

The fees paid to the external auditor is included in note 2.3 of the Notes to the Consolidated Financial Statements. A total of $175k

was paid for audit and assurance-related services, $90k was paid for tax compliance services. No other fees were paid to the external

auditor for professional fees.

All non-assurance services provided must have the prior approval of the Audit and Risk Committee.

The external auditor is regularly invited to meet with the Committee including without management present.

The external auditor has been invited to attend the Annual Shareholders’ Meeting and will be available to answer questions about the

audit process and the independence of the auditor.

Internal Audit

The Company does not have an inhouse internal audit function. The internal control framework that Radius Care uses to manage risk

is described in further detail under Principle 6 above. External specialists will be appointed to carry out the internal audit plan, once

set by the Audit and Risk Committee.

Principle 8. Shareholder rights and relations

The board should respect the rights of shareholders and foster constructive relationships with shareholders that encourage them to

engage with the issuer.

Shareholder Relations

The Board is committed to maintaining open and transparent communications with investors and other stakeholders. Radius

Care listed in December 2020 and has not yet completed a full 12 months as an NZX-listed company. The Board’s shareholder

communications programme will see the annual report, NZX releases, governance policies and charters and a variety of corporate

information posted to the Company’s website.

Recordings of results briefings, when undertaken, will be in the Investors section of the website.

Each shareholder is entitled to receive a hard copy of the annual report, unless they have elected to receive it electronically.

A Shareholder Meetings page will be available in the Investor’s Centre section of the website and will include all relevant documents

relating to the meeting. Shareholder meetings will be held at a time and location to encourage participation in person by shareholders.

Corporate Governance continued

Annual Report 2021
85

Electronic Communications

Shareholders have the option of receiving their communications electronically. Contact details for Radius Care’s support office and its

share registrar, Computershare, are available on the website.

Major Decisions

The Market Disclosure Policy sets out directors’ commitment to timely and balanced disclosure and to advising shareholders on any

major decisions. Where voting on a matter is required, the Board encourages investors to attend the meeting or to send in a proxy

vote. Shareholders may raise matters for discussion at the Annual Shareholders’ Meeting either in person or by emailing Radius Care

with a question to be asked.

Radius Care will conduct voting at its Annual Shareholders’ Meetings by way of poll and on the basis of one share, one vote.

Additional equity

Should additional equity be sought through a capital raising the Board will take NZX Code Recommendation 8.4 into account.

Availability of ASM / ESM notices of meeting

The Board is committed to ensuring that notices of meetings of shareholders are posted to Radius Care’s website as soon as possible

and, where practicable, at least 20 working days prior to the meeting. Where a notice of meeting is circulated less than 20 working

days in advance of the meeting in question, Radius Care will explain why in its next corporate governance statement. There have been

no shareholder meetings held in the period to which this annual report relates.

Differences in practice to NZX Code

Material differences between Radius Care’s corporate governance practices and the NZX Code in the period between listing on 10

December 2020 and 31 March 2021 are set out below. Where there are differences, these have been approved by the Board. Further

developments in corporate governance practices are expected to be implemented during FY2022.

NZX Code

PrincipleNZX Code RecommendationKey differenceCurrent status

2. Board

Composition and

Performance

2.5 Diversity policy

An issuer should have a

written diversity policy

Radius Care does not currently have a

written Diversity Policy

A written Diversity Policy

and Inclusion Policy will

be prepared in FY2022

2. Board

Composition and

Performance

2.8 A majority of the board

should be independent

directors

Radius’ Constitution requires that the

Board be comprised of not less than

five Members. The Board will comprise

at least two Independent Directors

Of the six directors, two

have been determined to

be independent

3. Board

Committees

3.3 Majority of the

Remuneration Committee

should be Independent

Directors

The majority of members are not

independent directors

Of the three members,

one has been determined

to be an independent

director

3. Board

Committees

3.6 The Board should

establish appropriate

takeover protocols

Radius Care does not currently have

any takeover protocols

Formal takeover protocols

will be adopted in FY2022

4. Reporting and

Disclosure

Non-financial disclosures,

including environmental,

economic and social

sustainability risks

Yet to fully develop a sustainability

programme

The Board intends

to actively focus

on developing a

sustainability programme

5. Remuneration5.2 Remuneration policy for

directors and officers

An issuer should have a remuneration

policy for directors and officers

A written Remuneration

Policy will be prepared in

FY2022

Radius Residential Care Limited
86

Other

Disclosures

Interests Register

Disclosure of Directors’ Interests

The full list of Directors’ Interests were disclosed in the 31 March 2020 Consolidated Financial Statements that’s available on the

Radius Care website.

The following particulars are updates that were entered in the Interests Register kept for Radius Care and its subsidiaries during the

year ended 31 March 2021:

Duncan Cook: Disclosed he ceased to hold the following positions:

Entity Nature of Interest

M G Hill Trustee Limited Director

New Horizons Limited Shareholder

Landscape Supplies 15th Ave Limited Shareholder

Sharp Tudhope Protector Services Limited Director

Sharp Tudhope Trustee Holdings Limited Director and Shareholder

Sharp Tudhope Trustee Services Limited Director

Sharp Tudhope Trustee Services No 2 Limited Director

Sharp Tudhope Trustee Services No 3 Limited Director

Sharp Tudhope Trustee Services No 4 Limited Director

Sharp Tudhope Trustee Services No 5 Limited Director

Sharp Tudhope Trustee Services No 6 Limited Director

Sharp Tudhope Trustee Services No 7 Limited Director

Sharp Tudhope Trustee Services No 8 Limited Director

Sharp Tudhope Trustee Services No 9 Limited Director

Sharp Tudhope Trustee Services No 10 Limited Director

Sharp Tudhope Trustee Services No 11 Limited Director

Sharp Tudhope Trustee Services No 12 Limited Director

Sharp Tudhope Trustee Services No 13 Limited Director

Sharp Tudhope Trustee Services No 14 Limited Director

Sharp Tudhope Trustee Services No 15 Limited Director

Sharp Tudhope Trustee Services No 16 Limited Director

Sharp Tudhope Trustee Services No 17 Limited Director

Sharp Tudhope Trustee Services No 18 Limited Director

Sharp Tudhope Trustee Services No 19 Limited Director

Sharp Tudhope Trustee Services No 20 Limited Director

Annual Report 2021
87

Entity Nature of Interest

Sharp Tudhope Trustee Services No 21 Limited Director

Sharp Tudhope Trustee Services No 22 Limited Director

Sharp Tudhope Trustee Services No 23 Limited Director

Sharp Tudhope Trustee Services No 24 Limited Director

Sharp Tudhope Trustee Services No 25 Limited Director

Sharp Tudhope Trustee Services No 26 Limited Director

Sharp Tudhope Trustee Services No 27 Limited Director

Sharp Tudhope Trustee Services No 28 Limited Director

Sharp Tudhope Trustee Services No 29 Limited Director

Sharp Tudhope Trustee Services No 30 Limited Director

Sharp Tudhope Trustee Services No 31 Limited Director

Sharp Tudhope Trustee Services No 32 Limited Director

Sharp Tudhope Trustee Services No 33 Limited Director

Sharp Tudhope Trustee Services No 34 Limited Director

Sharp Tudhope Trustee Services No 35 Limited Director

Sharp Tudhope Trustee Services No 36 Limited Director

Sharp Tudhope Trustee Services No 37 Limited Director

Sharp Tudhope Trustee Services No 38 Limited Director

Sharp Tudhope Trustee Services No 39 Limited Director

Sharp Tudhope Trustee Services No 40 Limited Director

Sharp Tudhope Trustee Services No 41 Limited Director

Sharp Tudhope Trustee Services No 42 Limited Director

Mary Gardiner: Disclosed the following positions:

Entity Nature of Interest

Southern Cross Pet Insurance Limited Director

Northern Netball Zone Incorporated Chair

Mangere Mountain Education Trust Trustee

Kidsen Limited Director and Shareholder

Radius Residential Care Limited
88

Other Disclosures continued

Hamish Stevens: Disclosed the following positions:

Entity Nature of Interest

Pacific Radiology Group Limited Director

Marsden Maritime Holdings Limited Director

Pharmaco NZ Limited Director

Pharmaco House Limited Director

Pharmaco (Australia) Limited Director

The Kennedy’s Limited Director

Botany Health Hub Limited Director

Northport Limited Director

ECL Group Limited Director

Counties Power Limited Director

Evolve Education Group Limited Director

Governance and Advisory Limited Director and Shareholder

East Health Services Limited Director

Ormiston Health Properties Limited Director

Health Improvement Group Limited Director

East Health Clinic Investments Limited Director

Au Pair (Evolve) Limited Director

Evolve ECEM Limited Director

Evolve Group 1 Limited Director

Evolve Group 2 Limited Director

Evolve Group 3 Limited Director

Evolve Group 4 Limited Director

Evolve Group 5 Limited Director

Evolve Group 6 Limited Director

Evolve Home Day Care Limited Director

Evolve Management Group Limited Director

Lollipops Educare (Birkenhead) Limited Director

Lollipops Educare (Hastings) Limited Director

Lollipops Educare Centres Limited Director

Lollipops Educare Holdings Limited Director

Lollipops Educare Limited Director

Specific Disclosures

See related party note 5.5 in the consolidated financial statement section for any disclosures made by Directors during the year ended

31 March 2021 of any interests in transactions with Radius Care or any of its subsidiaries.

Use of Company Information

During the year ended 31 March 2021, the Board did not receive any notices from Directors requesting use of Radius Care’s or any of

its subsidiaries’ information.

Annual Report 2021
89

Securities Dealings of Directors

Dealings by Directors in relevant interests in Radius Care’s ordinary shares in the year ended 31 March 2021 as entered in the

Interests Register:

DirectorTransactionNo. of

shares

Nature of relevant interestPrice

per

share

Date of

transaction

Brien CreeShare disposal by

Wave Rider Holdings

Limited as trustee of

Wave Rider Trust

500,000Has the power to control the exercise of the

rights attaching to the shares held by Wave

Rider Holdings Limited as trustee of Wave

Rider Trust, by virtue of having the power to

appoint and remove trustees of the Wave

Rider Trust

-9-Dec-20

Bret JacksonShare disposal by

Knox Radius L.P.

79,187,500Has a relevant interest in shares held by Knox

Radius L.P. as, by virtue of being a director

of Knox Investment Partners, together with

Timothy Sumner, he has the power to control

the exercise of rights attaching to shares held

by Knox Radius L.P.

-9-Dec-20

Bret JacksonShare acquisition

by Takatimu

Investments

Limited as trustee

of the Takatimu

Investment Trust

29,434,590Has a relevant interest in shares held by

Takatimu Investment Trust, by virtue of

being the sole shareholder and a director of

Takatimu Investments Limited

-9-Dec-20

Bret JacksonShare acquisition by

Knox Fund IV NZD LP

22,501,977Has a relevant interest in shares held by Knox

Fund IV NZD LP as, by virtue of being a director

of Knox Investment Partners, together with

Timothy Sumner, he has the power to control

the exercise of the rights attaching to shares

held by Knox Fund IV NZD LP

-9-Dec-20

Bret JacksonShare acquisition by

Knox Fund IV AUD LP

4,320,051Has a relevant interest in shares held by Knox

Fund IV AUD LP as, by virtue of being a director

of Knox Investment Partners, together with

Timothy Sumner, he has the power to control

the exercise of the rights attaching to shares

held by Knox Fund IV AUD LP

-9-Dec-20

Timothy SumnerShare disposal by

Knox Radius L.P.

79,187,500Has a relevant interest in shares held by Knox

Radius L.P. as, by virtue of being a director

of Knox Investment Partners, together with

Bret Jackson, he has the power to control the

exercise of rights attaching to shares held by

Knox Radius L.P.

-9-Dec-20

Timothy SumnerShare acquisition997,456Registered holder and beneficial owner-9-Dec-20

Timothy SumnerShare acquisition by

Knox Fund IV NZD LP

22,501,977Has a relevant interest in shares held by Knox

Fund IV NZD LP as, by virtue of being a director

of Knox Investment Partners, together with

Bret Jackson, he has the power to control the

exercise of the rights attaching to shares held

by Knox Fund IV NZD LP

-9-Dec-20

Timothy SumnerShare acquisition by

Knox Fund IV AUD LP

4,320,051Has a relevant interest in shares held by Knox

Fund IV AUD LP as, by virtue of being a director

of Knox Investment Partners, together with

Bret Jackson, he has the power to control the

exercise of the rights attaching to shares held

by Knox Fund IV AUD LP

-9-Dec-20

Radius Residential Care Limited
90

Other Disclosures continued

Duncan CookShare issue for

services provided

as a long-term

employee

250,000Registered holder and beneficial owner$0.80

per

share

9-Dec-20

Duncan CookShare acquisition125,000Registered holder and beneficial owner-9-Dec-20

Directors’ Interest in Shares

Directors of Radius Care have disclosed the following relevant interests in shares as at 31 March 2021:

Director Number of Shares in which Relevant Interest is Held

Brien Cree 95,312,500

Bret Jackson 29,434,590

Timothy Sumner 27,819,484

Duncan Cook 375,000

Indemnity and Insurance

Radius Care has granted indemnities, as permitted by the Companies Act 1993 and the Financial Markets Conduct Act 2013, in favour

of each of its Directors. Radius Care also maintains Directors’ and Officers’ liability insurance for its Directors and Officers.

Subsidiary Company Directors

Brien Cree and Duncan Cook are Directors of all Radius Care subsidiaries as at 31 March 2021, with the exception of:

Radius Care Limited, Radius Care Holdings Limited and Radius Arran Court Limited (the Directors of which are Brien Cree and Stuart

Bilbrough). No extra remuneration is payable for any directorship of a subsidiary.

Other information

Auditor’s Fees

Baker Tilly Staples Rodway is the external auditor of Radius Care and it’s subsidiaries. Total fees paid by Radius Care and its

subsidiaries to Baker Tilly Staples Rodway in its capacity as auditor during the financial year ended 31 March 2021 were $175k. Total

fees paid to Baker Tilly Staples Rodway for other professional services (being taxation services) during the financial year ended 31

March 2021 were $90k. No other fees were paid to Baker Tilly Staples Rodway for other professional services.

Donations

For the year ended 31 March 2021, Radius Care and it’s subsidiaries paid a total of $14k in donations. No donations were paid to

political parties.

Stock Exchange Listings

Radius Care’s shares are listed on the NZX. Radius Care is required to comply with the NZX Listing Rules. Radius Care confirms that it

has complied with the NZX Listing Rules for the period from its listing to 31 March 2021.

NZX Waivers

Radius Care does not have any waivers from the requirements of the NZX Listing Rules.

Credit Rating

Radius Care has no credit rating.

Annual Report 2021
91

Twenty Largest Shareholders

(as at 31 March 2021)


Registered Shareholder Number of shares % Shares

WAVE RIDER HOLDINGS LIMITED 95,312,500 54.00

KNOX FUND IV NZD LP 22,501,977 12.75

FORSYTH BARR CUSTODIANS LIMITED 6,646,364 3.77

PERPETUAL CORPORATE TRUST LIMITED - ACT PRIVATE EQUITY NO 3 FUND 5,994,760 3.40

PERPETUAL CORPORATE TRUST LIMITED - ROC ALTERNATIVE INVESTMENT TRUST VI 5,994,760 3.40

PERPETUAL CORPORATE TRUST LIMITED - ROC ASIA PACIFIC CO-INVESTMENT FUND II 5,994,760 3.40

KNOX FUND IV AUD LP 4,320,051 2.45

AARON SNODGRASS & BRIAN MALTBY & SIMON CURRAN & FRANCES VALINTINE

& PETER ALEXANDER & JONATHAN MASON 3,750,178 2.12

TAKATIMU INVESTMENTS LIMITED 2,612,562 1.48

HSBC NOMINEES (NEW ZEALAND) LIMITED - NZCSD 1,866,430 1.06

ANDREW JOHN CLARK 1,854,935 1.05

CENTRAL LAKES DIRECT LIMITED 1,750,083 0.99

TIMOTHY SUMNER 997,456 0.57

MCGREGOR CORPORATION PTY LIMITED 943,394 0.53

PETER YOUNG & MARIE YOUNG 896,870 0.51

BRIDGETTE JACKSON & MJ BENNETT TRUSTEES LIMITED 784,725 0.44

NEW ZEALAND DEPOSITORY NOMINEE LIMITED 759,394 0.43

BRENT COOK 749,645 0.42

NICHOLAS WELLS & JEREMY VALENTINE 610,949 0.35

OLGA SKORIK & GEOFF HOSKING 439,861 0.25

Total 164,781,654 93.37


Shareholder

Information

Radius Residential Care Limited
92

Shareholder Information continued

Spread of Holdings

(as at 31 March 2021)

Number

Size of Holding Number of Shareholders % of shares %

1 - 1,000 101 14.28% 67,437 0.04%

1,001 - 5,000 357 50.50% 853,537 0.48%

5,001 - 10,000 91 12.87% 775,636 0.44%

10,001 - 100,000 111 15.70% 3,706,583 2.10%

100,001 and over 47 6.65% 171,091,807 96.94%

Total 707 100% 176,495,000 100%


Substantial Product Holders

According to Radius Care’s records and notices given under the Financial Markets Conduct Act 2013, the following were substantial

product holders of Radius Care as at 31 March 2021:

Substantial Product HolderNumber of shares

% of shares

Held at Date

of Notice

Date

of Notice

Wave Rider Holdings Limited is the registered

holder and beneficial owner of shares as

trustee for the Wave Rider Trust. As a result

of Brien Cree having the right to appoint and

remove trustees of the Wave Rider Trust, he

has a relevant interest in shares held by Wave

Rider Holdings Limited as trustee for the Wave

Rider Trust.

95,312,500 54.00 10 December 2020

Knox Investment Partners is the manager of

Knox Fund IV NZD LP and Knox Fund IV AUD LP

(“Knox Funds”). As a result of the management

role performed by Knox Investment Partners for

the Knox Funds, Knox Investment Partners has a

relevant interest in the shares held by the Knox

Funds, being:

• 22,501,977 shares held by Knox Fund IV NZD LP;

and

• 4,320,051 shares held by Knox Fund IV AUD LP.

Each of Bret Jackson and Timothy Sumner also

has a relevant interest in the shares held by

the Knox Funds as, by virtue of being a director

of Knox Investment Partners, he has (together

with the other) the power to control the

exercise of the rights attaching to the shares

held by the Knox Funds.

26,822,028 15.20 10 December 2020

Knox Fund IV NZD LP is the registered holder

and beneficial owner of shares.

22,501,977 12.75 10 December 2020

Annual Report 2021
93

Substantial Product HolderNumber of shares

% of shares

Held at Date

of Notice

Date

of Notice

ROC Capital Pty Limited is the manager of ACT

Private Equity No.3 Fund, ROC

Alternative Investment Trust VI and ROC Asia

Pacific Co-Investment Fund II (“ROC Funds”). As

a result of the management role performed by

ROC Capital Pty Limited for the ROC Funds, ROC

Capital Pty Limited has a relevant interest in the

shares held by Perpetual Corporate Trust Limited

as custodian for the ROC Funds as follows:

• 5,994,760 shares held on behalf of ACT Private

Equity No.3 Fund;

• 5,994,760 shares held on behalf of ROC

Alternative Investment Trust VI; and

• 5,994,760 shares held on behalf of ROC Asia

Pacific Co-Investment Fund II

17,984,280 10.19 10 December 2020

The total number of ordinary shares (being the only class of quoted voting products) on issue in Radius Care as at 31 March 2021 was

176,495,000.

Radius Residential Care Limited
94

Directory

Registered office

Radius Residential Care Limited

Level 4, 56 Parnell Road

Parnell

Auckland 1052

Postal address

PO Box 450

Shortland Street

Auckland

Phone

+64 9 304 1670

Fax

+64 9 377 6122

Email

investor@radiuscare.co.nz

Share registrar

Computershare Investor Services Limited

Level 2, 159 Hurstmere Road

Takapuna

Auckland 0622

Phone: +64 (9) 488 8700

Postal Address: Private Bag 92119

Victoria Street West

Auckland 1142

Investor Enquiries: 09 488 8777

www.computershare.co.nz/investorcentre

Bankers

ASB

ASB North Wharf

12 Jellicoe Street

Auckland 1010

Lawyers

Harmos Horton Lusk Limited

Level 33, Vero Centre

48 Shortland Street

Auckland 1140

Auditors

Baker Tilly Staples Rodway

Level 9, Tower Centre

45 Queen Street

Auckland 1010

Annual Report 2021
95

---

Results for announcement to the market
Name of issuer Radius Residential Care Limited

Reporting Period 12 months to 31 March 2021

Previous Reporting Period 12 months to 31 March 2020

Currency NZD


Amount (000s) Percentage change

Revenue from continuing

operations

$122,298 7.3%

Total Revenue $126,042 10.8%

Total net profit/(loss) $1,705 NM

Underlying EBITDA (non-

GAAP) – see explanation

below


$23,351


28.2%

AFFO (Available Funds from

Operations)


$3,721


NM

Final Dividend

Amount per Quoted Equity

Security

$0.00888048

Imputed amount per Quoted

Equity Security

$0.00248654

Record Date 14 June 2021

Dividend Payment Date 21 June 2021

Current period Prior comparable period

Net tangible assets (000s) $3,462 $1,818

Net tangible assets per

Quoted Equity Security

$0.02 $0.15

A brief explanation of any of

the figures above necessary

to enable the figures to be

understood

Underlying EBITDA and AFFO are non-GAAP (non-Generally

Accepted Accounting Practice) measures and differ from NZ

IFRS and IFRS Net Profit after Tax and Net cash provided by

Operating Activities, respectively. Underlying EBITDA and AFFO

do not have a standardised meaning prescribed by NZ GAAP

(Generally Accepted Accounting Practice in New Zealand) and

so may not be comparable to similar financial information

presented by other entities. The Group uses Underlying EBITDA

and AFFO, with other measures, to monitor financial

performance and for shareholder dividend determination

considerations. The Group uses these measures consistently

across reporting periods.

AFFO is a non-GAAP measure of available cash used by the
Group to indicate the level of shareholder dividend it may pay.

Where percentage change is listed as NM that metric in the prior

corresponding period was negative.

Net tangible assets per quoted equity share has declined as a

result of the share split undertaken in conjunction with Radius

Care’s December 2020 NZX listing.


Authority for this announcement

Name of person


authorised

to make this announcement

Stuart Bilbrough

Contact person for this

announcement

Stuart Bilbrough

Contact phone number 021 252 5778

Contact email address stuart.bilbrough@radiuscare.co.nz

Date of release through MAP


28 May 2021


Audited financial statements accompany this announcement.

---

Section 1: Issuer information
Name of issuer Radius Residential Care Limited

Financial product name/description Ordinary share

NZX ticker code RAD

ISIN NZRADE0005S4

Type of distribution

(Please mark with an X in the

relevant box/es)

Full Year X Quarterly

Half Year Special

DRP applies

Record date 14/06/2021

Ex-Date (one business day before the

Record Date)

11/06/2021

Payment date (and allotment date for

DRP)

21/06/2021

Total monies associated with the

distribution

$1,128,500

Source of distribution (for example,

retained earnings)

Retained Earnings

Currency NZ$

Section 2: Distribution amounts per financial product

Gross distribution $0.00888048

Gross taxable amount $0.00888048

Total cash distribution $0.00639395

Excluded amount (applicable to listed

PIEs)

N/A

Supplementary distribution amount N/A

Section 3: Imputation credits and Resident Withholding Tax

Is the distribution imputed Fully imputed

If fully or partially imputed, please state

imputation rate as % applied

28%

Imputation tax credits per financial

product

$0.00248654

Resident Withholding Tax per financial

product

$0.00044402

Section 5: Authority for this announcement
Name of person authorised to make this

announcement

Stuart Bilbrough

Contact person for this announcement Stuart Bilbrough

Contact phone number 021 252 5778

Contact email address stuart.bilbrough@radiuscare.co.nz

Date of release through MAP 28/05/2021

=== IR PAGE TRANSCRIPT: FY21 Annual Results – Call Transcriptf ===

28 May 2021

Radius Residential Care Limited FY21 annual results call


The slides are presented at the end of the transcript

Stuart Bilbrough: Good morning. My name is Stuart Bilbrough. I am the chief executive of Radius Care. Thank

you for joining us today as we outline the key aspects of our year ended 31 March 2021.

We have a few slides to provide some colour around the results and we'll open the lines for

questions at the end of the presentation.

I'd like to now move on to slide four.

Slide 4 Here with me today is that executive chairman and managing director, Brien Cree. Brien

founded Radius Care 18 years ago, and the successful aged care business we present today.

Brien now focuses on growth opportunities through development and acquisition, while I

look after the day-to-day business management. Having worked together for about a

decade and with Brien's long membership on the New Zealand Aged Care Association, we

collectively have a significant understanding of our industry. And also joining us is Michelle

Slabber, our general manager of finance, whose done a fantastic job getting the financial

results completed, audited and available for you today.

This is Radius Care's first results announcement as a listed company. And the three of us

are excited to be able to present them to you today.

Move on to slide five.

Slide 5 As a reminder of who Radius Care is, in a nutshell, we provide investors with the exposure

to high-acuity and specialised care end of the aged care sector in New Zealand. This means

caring for patients and residents with hospital, dementia, psychogeriatric, physical and

intellectual care needs. This makes Radius quite different to the other listed retirement

sector providers in New Zealand, in that we are more medical and aged care provider, and

less about the property. 96% of our portfolio caters for aged care.

Moving on to slide six.

Slide 6 In business since 2003, the Radius Care team has grown our portfolio to 24 sites made up

of 22 care facilities and two retirement villages.

We are located throughout New Zealand. Radius Care owns both villages and the land and

building of three facilities and 19 of our facilities are leased. The average time to the next

lease renewal of the leases is currently 9.1 years and with an average time of expiry of 27.7

years. We have over 1700 care beds for our residents and 1500 dedicated team members.

We look forward to expanding our business significantly.

We'll now move to slide seven.


Slide 7 Our agenda for today's briefing will provide you with an overview of the company's strong

financial results. We'll then dive a bit more deeply into the financial and operational aspects

of these results and our strong track record of delivery. We'll outline our strategy, which is

also provided in more detail in the listing profile that you can download from Radius's

website under Investor's Centre, and then provide you with an outlook and guidance for our

full year 2022, and where we see that heading. At the back of this presentation are some

slides that we are sure you will find useful.

Now going to move on to slide number nine.

Slide 9

We are extremely pleased to have met the guidance provided at the time of listing. Radius

has always had a good track record of delivering on our financial result expectations as a

private company. And it is now fantastic that we can demonstrate this delivery as a public

listed company. If you are after more detailed financial information than provided in this

presentation, you can download our audited financial statements from Radius's website

under Investor's Centre.


The 2021 financial year was a record for Radius Care, despite COVID-19. Our success in

keeping COVID-19 out of our sites rests squarely with the impressive and dedicated actions

of our incredible team members at the facilities and support office who tirelessly and quickly

adapted to the changing environment as COVID-19 turned from an obscure virus to a

worldwide pandemic. If that wasn't stressful enough, we decided it would be a great time to

list on the NZX. This happened on the 10th of December last year, and our new ticket

appeared on that day as RAD.


In April of this year, we exercised the option to buy 4.3 hectares of land in Belfast in

Christchurch. Radius has successfully developed our first 54 villa retirement village in

Timaru, alongside our established care home there.


Christchurch will be our first full development as a listed company, acquiring greenfield land

for a fully integrated retirement and aged care village. This is very exciting for us.

Now move to slide number ten.

Slide 10

Our success going forward rests with our people. This starts with Radius Care's board of

directors, which has been strengthened by the addition of incredibly capable new

independent directors, Mary Gardiner and Hamish Stevens. We've also bolstered the

strength of the management team, starting with me realising in early 2020 that I missed

aged care and Radius Care, having left to try another area of the health industry in 2017.

That was after seven years as CFO at Radius. With a renewed passion for aged care, I

returned full-time to Radius in June of 2020 as the CEO to look after the day-to-day, and

Brien moved to the role of Executive Chairman and Managing Director, focusing on the

delivery of our development and acquisition growth strategy.


We also took a critical look at our most important resource, which is our team across the

group, and our continued training needs. We hired highly skilled learning and development

expert, Marg Paramore, into the newly created General Manager of People and Culture, and

expanded the property team to ensure an even greater focus on facility presentation and

stepping up our growth in accommodation supplement revenue.

Move on to slide number 11.
Slide 11 Slide 11 provides a deeper dive into the numbers. Since 2018 and before, revenue has

consistently increased. Revenue includes our villages, which have performed very well,

although a small part of Radius's revenue at this stage. From an underlying EBITDA and

AFFO point of view, we've had a very strong end to the current financial year, achieving our

guidance as provided in the December listing profile.

What is important to note is that Radius Care's growth, excluding the smaller contribution

of our villages, has been largely organically achieved through continuously improving

occupancy and bed mix, weighted towards high-acuity care which Radius focuses on, and

accommodation supplements. This is where we see an area of ongoing improvement in

growth. What has been difficult for Radius and the whole aged care and health industry has

been the containment of staff costs. Radius is a strong supporter of ensuring our team

members at the facility are paid an hourly rate that recognises their incredible

contribution. We do this by striving to provide the training, work environment and pay rate

we can. We also recognise that the ability for health workers, especially registered nurses,

to move freely within the health industry and abroad is a peculiarity that has become

normalised in our industry. We continue to strive to reduce staff turnover.

Moving to slide 12.

Slide 12 Radius' AFFO for the year came in slightly higher than the guidance provided in the recent

listing profile. We are very happy with this great outcome. AFFO is Available Funds From

Operations, and is the non-GAAP estimate of cash generated and available at the end of a

financial period. Paying dividends from cashflow is the preferred approach of Radius Care's

board of directors. This is why the AFFO method is used for calculating investor dividends.

The strong AFFO result for the full year 2021 therefore has a direct and positive impact on

our final dividend. The Radius board of directors has recommended that the dividend for

the full financial year be set at 50% of AFFO, and in line with the dividend policy in the

listing profile. With total AFFO at $3.7 million, this represents a fully imputed gross

dividend per share of 1.46 cents. Net of imputation is 1.05 cents, which is above our listing

profile's guidance, which had an upper end of one cent.

I will now pass across to Michelle.

Michelle Slabber: Thank you, Stuart. And good morning, everybody.

Slide 13 The EBITDA bridge in this slide explains what the material key changes for the year were.

Also, please refer to the appendices at the back of this presentation and the listing profile

for the EBITDA bridge, that explains the key areas of why the full year ending 2020 was a

difficult and unusual year for Radius Care. As we entered the 2021 financial year, those

areas that had impacted our impressive growth from prior years were coming under

control. In FY 2021 COVID assisted, through infection control requirements, a slowing

turnover down. We have not rested on our laurels since the lock downs and continue to

implement ways of ensuring Radius and aged care is the best place for the likes of our

healthcare workers, particularly registered nurses, to start out. Over a number of years this

turnover has become business as usual and the current slowdown in turnover of registered

nurses leaving our employment is an indication we continue to provide the best place for

healthcare workers to work.

This year we have improved our overall aged care EBITDA by $4.3 million. There has been a
significant reduction in bureau staff, extension at two facilities have contributed $800,000,

we have increased private revenue through our focus on growth, accommodation

supplement in revenue, and retirement village EBITDA is up $700,000 as well. We have

invested in more senior management at our support office that has been targeted towards

focusing on issues like bureau costs, training and accommodation supplements. And we are

very happy with the results. The support office team is also getting positioned for the coming

business expansion which is very exciting for us all.

Move to slide 15, and over to you, Brien.

Brien Cree: Thanks, Michelle. It's Brien Cree speaking.

Slide 15

I'll run through a little on our revenue growth and diversification. Slide 15 demonstrates the

strong track record of year on year annual revenue growth that Radius Care has been able to

achieve over a number of years. Ministry of Health fee increases normally sit at around 3%

per annum, yet Radius has been able to achieve 8.5% through our focus on increasing

occupancy, a focus towards higher-acuity care and the higher rate per night from our

accommodation supplement.

Take you now to slide 16.

Slide 16

Radius Care is continuing to move towards higher-acuity care for its residents. We have a bed

mix of 86% of our beds certified for high-acuity care, which includes swing beds. The

opportunity to increase the revenue going forward comes from increased utilisation of the

high-acuity beds, which is currently sitting at 67%. We will be increasing the total available

high-acuity beds this year, with the conversion of 20 rest home rooms at Radius Arran Court

in Henderson into a dementia unit. This is our first dementia unit in the Auckland region and

a much-needed care level for the West Auckland area. This conversion will be a positive

contributor to the next financial year.

Moving now to slide 17.

Slide 17

This slide demonstrates our market and the occupancy growth opportunity. Radius Care's

portfolio is orientated to high-acuity and specialist care, so less driven by property market

cycles, but more by population demographics, which puts us in a strong position for the

future. A number of our 22 facilities run at 95 to 100% bed occupancy. And this number of

sites is expected to keep increasing.


In the 2019 Ernst and Young report, titled "Aged Residential Care Funding Model Review",

they acknowledged the increased acuity of New Zealand residents that often come with a

range of serious health conditions requiring specialist care, and that will likely see the

number of people living over 85 tripling by 2043.

I’ll turn now to slide 18.

Slide 18

This slide demonstrates our continued strong performance. Radius Care has a very

systematic approach to providing care, and that enables us to focus on what is important to

us, and that is providing the best care we can. It is a proven model we have perfected over

almost two decades. Good facility management, strong clinical care, a well-managed roster

and the right people in the right place, doing the right things are the best combination for
delivering a strong underlying EBITDA per care bed. And we worked hard to achieve this.

Accommodation supplements are an important source of non-government revenue for

Radius. It has a lot of potential to continue growing as it has over a number of years, since

first being introduced approximately 10 years ago. We will have a dedicated team member

focusing on this opportunity so that we can improve our penetration beyond the current

60% of total rooms.

I’ll now just flick across to slide 21, and just talk a little bit about strategy.

Slide 21 So the exercising of the option for the Belfast property is a cornerstone of Radius Care's

growth in the immediate future. We are currently focused on the final design process,

obtaining building consents and commencing construction in relation to this development.

The project will be constructed across multiple stages, providing a degree of funding

flexibility, with the optimal timing to be determined as the planning progresses. We have

some other great brownfield expansion opportunities that will kick off in 2022. We have

resource consent at Radius Thornleigh Park in New Plymouth to add 24 hospitals level care

beds. We are also progressing resource consent for the extension at Radius Lexham Park in

Katikati in the Bay of Plenty. And that will also kick off in 2022. Along with that, we're also

reviewing a number of opportunities and we'll update the market as and when required

regarding these.

So now I will pass you back to Stuart.

Stuart Bilbrough: Thank you, Brien. I'm now on slide 23.

Slide 23 So now we will focus on our strong growth trajectory, the trajectory we have in place. Our

outlook for the full year 2022 is that aged care will continue to have staff cost challenges,

as we have always had. For Radius this will be more than offset by revenue opportunities,

with accommodation supplement growth and the government fee increase we get each

year that we expect this year to be higher than CPI.

On the horizon, and not included in our outlook calculations, is an anticipated positive

outcome for nurses' pay equity, which has been discussed by the Labour Government over

the past year, and being pushed vigorously by the New Zealand Aged Care Association. We

also have further occupancy capacity and bed mix opportunities that will further grow

revenue and ensure that earnings for the current year remain achievable.

Moving to slide 24.

Slide 24 Thank you for joining our briefing today. We are looking forward to providing our investors

a strong 2022. Radius is the most experienced manager of the high-acuity aged care in New

Zealand in the care sector. This is a sector we deeply understand and excel at. Our

competitive advantages are our team, state of the art IT solutions and exceptional levels of

care. We see the industry dynamics offer strong growth opportunities, which we will

continue to capture. As Radius moves forward, our strategy as a listed company will be to

ensure clear pathways of growth through acquiring existing leased facilities and extending

them, opportunistic acquisitions of existing businesses from other operators and

undertaking greenfield developments, like what we're about to embark on in Christchurch.

I look forward to sharing our journey with you. Thank you for joining this briefing call. I will

now hand back to you, Harmony.

Operator Thank you. If you wish to ask a question, please press star one on your telephone and wait
for your name to be announced. If you wish to cancel your request, please press star two. If

you're on a speaker phone, please pick up the handset to ask your question. We'll now

pause a moment for any questions to register.

Once again, if you wish to ask a question, please press star one on your telephone and wait

for your name to be announced. Thank you. There are no further questions at this time. I'll

now hand back to Mr. Bilbrough for closing remarks.

Stuart Bilbrough: Thank you everybody for joining the call. We really appreciate you spending the time. This

is our first presentation as a listed company. We're very excited. If you've got any

questions, my details are on our website, and feel free to call me or drop me an email at

any time. Thanks a lot.

1/06/2021
1

Radius Residential Care Limited

Full Year 

Results

31 March 2021

Radius Care

2

Importance 

Notice and 

Disclaimer  

This presentation has been prepared by Radius Residential Care Limited (“Radius Care”), for informational purposes. This disclaimer

applies to this document and the verbal or written comments of any person presenting it.

This presentation sets out information relating to Radius Care’s full year result for the period to 31 March 2021. As such, it should

be read in conjunction with the audited consolidated financial statements for Radius Care and its subsidiaries for the period ended

31 March 2021 (“Financial Statements”) and other material that Radius Care has released to NZX along with this presentation. That

material is also available at www.radiuscare.co.nz.

In certain sections of this presentation, Radius Care has chosen to present certain financial information exclusive of the impact of

significant items. A number of non‐GAAP financial measures are used in this presentation which are used by management to assess

the performance of the business and have been derived from the Financial Statements. You should not consider any of these

financial measures in isolation from, or as a substitute for the information provided in the Financial Statements.

This presentation may contain forward‐looking statements and projections. Such forward‐looking statements are based on current

expectations, estimates and assumptions and are subject to a number of risks and uncertainties, including material adverse events,

significant one‐off expenses and other unforeseeable circumstances. There is no assurance that results contemplated in any of

these projections and forward‐looking statements will be realised. Actual results may differ materially from those projected. Except

as required by law, or the NZX Listing Rules, no person is under any obligation to update this presentation at any time after its

release or to provide further information about Radius Care.

The information in this presentation has been prepared in good faith by Radius Care. Neither Radius Care nor any of its directors,

employees, shareholders nor any other person given any representations or warranties (either express or implied) as to the

accuracy or completeness of the information in this presentation and to the maximum extent permitted by law, no such person

shall have any liability whatsoever to any person for any loss (including, without limitation, arising from any fault or negligence)

arising from this presentation or any information supplied in connection with it.

This presentation is not a product disclosure statement or other disclosure document, or an offer of shares for subscription, or sale,

in any jurisdiction. The information in this presentation does not constitute financial product, legal, financial, investment, tax or any

other advice or a recommendation.

Radius Care

3

Radius Care

4

Presenting Today

Brien Cree

Executive Chairman / Managing Director

•Founded Radius Care in 2003, then part of 

Radius Health Group

•Moved into Executive Chairman role in 

June 2020 focusing on growth 

opportunities through development and 

acquisition

•Majority shareholder since undertaking 

management buy out in 2010 and currently 

holds 54.0% through Wave Rider Trust

•Board member of the New Zealand 

Aged 

Care Association for more than 10 years

•Over 30 years’ experience in the Aged Care 

sector

Stuart Bilbrough

Chief Executive Officer

•Appointed Chief Executive Officer in 

June 2020

•Formerly Radius Care Chief Financial 

Officer from 2010 to 2017

•Over 30 years’ experience in finance 

roles in industries including 

healthcare, FMCG, logistics, telecoms 

and financial services

•New Zealand Chartered Accountant 

and holds an MBA with distinction 

from Massey University.

•Joined Radius Care in 2016

•Has nearly 25 years’ experience in 

finance roles in various 

•Industries worked in include 

healthcare and financial services

•Michelle trained with 

PricewaterhouseCoopers in South 

Africa

•She is a New Zealand Chartered 

Accountant.

Michelle Slabber

General Manager, Finance

Radius Care

5

Radius Care 

at a Glance 

HIGH ACUITY AND 

SPECIALIST AGED 

CARE PROVIDER

Radius Care operates 22 aged 

care facilities nationally, 

comprising more than 1,700 

aged care beds.  

We own three of these facilities 

and lease 19 from 3rd party 

property investors.  

We also own two retirement 

villages comprising of 76 units.

Radius Care OwnedLeased from 3

rd

Parties*

Total

Existing Portfolio

Sites51924

Aged Care Beds1781,5371,715

Retirement Village Units

1

76-76

Total Places2541,5371,791

Existing Facility - Landbank

Aged Care Beds4460104

Retirement Village Units202040

Belfast, Christchurch194-194

Total Existing + Landbank5121,6172,129

* All leases are triple net lease and long term in nature ‐with an average term to next renewal of 9.1 years but 27.7 years after 

accounting for all renewals. 

Portfolio summary as at 31 March 2021Portfolio summary as at 31 March 2021

Radius Care 

announced on 7 April 

2021 the exercise of 

its option to acquire 

4.3 hectares of 

development land in 

Christchurch 

Note: As part of its December 2020 listing Radius Care prepared:

•A Listing Profile (which contains similar information to a Product Disclosure Statement) providing an overview of the business, the industry, risks and financial performance.

•Supplementary Financial Information providing more granular financial and operational information.

This information is contained on the 

Radius Care website https://www.radiuscare.co.nz/investors‐centre/listing‐documents

Radius Care

6

4.2% 95.8% 

UnitsCare Beds

Radius Care

at a Glance 

National aged care focused portfolio with strong regional presenceNational aged care focused portfolio with strong regional presence

Residents and EmployeesResidents and Employees

1,500+ 

employees

1,700+ 

beds

Denotes leasehold sitesDenotes freehold sites

AUCKLAND

SitesBedsILUsTotal

Leased3248‐248

WAIKATO

SitesBedsILUsTotal

Leased4334‐334

Owned1‐2222

NEW PLYMOUTH

SitesBedsILUsTotal

Leased155‐55

Owned163‐63

NORTHLAND

SitesBedsILUsTotal

Leased3155‐155

BAY OF PLENTY

SitesBedsILUsTotal

Leased2266‐266

Owned163‐63

NAPIER

SitesBedsILUsTotal

Leased145‐45

PALMERSTON NORTH

SitesBedsILUsTotal

Leased162‐62

CANTERBURY

SitesBedsILUsTotal

Leased3279‐279

Owned25254106

Units vs Care BedsUnits vs Care Beds

OTAGO

SitesBedsILUsTotal

Leased193‐93

1/06/2021
2

Radius Care

7

Agenda

Appendix

—Key operational and 

financial metrics

—Summary P&L, Balance 

Sheet, Cash Flow

44

Overview 

of FY21 financial 

performance 

First year as a listed 

company

22

Analysis of result

Continuation of strong track 

record

33

Positioning Radius Care 

for Growth phase, 

strategy update and 

FY22 guidance

11

Radius Care

8

Overview of 

FY21 Financial

Performance

FIRST YEAR AS A LISTED 

COMPANY

Radius Care

9

FY21 Highlights 

and Key Events

FY21 Guidance provided at 

the time of listing met or 

exceeded across all metrics.

Progress on Strategy

‐Option exercised to purchase 4.3 hectares of Greenfield 

Development land in Belfast, Christchurch post balance date

1

‐Increases Greenfield Development pipeline by 70 Care Beds, 

30 Care Suites and 94 Retirement Village Units

‐Work progressing on final design, building consents and 

construction discussions

‐Multi‐stage development approach provides funding 

flexibility

Progress on Strategy

‐Option exercised to purchase 4.3 hectares of Greenfield 

Development land in Belfast, Christchurch post balance date

1

‐Increases Greenfield Development pipeline by 70 Care Beds, 

30 Care Suites and 94 Retirement Village Units

‐Work progressing on final design, building consents and 

construction discussions

‐Multi‐stage development approach provides funding 

flexibility

Financial Performance

‐Record result ‐all guidance metrics met or exceeded

‐Underlying EBITDA up 28% to $23.4m (vs. guidance of $23.0m 

to $23.8m)

‐Underlying EBITDA per bed up 13% to $19.5k

‐Continued strong occupancy, private accommodation 

supplements and cost control

Financial Performance

‐Record result ‐all guidance metrics met or exceeded

‐Underlying EBITDA up 28% to $23.4m (vs. guidance of $23.0m 

to $23.8m)

‐Underlying EBITDA per bed up 13% to $19.5k

‐Continued strong occupancy, private accommodation 

supplements and cost control


See NZX release dated 7 April 2021 

Radius Care

10

Enhanced management 

and governance for listing

‐Brien Cree transitioned in 

Executive Chairman role focused 

on growth opportunities through 

development and acquisition

‐Stuart Bilbrough returned as CEO

‐Hamish Stevens and Mary 

Gardiner appointed as 

independent directors

‐Direct listing undertaken on 10 

December 2020

Enhanced management 

and governance for listing

‐Brien Cree transitioned in 

Executive Chairman role focused 

on growth opportunities through 

development and acquisition

‐Stuart Bilbrough returned as CEO

‐Hamish Stevens and Mary 

Gardiner appointed as 

independent directors

‐Direct listing undertaken on 10 

December 2020

COVID‐19 resilience

‐Processes and procedures 

introduced in mid‐2000s for 

Bird Flu performed well 

through COVID‐19 period

‐Locked down facilities early 

with industry following

‐No COVID‐19 cases amongst 

residents or staff 

1

COVID‐19 resilience

‐Processes and procedures 

introduced in mid‐2000s for 

Bird Flu performed well 

through COVID‐19 period

‐Locked down facilities early 

with industry following

‐No COVID‐19 cases amongst 

residents or staff 

1

Balance Sheet Position

‐Net debt of $24.5m down $4.7m 

from pcp (31 March 20)

‐Lease liabilities of $184.3m down 

from $185.3m for pcp

Balance Sheet Position

‐Net debt of $24.5m down $4.7m 

from pcp (31 March 20)

‐Lease liabilities of $184.3m down 

from $185.3m for pcp

Balance Sheet Position

‐Net debt of $24.5m down $4.7m 

from pcp (31 March 20)

‐Lease liabilities of $184.3m down 

from $185.3m for pcp

FY21 highlights 

and key events

FY21 Guidance provided at 

the time of listing met or 

exceeded across all metrics.


As at the date of this presentation

Radius Care

11

7.7

8.0

5.8

10.5

0.0

2.0

4.0

6.0

8.0

10.0

12.0

$m

FY18FY19FY20FY21

Financial performance overview

FY21 Underlying EBITDA and Pre‐NZ IFRS 16 Underlying EBITDA within Guidance range provided at time of listing

Pre‐NZ IFRS 16 Underlying EBITDA

‐FY21 Pre‐NZ IFRS 16 Underlying EBITDA 

of $10.5m up 82%

FY21 guidance range $10.2m –11.0m

Underlying EBITDA

‐FY21 Underlying EBITDA of $23.4m up 

28%

FY21 guidance range $23.0 ‐$23.8m

FY21 Guidance achievedFY21 Guidance achieved

19.7

20.4

18.2

23.4

0.0

5.0

10.0

15.0

20.0

25.0

$m

FY19FY18FY20

FY21

Total Revenue

‐FY21 Revenue of $126m up 11%

$m

100.2

110.1

113.7

126.0

0.0

20.0

40.0

60.0

80.0

100.0

120.0

140.0

FY19FY20FY21FY18

Radius Care

12

Cash Flow and Dividends

AFFO

‐FY21 AFFO of $3.7m

‐Outperformance partly due to lower maintenance capex 

Achieved AFFO in excess of FY21 Guidance

Dividends

FY21 Final Dividend

‐Gross fully imputed FY21 final dividend declared of 

0.89 cents per share (which includes 0.25 cents per 

share of attaching imputation credits)

‐Ex Dividend date Friday 11 June 2021

‐Record date Monday 14 June 2021

‐Payment date Monday 21 June 2021

FY21 Total Dividends

‐Including February dividend of 

0.58 cents per share 

gives a total gross dividend in relation to the FY21 

financial year of 1.46 cents per share (which includes 

attaching imputation credits of 0.41 cents per share)

‐The total FY21 cash dividend of 1.05 cents per share is 

above the FY21 cash dividend guidance of 0.83 to 1.00

 

cents per share

FY21 Guidance exceeded

FY21 guidance range $2.9m to $3.5m

1.3

2.0

(0.5)

3.7

(1.0)

0.0

1.0

2.0

3.0

4.0

$m

FY18FY19FY20FY21

Radius Care’s dividend policy is target to pay 50% to 70% of AFFO

1/06/2021
3

Radius Care

13

Summary of Key Drivers of FY21 Financial Performance

Strong growth in Underlying EBITDA driven primary by (1) improving care occupancy (2) increasing 

accommodation supplements (3) cost control containment and (4) contributions from new developments

Aged Care: $4.3m

‐Bureau: $1.6 million improvement 

through strong cost control focus

‐Brownfield and Greenfield 

Developments contribution: $0.8 

million from Windsor Court 

Brownfield development ($0.6m) 

and Glaisdale (Hamilton) 

Greenfield development ($0.2m)

‐Other aged care: $1.9 million. 

Primarily driven by the increase in 

occupancy $0.7m, 

accommodation supplements 

$0.7m and other $0.4m

Retirement Village: $0.7m

‐Compounding impact of DMF and 

additional unit sales

Group Support: $0.2m

‐Reduced travel as a result of 

COVID‐19 disruptions 

$1.6 

$0.8 

$0.7 

$0.7 

$0.4 

$0.4 

$0.4 

$0.2 $(0.1)

$18.2 

$23.4 

 17.0

 19.0

 21.0

 23.0

 25.0

FY20 Underlying

EBITDA

Bureau costsBrownfield &

Greenfield

Developments

Occupancy Accommodation

supplements

Other aged care

operations

DMF and weekly

service fees

Realised Gains on

Resales and

Development

Margin

Other village

operations

Support office

expenses

FY21 Underlying

EBITDA

NZ$m

Aged careRetirement village

Group 

support

Radius Care

14

Analysis of result 

CONTINUATION OF STRONG 

TRACK RECORD

Radius Care

15

Strong revenue growth continues with an increasing proportion from direct private (non‐Government) revenue streams

Revenue Growth and Diversification 

65.4

70.370.0

76.1

87.0

100.2

110.1

113.7

126.0

0.0

20.0

40.0

60.0

80.0

100.0

120.0

140.0

FY13FY14FY15FY16FY17FY18FY19FY20FY21

Total revenueAged careRetirement villageGroup support

End of Financial 

period

FY13FY14FY15FY16FY17FY18FY19FY20FY21

No. of Beds

1,3071,3821,3711,3791,5251,6821,7011,7041,715

No. of Units

222222364855637376

Total revenue Total revenue Direct private (non‐Government) revenue

1

Direct private (non‐Government) revenue

1


Includes accommodation supplements, retirement village units, Radius Online Shop and other privately paid revenues

2.2 

3.0 3.0 

4.5 

6.2 

7.1 

10.1 

9.2 

13.8 

3.4% 

11.0%

0.0%

2.5%

5.0%

7.5%

10.0%

12.5%

0.0

2.5

5.0

7.5

10.0

12.5

15.0

FY13FY14FY15FY16FY17FY18FY19FY20FY21

Proportion

 

of

 

total

 

revenue

 

(%)

Direct

 

Private

 

Revenue

 

(NZ$m)

Direct private revenue (LHS)

Direct private proportion of total revenue (RHS)

Radius Care

16

Bed Mix Oriented to High Acuity and Specialist Care

Over FY21, beds certified for high acuity and specialist care have increased from 82% to 86% of the portfolio. Radius Care 

continues to provide more care offerings and in particular more specialist care offerings per facility than peers.

Care Beds by use and typeCare Beds by use and type

1 Source: CBRE analysis, September 2020

2 Source: Ministry of Health audit reports as disclosed on Ministry of Health website –https://www.health.govt.nz/your‐health/certified‐providers/aged‐care/based on data as at 4 May 2021

3 Dementia and Specialist offerings include Dementia, Psychogeriatric, Physical and Intellectual but does not include Rest Home or Hospital – Geriatric or Hospital –Medical care. Average based on simple average of all certified facilities

3.9 

3.2 3.2 

3.0 

3.6 

Radius Oceania Arvida Summerset Ryman

0.9

0.5

0.5

0.2

0.8

Radius Oceania Arvida Summerset Ryman

Total and specialist offerings

2

Total and specialist offerings

2

Total offerings aged care

(per Aged Care facility)

Dementia and Specialist offerings

3

(per Aged Care facility)

Care bed 

type

Care bed 

use

47.1%38.1%11.1%3.6%

Industry 

average

1

17.9%

14.4%

34.1%

41.4%

30.3%

26.5%

10.3%

11.1%

6.6%

5.7%

0.8%

0.9%

FY20

FY21

85.6% high acuity and specialist

52.9% high acuity and specialist

34.4%

32.8%

47.9%

49.6%

10.2%

10.8%

6.3%

5.8%

1.2%

1.0%

FY20

FY21

Rest homeSwingHospitalDementiaPsychogeriatricPhysical and intellectual

65.6% high acuity and specialist

67.2% high acuity and specialist

82.1% high acuity and specialist

Radius Care

17

Strong Occupancy Growth

1. Aging New Zealand population

1

1. Aging New Zealand population

1

Growing Occupancy v.s. industry

3

Growing Occupancy v.s. industry

3

3. Increasing years in dependency3. Increasing years in dependency

•Life expectancy is increasing but more years are being spent in dependency

90.1%

89.2%

89.1%

90.4%

90.9%

91.3%

91.0%

92.1%

93.0%

93.7%

93.4% as 

at 31 

March 

2021

87.2%

87.2%

86.9%

86.5%

86.9%

87.0%

86.8%

87.6%

87.9%

87.8%

85.0%

86.0%

87.0%

88.0%

89.0%

90.0%

91.0%

92.0%

93.0%

94.0%

95.0%

Jun‐19Sep‐19Dec‐19Mar‐20Jun‐20Sep‐20Dec‐20Mar‐21

Occupancy

 

rate

 

%

 

Radius Care (monthly)Industry average (quarterly)

0.0%

2.0%

4.0%

6.0%

8.0%

Jan‐03 Jan‐08 Jan‐13 Jan‐18 Jan‐23 Jan‐28 Jan‐33 Jan‐38 Jan‐43 Jan‐48 Jan‐53 Jan‐58

Rolling

 

5


year

 

pop.

 

CAGR

 

(%)

65 ‐ 85 5‐yr CAGR85+ 5‐yr CAGR

Aged care demand peak growth 

from 2023 ‐2043

Occupancy growth underpinned by supportive industry backdrop of (1) aging population (2) increasing bed demand 

particularly for high acuity and specialist care and (3) rising years in spent in dependency 

Increasing number of high occupancy facilitiesIncreasing number of high occupancy facilities

88

7

11

9

3

7

7

5

4

2

5

6

4

2

0

5

10

15

20

25

FY18FY19FY20FY21

Number

 

of

 

Facilities

95.0% to 100%90.0% to 94.9%85.0% to 89.9%<85%

1 Source: Statistics New Zealand

2 Source: EY Aged Residential Care Funding Model Review analysis using ARC model, August 2019. Historical information based on actual demand data per the ARC demand model which EY have extended using the past 5 year trend over the projection period

3 Source: Industry Information based on

 NZACA Occupancy –TAS Aged Residential Care Quarterly Reporting Survey as at 31 December 2020. Includes ORA ARRC‐certified beds and residents 

2. Increasing high acuity bed demand

2

2. Increasing high acuity bed demand

2


2,000

4,000

6,000

8,000

20062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028202920302031

ActualProjection

Bed

 

days

 

(000s

 

of

 

days)

DementiaHospitalPsychogeriatricResthome

Radius Care

18

Growing Underlying EBITDA per Care Bed

Underlying EBITDA per Care Bed ($000)

Strong Occupancy (see previous page)

Increasing Underlying EBITDA per care bed

1

Increasing Underlying EBITDA per care bed

1

Growing accommodation supplementsGrowing accommodation supplements

Strong wage controlStrong wage control

18.3

17.9

17.2

19.5

0.0

5.0

10.0

15.0

20.0

FY18FY19FY20FY21

51.9 

57.6 

62.8 

64.4 

52.9%

54.1%

56.1%

53.9%

0.0%

10.0%

20.0%

30.0%

40.0%

50.0%

60.0%

0.0

10.0

20.0

30.0

40.0

50.0

60.0

70.0

FY18FY19FY20FY21

$m

Direct Employee Costs% of Direct Revenue

$3.03 

$4.07 

$4.92 

$5.61 

$1,819 

$2,400 

$2,902 

$3,300 

0

500

1,000

1,500

2,000

2,500

3,000

3,500

0.0

1.0

2.0

3.0

4.0

5.0

6.0

FY18FY19FY20FY21

Accommodation

 

supplement

 

per

 

Care

 

Bed

  

NZ$

Accommodation

 

supplements

  

NZ$m

Accommodation supplements (LHS)Accommodation supplements per available Care Bed (RHS)

1 Underlying EBITDA for aged care segment divided by the average number of care beds occupied during the period 

1/06/2021
4

Radius Care

19

Positioning Radius 

Care for Growth 

Phase, Strategy 

Update and FY22 

Guidance

Radius Care

20

Senior management and board strengthened 

and sized for next phase of growth.

Positioning 

Radius Care for 

Growth Phase

‐Brien Cree transitioned to Executive Chairman role 

focused on growth opportunities through 

development and acquisition

‐Stuart Bilbrough returned as CEO (previously CFO 

from 2010 to 2017)

‐Hamish Stevens and Mary Gardiner appointed as 

independent directors

‐Employee turnover reduced vs. FY20

‐A focus on employees continuing professional 

development and ongoing property 

investments 

that enhances accommodation supplement 

revenue is a focus for the coming year

Radius Care

21

GO FORWARD STATERGYHISTORICAL TRACK RECORDCURRENT STATUS

1. Brownfield development

•Windsor Court (FY18) –15 Care Beds

•Waipuna (FY17) –28 Care Beds

•Elloughton Gardens (FY17) –27 Care Beds

Brownfield potential identified at owned sites at:

‐Lexham Park (Katikati)

‐Thornleigh (New Plymouth)

Detailed feasibility studies underway

2. Purchase of strategically 

important facilities already 

operated by Radius

•Lexham Park

 (FY20) –63 Care Beds

•Thornleigh Park (FY14) –63 Care Beds

•St Helenas (FY14) –52 Care Beds

Continuing work to identify strategically important facilities

3. Greenfield development

Greenfield Development on owned facilities undertaken and funded by 

Radius Care:

•Elloughton Grange Village (FY21) –54 Units

Greenfield Development on leased facilities undertaken with and funded 

by 

landlords:

•Glaisdale (FY18) –80 Care Beds

•Millstream (FY18) –80 Care Beds

Purchase of Belfast, Christchurch Greenfield development land

•As announced in April 2021, Radius Care has exercised its right 

to acquire c. 4.3 hectares of land 

•Settlement of the land ($5.5m) is expected to take place 

between December 2021 and March

 2022

•Work progressing on final design, building consents and 

construction discussions

•Multi‐stage program provides funding flexibility

4. Opportunistic value accretive 

acquisition

•Acquired the operations of 26 aged care facilities and retirement 

villages comprising 1,998 Residences since 2003

•Continuing to seek and evaluate potential acquisition 

opportunities

Strategy Update

Focus continues on the execution of Radius Care’s growth strategy, with the exercise of Radius Care’s option to acquire the 

4.3 hectare Belfast, Christchurch site being a key milestone since Listing



Execution of strategy



Growth Strategy as outlined in the Listing Profile

Radius Care

22

Radius Care

23

Aged Care

•Average occupancy expected to increase further in FY22 given current run 

rate

•Continued accommodation supplements growth in FY22 expected 

•Additional funding from the Government as part of the Equal Pay claim 

for Health Care Assistants 

•Operating costs will increase with staffing wage growth but wages to 

revenue expected to 

remain stable

•Conversion of Dementia rooms at Arran Court

Retirement village

•Sale of final 4 units at Elloughton Grange Village expected

•Resale of 5 units expected

Guidance for the

12 months to 31 March 2022 

demonstrates expected 

continued earnings uplift.

FY22 Outlook 

and Guidance

Guidance

FY21Listing Profile FY21FY22

Actual ($m)Guidance ($m)Guidance ($m)

Underlying EBITDA 23.423.0 ‐23.823.5 – 25.5

Pre‐NZ IFRS 16 Underlying 

EBITDA

10.510.2 ‐11.010.5 – 12.5

AFFO3.72.9 ‐3.53.7 –4.7

Radius Care

24

Radius Care provides unique exposure to a high acuity, specialised care provider that remains committed to and 

focused on delivering compassionate and outstanding clinical care outcomes

1. Demand 

2. Portfolio

3. 

Systematic 

Approach

4. Growing 

Non‐

Government 

Revenues

5. Growth 

Pathway

6. Strong 

Founder 

Backed 

Team

KeyInvestmentHighlights

0.0%

2.0%

4.0%

6.0%

8.0%

2003 2008 2013 2018 2023 2028 2033 2038 2043 2048 2053 2058

Rolling

 

5


year

 

pop.

 

CAGR

 

(%)

65 ‐ 85 5‐yr CAGR85+ 5‐yr CAGR

1

Demand underpinned by population demographics

1

3.9 

3.2 3.2 

3.0 

3.6 

RadiusOceaniaArvidaSummersetRyman

2

Portfolio oriented to high acuity and specialist care

2

Systematic approach to provision of care

1) Centralised head‐office systems and support

2) Leading IT systems

3) Immigration accreditation 

4) Early engagement through Radius Online Shop

3

3.4% 

11.0%

0.0%

2.0%

4.0%

6.0%

8.0%

10.0%

12.0%

FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Direct

 

private

 

portion

 

of

 

total

 

revenue

 

(%)

Growing direct non‐Government revenues

4

5

Clear growth pathway via

1) Purchase of strategically important 

facilities’ land and buildings

2) Brownfield and greenfield development 

with ownership of land and buildings

3) Opportunistic acquisitions

Strong founder backed team

Brien Cree

Founder and Executive Chairman

Stuart Bilbrough

Chief Executive Officer

6

1 Source: Statistics New Zealand

2 Source: Ministry of Health audit reports as disclosed on Ministry of Health website –https://www.health.govt.nz/your‐health/certified‐providers/aged‐care/based on data as at 4 May 2021

3 Includes accommodation supplements, retirement village units, Radius Online Shop and other privately paid revenues

1/06/2021
5

Radius Care

25

Appendix

Radius Care

26

Financial periodFY18FY19FY20FY21

$m

Aged Care

27.227.226.330.6

Retirement Village

0.30.80.81.4

Group support

(7.8)(7.6)(8.9)(8.7)

Underlying EBITDA 

19.720.418.223.4

Key operational and financial metrics

Financial periodFY18FY19FY20FY21

Number of Care Beds (period end)

1

1,6821,7011,7041,715

Average Care Bed Occupancy

2

89.1%89.5%90.092.4%

Underlying EBITDA per Care Bed

3

(000s)$18.3$17.9$17.2$19.5

Number of Units (period end)

4

55637376

Number of new Unit sales 9118 6

Number of existing Unit resales23‐7

Realised gains on resales (m)$0.2$0.1‐$0.5

Realised development margins (m)$0.2$0.5$0.4$0.3

Cash DMF realised upon resale (000s)$67$66‐$525

Average resale price (000s)$323$355‐$407

Average new unit sale price (000s)$395$377$403$408

Operating metricsOperating metrics

1 Comprises Care Beds occupied, available to be occupied or unavailable due to refurbishment

2 Total occupied Care Bed days divided by total Care Bed days available during the period

3 Underlying EBITDA for aged care (as set out in the lower right table) divided by the average number of Care Beds

 occupied during the period

4 Comprises Units occupied, available to be occupied or unavailable due to refurbishment 

Financial periodFY18FY19FY20FY21

Accommodation Supplements Revenue

$3.0m$4.1m$4.9m$5.6m

Number of Care Beds

1,6821,7011,7041,715

Number of Available Care Beds with Accommodation Supplements

1,0051,1341,1381,146

Percentage of Care Beds with Accommodation Supplements

59.8%66.7%66.8%66.8%

Accommodation supplementsAccommodation supplements

Financial periodFY18FY19FY20FY21

$m

Aged Care

98.8107.3112.6120.3

Retirement Village

1.32.30.54.4

Group support

0.10.50.61.3

Total revenue

100.2110.1113.7126.0

Revenue by segmentRevenue by segment

DMF terms for Retirement Village unitsDMF terms for Retirement Village units

•30% over three years

•FY20 –21 average resident tenure: 4 years

Underlying EBITDA by segmentUnderlying EBITDA by segment

Corporate function growth from FY19 to FY20 and FY21 reflects strengthening of senior management and board for 

next phase of growth. 

Radius Care

27

Underlying EBITDA to AFFO Reconciliation

($m)FY18FY19FY20FY21

Underlying EBITDA19.720.418.223.4

Include: Pre‐NZ IFRS 16 operating rental lease expense(12.0)(12.4)(12.4)(12.9)

Pre‐NZ IFRS 16 Underlying EBITDA7.78.05.810.5

Include: Depreciation and amortisation (Pre‐NZ IFRS 16)(3.0)(3.6)(3.7)(4.3)

Include: Net interest expense (Pre‐NZ IFRS 16)(0.6)(0.9)(1.2)(0.8)

Include: Current tax expense(0.9)(0.7)(1.0)(2.1)

Include: Income tax impact from Pro forma adjustments0.20.20.3(0.3)

Pre‐NZ IFRS 16 Underlying NPAT3.43.00.23.0

Remove: Depreciation and 

amortisation (excl. NZ IFRS 16 

related)

3.03.63.74.2

Include: Maintenance capital expenditure(5.1)(4.6)(4.4)(3.5)

AFFO1.32.0(0.5)

1

3.7

AFFO outperformance in part due to maintenance capex below historical levels

Refer to Note 2.1 in the 31 March 2021 Annual Report for reconciliation of Underlying profit to Reported net profit after tax – see Appendix attached


The +$4.2m change in AFFO in FY2021 is calculated on AFFO for FY2020 of $(0.5)m, which has been revised from the FY2020 AFFO of $0.8m shown in the 10 December 2020 NZX Listing Profile due to a reclassification of the deferred tax on 

the FY2020 revaluation of the three owned properties.

  The impact of this reclassification was an increase of $1.339m in FY2020 current tax and a corresponding decrease of $1.339m in FY2020 deferred tax. There is no impact on AFFO in 

any other period and there is no impact going forward.

Capex 

maintenance 

guidance is 

$4.0m

Radius Care

28

Statement of Comprehensive Income

($000)FY20FY21

Revenue

Revenue from contracts with customers113,359121,217

Deferred management fees6711,081

Total revenue114,030122,298

Fair value movement of investment properties(649)2,879

Government subsidy received353794

Interest income4971

Total revenue and other income113,783126,042

Expenses

Employee costs(70,852)(74,457)

Depreciation expense(10,911)(11,552)

Finance costs(10,583)(9,706)

Other expenses(24,770)(28,298)

Total expenses(117,116)(124,013)

Profit / (loss) before income tax(3,333)2,029

Income tax (expense) / benefit 500(324)

Profit / 

(loss) for the year(2,833)1,705

Other comprehensive income

Items that will not be reclassified subsequently to profit and loss

Revaluation of property, plant and equipment, net of tax5,7081,104

Other comprehensive income for the year5,7081,104

Total comprehensive income 2,8752,809

Radius Care

29

Statement of Financial Position

($000)FY20FY21

Assets

Cash and cash equivalents2,3172,761

Trade and other receivables7,6487,744

Inventories308548

Property, plant and equipment32,30332,896

Right‐of‐use assets181,431177,170

Investment properties27,83131,675

Deferred tax assets2,0063,635

Intangible assets16,99616,996

Total assets270,840273,425

Liabilities

Trade and other payables14,08614,911

Current tax liabilities7231,135

Borrowings31,42727,212

Deferred management fee9621,178

Refundable occupation right agreements17,51820,591

Lease liabilities185,304184,305

Total liabilities250,020249,332

Net assets20,82024,093

Equity

Share capital4,7365,932

Asset revaluation5,7086,812

Retained earnings10,37611,349

Total equity20,82024,093

Radius Care

30

Statement of Cash flows

($000)FY20FY21

Cash flow from operating activities

Receipts from residents for care fees and village fees113,282122,337

Receipts of government subsidy‐1,210

Payments to suppliers and employees(95,436)(101,724)

Proceeds from the sale of Refundable occupation right agreements3,7053,927

Payments for the repurchase of Refundable occupation right agreements‐(464)

Interest received4971

Interest paid – borrowings(1,183)(883)

Interest paid –lease liabilities(9,400)(8,823)

Income tax paid (814)(1,744)

Net cash provided by operating activities10,20313,907

Cash flow from investing activities

Proceeds from the sale of property, plant and equipment11454

Payments for the purchase of plant and equipment(11,305)(3,577)

Payments for village developments(3,723)(965)

Net cash used in investing activities(14,914)(4,488)

Cash flows from financing activities

Proceeds from bank borrowings15,120‐

Repayments

 of bank borrowings4,038(4,215)

Repayments of shareholder loans(5,030)‐

Principal repayment of lease liabilities(3,035)(4,028)

Dividends paid(225)(732)

Net cash (used in) / provided by financing activities2,792(8,975)

Reconciliation of cash and cash equivalents

Cash and cash equivalents at beginning of the year4,2362,317

Net increase / (decrease) in cash held(1,919)444

Cash and cash equivalents at 

end of year2,3172,761

1/06/2021
6

Radius Care

31

Reconciliation of NZ GAAP financial measures to non‐GAAP financial measures

($000)FY20FY21

Profit/(loss) for the year(2,833)1,705

Adjustments

Non‐recurring or infrequent items

Remove: COVID‐19 related expenses34653

Remove: Government COVID‐19 Subsidy(353)(857)

Remove: One‐off listing costs‐1,227

Remove: Share based payments‐1,464

Structural changes and other

Include: Listed & other company costs(1,084)(714)

Remove: Historical governance costs350417

Include: Income tax impact from adjustments295(270)

Underlying adjustments

Remove: Change

 in fair value of investment properties649(2,879)

Include: Realised development margins512343

Include: Realised gains on resales‐480

Remove: Deferred tax expense(1,533)(1,831)

Underlying Net profit before tax(3,963)(262)

Remove: Depreciation10,91111,552

Remove: Net interest expense10,5349,636

Remove: Current tax expense1,0332,155

Remove: Income tax impact from adjustments(295)270

Underlying EBITDA18,22023,351

Include: Pre‐NZ IFRS 16 operating lease expense

(12,435)(12,850)

Pre‐NZ IFRS 16 Underlying EBITDA5,78510,501

Include: Depreciation (Pre‐NZ IFRS 16)(3,700)(4,262)

Include: Net interest expense (Pre‐NZ IFRS 16)(1,134)(812)

Include: Current tax expense(1,033)(2,155)

Include: Income tax impact from adjustments295(270)

Pre‐NZ IFRS 16 Underlying Net profit after tax2133,002

Remove: Depreciation (excl. NZ IFRS 16 related)3,7004,262

Include: Maintenance capital expenditure(4,400)(3,543)

AFFO(487)3,721

Radius Care

32

$0.1 

$0.1 

$(0.8)

$(0.2)$(0.1)

$(0.6)

$(0.7)

$20.4 

$18.2 

 17.0

 19.0

 21.0

FY19 Pro forma

Underlying EBITDA

Brownfield &

Greenfield

Developments

BureauOther aged care

operations

DMF and weekly

service fees

Realised Gains on

Resales and

Development

Margin

Support office

personnel costs

Support office

other expenses

FY20 Pro forma

Underlying EBITDA

NZ$m

Aged careRetirement villageGroup support

Historical Pro forma Underlying EBITDA –FY19 to FY20

Note: Extract from the NZX Listing Profile of 10 December 2020

Radius Care

33

Leased facilityLocationCare BedsUnitsCurrent lease term Time to next renewal Rights of renewal Time to final expiry Landlord

HeatherleaNew Plymouth55‐12 yrs5 yrs3 x 12 yrs41.1 yrsA

Taupaki GablesKumeu60‐12 yrs5 yrs3 x 12 yrs41.1 yrsA

Windsor CourtOhaupo76‐12 yrs5 yrs3 x 12 yrs41.1 yrsA

Elloughton GardensTimaru86‐12 yrs5 yrs3 x 12 yrs41.1 yrsA

KensingtonHamilton96‐10 yrs3.2 yrs2 x 10 yrs13.2 yrsB

PeppertreePalmerston North62‐10 yrs3.7 yrs2 x 10 yrs13.7 yrsB

St

 JoansHamilton82‐10 yrs4.1 yrs2 x 10 yrs14.1 yrsB

Fulton HomeDunedin93‐10 yrs4.6 yrs2 x 10 yrs14.6 yrsB

Arran CourtAuckland102‐10 yrs8.3 yrs1 x 10 yrs18.3 yrsB

Potter HomeWhangarei55‐20 yrs8.6 yrs2x 15 yrs38.6 yrsC

Rimu ParkWhangarei55‐20 yrs8.6 yrs2x 15 yrs38.6 yrsC

WaipunaAuckland86‐30 yrs25.9 yrs‐25.9 yrsD

Hampton CourtNapier45‐10 yrs7.9 yrs‐

7.9 yrsE

BaycareNorthland45‐12 yrs5 yrs3x 12 yrs41.1 yrsF

MatuaTauranga149‐30 yrs21.7 yrs‐21.7 yrsG

AlthorpTauranga117‐15 yrs7.5 yrs3x 10 yrs37.5 yrsH

MillstreamAshburton80‐35 yrs30.3 yrs‐30.3 yrsI

Millstream ApartmentsAshburton19‐5 yrs3.5 yrs2x 5 yrs13.5 yrsI

GlaisdaleHamilton80‐15 yrs11.2 yrs2x 15 yrs41.2 yrsJ

HawthorneChristchurch94‐10 yrs9.1 yrs2x 10 yrs19.1 yrsK

Total leased1537‐n/an/an/an/a

Simple average

 leased77‐15 yrs9.1 yrsn/a27.7 yrs

Owned facility/village

St HelenasChristchurch52‐n/an/an/an/an/a

Thornleigh ParkNew Plymouth63‐n/an/an/an/an/a

Lexham ParkKatikati63‐n/an/an/an/an/a

Windsor Court VillageOhaupo‐22n/an/an/an/an/a

Elloughton Grange VillageTimaru‐54n/an/an/an/an/a

Total owned17876

Total171576

Directory of facilities

Radius Care

34

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.